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6Abstract
Background
Mental stress is a recognized risk factor and trigger for heart disease. Socioeconomic
status (SES) is associated with morbidity and mortality, with low SES people having
poorer health compared to their counterparts. I hypothesised that those two factors
may interact with each other, so that when they are present simultaneously the total
harmful effect is more than the sum of the two risk factors alone.
Research aim
My aim was to test whether lower SES interacts with mental stress and amplifies its
effect on heart disease, so that the effect of mental stress on heart disease would be
more pronounced in people from low SES backgrounds.
Studies
I carried out three studies. For my first study, I analysed data from a cross-sectional
study involving about 500 disease-free middle/old-aged men and women drawn from
the Whitehall II epidemiological cohort. I evaluated their salivary cortisol responses
to standardized mental stress tests (exposure variable) and their cardiac troponin T
plasma concentration (a marker of heart damage) using a high-sensitivity assay (HS-
CTnT, outcome variable). I also used measures of coronary calcification levels using
electron-beam dual-source computed tomography and Agatston scores. After
adjustment for demographic and clinical variables associated with heart disease as
well as for inflammatory factors, I found a robust association between cortisol
7response to mental stress and detectable troponin T (odds ratio [OR] =3.8, 95%
confidence interval [CI] =1.5-9.4, P =0.005). The association remained when I
restricted the analysis to participants without coronary calcification (n =222, OR =4.8;
95% CI =1.2-18.3; P =0.023) or when I further adjusted for coronary calcification in
participants with positive Agatston scores (n =286, OR =6.2, 95% CI =1.9-20.6; P
=0.003). In analyses stratified by SES, there was a trend showing that the lower the
SES was, the higher the OR, although this trend was not significant (P >0.05).
In my second study, I selected about 67,000 male and female participants from the
Health Survey for England who were 35 years or older, free of cancer and
cardiovascular disease at baseline, and living in private households in England from
1994 to 2004. Selection used stratified random sampling (hence representative of the
nation), and participants were linked prospectively to mortality records from the
Office of National Statistics (mean follow-up, 8.2 years). Mental stress was measured
using the 12-item General Health Questionnaire, and SES was indexed by
occupational class. The crude incidence rates for heart disease and all-cause
mortality of the cohort were 1.9 (95%CI =1.7-2.0) and 14.5 (95%CI =14.2-14.8) per
1,000 person-years. After adjustment for age and sex, mental stress was associated
with increased mortality rates. In a stratified analysis, the association of mental stress
with the outcomes differed with SES, with the strongest associations being observed
in the lowest SES categories (the adjusted P values for interaction were 0.012 for all-
cause mortality and 0.047 for heart disease mortality).
My third study involved about 80,000 post-menopausal women selected from the
United Kingdom Collaborative Trial of Ovarian Cancer Screening study, who were
followed up for about three years on average. Mental stress was measured using the
8hopelessness/helplessness index and incident heart disease was assessed using
hospital electronic records. The overall incidence rate of hospitalisation for acute
heart disease event was 2.7 per 1,000 person years (95% CI=2.5-3.0). The augmented
incidence for people who experienced mental stress was higher in people of low SES,
medium in people of medium SES, and lower in people of high SES (adjusted P value
for interaction =0.013).
Conclusion
These studies suggest that the interaction between socioeconomic status and mental
stress is associated with ischemic heart disease, in such a way that people in low
socioeconomic circumstances are more vulnerable to the negative effects of mental
stress. In other words, the harmful effect of mental stress for human cardiac health
may be modified by socioeconomic position and rendered more deleterious for
people from disadvantaged backgrounds. Further research is needed to disentangle
the dynamics of this effect amplification.
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Chapter 1 - Introduction
This PhD dissertation is based on original medical research developed within
University College London, department of Epidemiology and Public Health,
Psychobiology group. The main domain that this dissertation refers to is psycho-
neuro-endocrino-immunology (PNEI), which is a relatively new branch of medicine
that takes an interdisciplinary approach and tends to integrate human body systems,
organs, tissues, and cells into a whole dynamic system, and that has its focus on the
communication and interaction between the different parts of the human body
rather than on the structures and functions of the individual components. For this
research I have therefore used concepts and instruments that are pertinent to
different disciplines such as psychology, sociology, economics, immunology,
endocrinology, and cardiology, and hence the description of this work cannot follow
the ordered and hierarchical structure that is typical of research presentations that
are centred on single and clear domains. Consequently this introduction will only
describe scientific areas of interest that are relevant to my research aims, without
the intent of being systematic and exhaustive.
I will initially give a brief description of the cardiovascular system and introduce
cardiovascular disease (CVD) with a focus on acute myocardial infarction (AMI). I will
then bring in two factors that are pertinent to disciplines other than medicine and
that are relevant to AMI: mental stress (psychology and psychiatry) and socio-
economic status (sociology and economics). Afterwards, I will present literature
relevant to my research hypothesis. Finally, I will show the results of a systematic
literature review that has been carried out to check whether my research hypothesis
has already been addressed, in order not to duplicate existing evidence.
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1.1 The cardiovascular system
Within the human body, blood flows continuously. Its perpetual and cyclical
movement is necessary to supply body organs, tissues, and cells with oxygen and
nutrients, and to remove carbon dioxide and other waste substances from them at
the same time. Blood circulation occurs within a close network of organs and vessels
called the cardiovascular system. The heart, the arteries, the capillaries, and the veins
are the main components of the cardiovascular system, and the automatic pumping
activity of the heart is the principal determinant of blood circulation. The heart is a
hollow muscular organ divided into four chambers: the right atrium, the right
ventricle, the left atrium, and the left ventricle.1
A complete cardiac cycle within the cardiovascular system can be described as
follows. The venous blood, coming from all districts of the organism, reaches the
right atrium through two veins called venae cavae and then flows into the right
ventricle. From this chamber venous blood is pumped into the pulmonary artery that
goes inside the lungs and then splits into smaller and smaller arteries, similarly to the
trunk of a tree that splits into smaller and smaller branches. When, after a number of
subdivisions, those arteries reach the smallest calibre, they become capillaries, their
walls acquire new structural and functional characteristics so that the inside-outside
exchange becomes possible, and the blood acquires oxygen and eliminates carbon
dioxide. The capillaries then merge into larger and larger veins that finally form the
pulmonary vein that is connected to the left atrium, which receives oxygenated
blood. From the left atrium the blood moves into the left ventricle from which it is
pumped into an artery called the aorta. Smaller and smaller branches of the aorta
reach all peripheral organs (excluding the lungs) where they form nets of capillaries,
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from which oxygen and nutrients diffuse into tissues and cells, and into which carbon
dioxide and catabolites are disposed. Capillaries then merge together into larger and
larger veins that form the venae cavae, which are connected to the right atrium. The
superior vena cava carries venous blood coming from the upper body (mainly the
brain), whereas the inferior vena cava carries venous blood coming from the rest of
the body (see figures 1.1. and 1.2).1
Figure 1.1. Schematic diagram of the pulmonary circulation
Adapted from http://www.bbc.co.uk/
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Figure 1.2. Schematic diagram of the systemic circulation.
The above describes one complete cycle of the cardiovascular system in a schematic
way and - for a matter of clarity - I have excluded many aspects of it. In fact many
other organs and sub-systems interact with that cycle and can determine
cardiovascular dysfunctions if they work in abnormal conditions. For example, liver
disease can have repercussions for the whole dynamics of the cardiovascular systems
because the liver is connected to the heart through the inferior vena cava.1,2 The
description of all indirect conditions that can affect the cardiovascular systems goes
beyond the aims of this thesis.
One additional aspect of the cardiovascular system that has to be noted because it is
relevant to my research is the following: as soon as the aorta emerges from the left
Adapted from http://www.bbc.co.uk/
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ventricle, some small branches split off to form the coronary circulation that serves
the heart muscle itself.1
The most important haemodynamic alterations are those that impair the inside-
outside exchange of gas and metabolites that I have described, because the
availability of oxygen and nutrients for the tissues can never be inferior to their need
in order to avoid cellular death. There are two main alterations of that can occur:
ischaemia and congestion. Ischaemia is a restriction of blood supply (i.e. a lack of
blood within the capillaries) to organs, tissues, or even small groups of cells, whereas
congestion is a stagnation of blood (i.e. a defect in blood replacement in the
capillaries after the inside-outside exchange). The terms ischaemia and congestion
are sometimes used interchangeably and often ischaemia acquires the more general
meaning of imbalance between oxygen demand and supply. Ischaemia can be caused
by a variety of conditions such as vessel compressions from the outside (e.g.
neoplasms), vessels ruptures (e.g. haemorrhagic stroke), vessel obstructions from the
inside, i.e. stenosis (e.g. atherosclerosis and thrombus), vessel spasms, arrhythmia
(irregular heart beat), as well as other conditions.2
1.2 Atherosclerosis, thrombus, and inflammation.
Arteriosclerosis can be generically defined as the thickening and hardening of the
arterial walls such that the lumen of the arteries is reduced (stenosis) and the blood
flow is impaired. Atherosclerosis is a form of arteriosclerosis, where the thickening is
due to the deposition of lipids within the wall of the arteries (particularly in the
stratum of the wall called the tunica intima), that typically occurs to medium and
large size arteries and has a defined localisation. The sites that are mostly damaged
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are the aorta and its major branches, the cerebral vessels, the vessels of the lower
limbs, and the coronaries (see figure 1.3).2
Figure 1.3. Diagram of atherosclerosis
There are two main phases for the formation of atherosclerosis.
1. The first phase is potentially reversible and is called a fatty streak.
Macrophages are cells produced by the differentiation of monocytes in
tissues, and monocytes are a type of white blood cells (leukocytes). A fatty
streak consists of the accumulation of aggregates of lipoprotein-loaded
macrophages, also called foam cells, in the tunica intima of the artery.
Adapted from http://www.nhlbi.nih.gov/
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2. The second phase is not reversible and is called an atheroma or an
atherosclerotic plaque. This is an additional deposit of degenerative material
consisting mostly of calcium and fibrous connective tissue, supported by
immune system cells other than macrophages, such as T lymphocytes
amongst others (see figure 1.4).2
Figure 1.4. Stages of atherosclerosis.
Atherosclerosis was traditionally considered as a passive process of lipid
accumulation, a sort of passive trapping and retention of cholesterol-rich,
apolipoprotein B–rich lipoproteins within the arterial wall. This was due to a variety
of observations. For example, it was noted that, even in the presence of other risk
Adapted from http://en.wikipedia.org/wiki/Atherosclerosis
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factors, atherosclerosis does not develop when serum cholesterol concentrations are
below 80 mg per decilitre (2.1 mmol per litre), a concentration found in many
animals. Genetic, dietary, and other interventions that raise serum concentrations of
atherogenic lipoproteins in animals provoke atherosclerosis, i.e. focal increases in
arterial LDL concentration precede development of fatty streak lesions. In animals
with newly induced hypercholesterolemia, intramural lipoprotein retention and
aggregation occur within hours in lesion-prone arterial sites. Interventions that
remove arterial lipids in animals reduce the size of the lesion and correct endothelial
dysfunction, and similar effects occur in humans treated aggressively with lipid-
lowering drugs. Finally, animals expressing mutations of human apolipoprotein B
engineered so that it no longer binds to arterial matrix have high serum LDL
concentrations but few atherosclerotic lesions; their LDL is no longer atherogenic,
because it cannot be retained within the prelesional vessel wall.3–5
While we now acknowledge the role of inflammation in the pathophysiology of
atherosclerosis, inflammation was previously viewed as a consequence rather than a
concurrent cause of atherosclerosis, mainly because it was observed that the arterial
wall contains matrix and enzymes that retain and modify lipoproteins, thereby
generating biologically active products that induce key components of the
inflammatory response, and because, once trapped, lipoproteins become
enzymatically and oxidatively modified, they accumulate, and then they stimulate,
among other responses, inflammation.3–5
Although it has been recently found that elevated low-density lipoprotein cholesterol
can cause heart disease even without inflammation,6 the medical community has
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now accepted the notion that inflammation plays a central role in the development
of atherosclerosis.7–9
Atherosclerosis and inflammation
Several conditions promote the atherosclerotic process:
 Lipoprotein blood levels. The augmented concentration of lipoproteins in
the blood plasma, and particularly of low-density lipoproteins carrying
cholesterol (LDL), facilitates atherosclerosis by increasing the rate of
lipoproteins being captured by macrophages.
 The alteration of LDL. Macrophages are one of the specialised cells that form
the immune system and their role is to engulf and digest cellular debris and
pathogens. Therefore if LDL molecules are altered through the phenomenon
of oxidation for example, the rate of their capture by macrophages is
increased.
 Endothelial lesions. Endothelial cells are cells that form the thin layer that
lines the interior surface of the artery and that are in direct contact with the
blood. Macrophages have to migrate from the blood to the tunica intima of
the arteries in order to start atherosclerosis and therefore their penetration
through the endothelium is necessary. It follows that lesions to the
endothelium promote atherosclerosis. Lesions to endothelium that
contribute to the atherosclerotic process can be of a mechanical nature, such
as the effect of high blood pressure as well as of a chemical nature, such as
the toxic chemicals inhaled through tobacco smoking for example, or the
direct cytotoxic activity that altered LDL has.
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 Macrophage adherence to endothelial cells. Macrophages have to adhere to
the endothelium to then be able to infiltrate the artery wall and move to the
tunica intima. The adherence is enhanced by chemical stimuli produced by
endothelial, macrophage, and other cells in response to inflammatory and
immunological processes of a diverse nature.2
The communication, the interaction, and the aggregation of the cell types that
promote atherosclerosis are crucial for the determination of the disease. That
communication is made possible by chemical signals called cytokines. These are
small, nonstructural proteins with molecular weights ranging from 8 to 40,000
dalton. Nearly all nucleated cells are capable of synthesizing these proteins and, in
turn, of responding to them. There is no amino acid sequence motif or three-
dimensional structure that groups cytokines; rather, their biological activities allow
us to classify them into different categories. Cytokines are regulators of host
responses to infection, immune responses, inflammation, and trauma, and promote
the communication and movement of cells (the term cytokine comes from the Greek
words cytos [cell] and kinesis [movement]). Some cytokines act to promote
inflammation (proinflammatory), whereas others serve to reduce inflammation (anti-
inflammatory).10
Due to the key role of proinflammatory cytokines in enhancing the cell’s activation
and interaction that trigger and maintain atherosclerosis, chronic inflammation has
been recently emphasised as a major determinant of that disease.7,11,12 For example,
immune cells, mediators of host defence and inflammation, are known to
concentrate in the earliest lesions of atherosclerosis. Moreover, normal endothelium
does not in general support the binding of white blood cells. However some specific
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molecules produced in response to inflammation such as vascular cell adhesion
molecule-1 (VCAM-1) bind to some types of leukocytes such as monocytes and T-
lymphocytes that are found in early atheroma. Additionally, VCAM-1 expression
increases on endothelial cells overlying emerging atheroma. Augmented wall stresses
due to hypertension, for example, may promote the production of proteoglycans (by
arterial smooth muscle cells) that bind and retain lipoprotein particles, facilitating
their oxidative modification and thus promoting an inflammatory response at sites of
lesion formation. Once the leukocytes adhere to the endothelium, they penetrate
into the intima and some molecules produced in response to inflammation, such as
monocyte chemoattractant protein-1 (MCP-1), are responsible for this
transmigration. Moreover, once the blood-derived inflammatory cells become
resident in the tunica intima they promote a local inflammatory response. For
instance, T cells release inflammatory cytokines such as gamma-interferon and
lymphotoxin (tumour necrosis factor [TNF]–beta) that in turn can stimulate
macrophages as well as vascular endothelial cells and arterial smooth muscle
cells.7,11,12
When the volume of an atherosclerotic plaque increases, the plaque tends to
protrude into the lumen of the artery and to reduce blood flow progressively,
eventually causing ischaemia.2 Furthermore, a plaque can encounter several
complications that are relevant to acute myocardial infarction:
 There can be ulceration and consequent rupture of the plaque surface that
determines the emptying of the necrotic residuals into the artery lumen, with
a resulting microembolism that blocks the terminal parts of the arteries and
therefore produces ischaemia.
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 The ulceration can start a coagulation process with platelet aggregation and
fibrin deposition that can result in the formation of a thrombus, i.e. a blood
clot that can suddenly block the blood flow of large vessels and consequently
cause ischaemia in large parts of organs.2
Inflammatory processes not only promote initiation and evolution of atheroma, but
also contribute decisively to the complications described above. For example, the
macrophages that become activated in response to inflammation that are abundant
in the atheroma can produce proteolytic enzymes capable of degrading the collagen
that forms the plaque’s protective fibrous cap, rendering the cap thin, weak, and
susceptible to rupture. Moreover, gamma-interferon arising from the activated T
lymphocytes in the plaque can halt collagen synthesis by arterial smooth muscle
cells, limiting their capacity to renew the collagen that reinforces the plaque.
Macrophages also produce tissue factor, the major procoagulant and trigger for
thrombosis that is found in plaques. Furthermore, inflammatory mediators regulate
tissue factor expression by plaque macrophages, demonstrating an essential link
between arterial inflammation and thrombosis.7,11,12
Therefore inflammation participates in all stages of atherosclerosis:
1. Initial phase: fatty streak formation. Blood leukocytes adhere poorly to
normal endothelium and when the endothelial monolayer becomes
inflamed, it expresses adhesion molecules for leukocytes. Also,
proinflammatory cytokines expressed within the atherosclerotic plaque
provide a chemotactic stimulus to the adherent leukocytes, directing their
migration into the tunica intima. Moreover, inflammatory mediators enhance
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the expression of macrophage receptors leading to the uptake of modified
lipoproteins and the formation of foam cells and other inflammatory
mediators produced in plaques which can also promote the replication of
macrophages within the intima.
2. Second phase: atherosclerotic plaque formation. T lymphocytes join
macrophages in the intima during lesion evolution. These leukocytes secrete
cytokines and growth factors that can promote the migration and
proliferation of smooth muscle cells, which express specialised enzymes that
can degrade the elastin and collagen in response to inflammatory
stimulation. This degradation of the arterial extracellular matrix permits the
penetration of the smooth muscle cells through the elastic laminae and
collagenous matrix of the growing plaque.
3. Last phase: ulceration and thrombus formation. Inflammatory mediators
can inhibit collagen synthesis and evoke the expression of collagenases by
foam cells within the intimal lesion. These alterations thin the fibrous cap
and render it weak and susceptible to rupture. Cross-talk between T
lymphocytes and macrophages heightens the expression of the tissue factor,
which is a strong procoagulant. Thus, when the plaque ruptures, the tissue
factor induced by the inflammatory signalling triggers the thrombus that
causes the most acute complications of atherosclerosis.7,11,12
1.3 Ischaemic heart disease
The term ischaemic heart disease (IHD) refers to a spectrum of disease that have
different aetiology but common pathophysiology, which is represented by the
imbalance between the metabolic demand of the heart and oxygen support. IHD is
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predominantly secondary to atherosclerosis of the coronary arteries but there can be
IHD without atherosclerosis and atherosclerosis without IHD. Apart from “fixed”
stenosis of an atherosclerotic nature, the myocardium can become ischaemic due to
“dynamic” stenosis of the coronaries: the most documented phenomenon of such
kind is coronary spasm, which is a temporary, sudden narrowing of the coronary
lumen that is due to a squeezing of muscles in the artery wall. The imbalance
between metabolic demand and oxygen support can happen even with normal
coronaries for a disproportionate increase in the demand. However, this happens
only when the metabolic demands become particularly elevated, for example, in the
presence of a marked myocardial hypertrophy especially if it is associated with aortic
valvulopathy.2
It is not infrequent that two or more pathophysiologic dynamics happen
simultaneously. For example, coronary spasm tends to happen more often and to
have more ischaemic effect in arterial segments where atherosclerosis accumulates.
Thrombus and spasm can also coexist; platelets can produce vasoactive substances
such as thromboxane A2, which has a strong vasoconstrictive effect.2 It is interesting
to note that inflammation is also a component of coronary spasm.13
The clinical manifestations of IHD are:
1. Primary cardiac arrest
2. Angina pectoris
3. Cardiac failure
4. Arrhythmia
5. Acute myocardial infarction
30
Acute myocardial infarction
Acute myocardial infarction (AMI) is caused by an ischaemia in one or more
coronaries that persists for a period of time that is sufficiently long to induce the
cellular necrosis (death) of myocytes. AMI is therefore characterised by an
irreversible anatomical alteration of the myocardium (see figure 1.5).2
Figure 1.5. A diagram of a typical AMI.
There are two main types of acute myocardial infarction:
1. Transmural AMI is associated with atherosclerosis involving a major coronary
artery and it extends through the whole thickness of the heart muscle and is
usually a result of complete occlusion of the area's blood supply, often by a
Adapted from http://nursingcrib.com/.
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thrombus. The spastic component is less important for the pathophysiology
of this type of AMI.
2. Intramural AMI does not extend through the whole thickness of the heart
muscle but only involves the subepicardial or the subendocardial wall, which
is particularly susceptible to ischemia. Therefore intramural AMI is usually a
result of incomplete occlusion for causes other than thrombus (see figure
1.6).2
Figure 1.6. Subendocardial vs transmural AMI
Coronary occlusion is therefore the most important factor of myocardial necrosis.
However it is not the only one. In the presence of myocardial ischaemia caused by an
acute blood flow reduction in a coronary region, catecholamine production is often
elicited and this has negative repercussions to the heart. In fact, the increase in
circulating catecholamines determines an increase in heart rate, an increase in
peripheral vessel resistance (smaller vascular calibre), and an increase in myocardial
contractility, which all entail an increase of oxygen demand which can start a vicious
circle that aggravates the ischaemia.2
The anatomical pathology of an AMI follows a typical pattern: soon after the heart
attack a pale and dry area appears on surface of the tissue that encountered the
Adapted from http://www.medicine-on-line.com/.
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necrosis; after two-four days it becomes yellow due to the occurrence of infiltration
by neutrophil granulocytes; after eight-ten days the area turns dark red due to the
formation of granulation tissue; after about four weeks cicatrisation begins and the
area tends to becomes grey; within three-six months scar formation is completed.
Therefore, when not fatal, an AMI implies the loss of muscular mass by the heart.2
The location, the extent, and the fatality of an AMI depend on which coronary artery
is affected, on its size, on the extent of the stenosis, on the duration of the
ischaemia, treatment processes, and other factors. A complete categorisation of the
different AMIs according to those parameters goes beyond the aim of this
dissertation.
The typical symptoms of an AMI are:
1. Pain in the chest or in the abdomen that tends to irradiate, often to the arms.
2. Intense asthenia
3. Pale skin and algid sweating
4. Nausea and vomiting
5. Anxiety
6. Arrhythmia
7. Shock and sudden death in severe cases
8. Others
However, the typical symptoms do not always occur. For example the incidence of
AMI without the typical associated pain is relatively frequent in diabetic and older
patients. Moreover symptoms such as pale skin and algid sweating do not co-exist
with nausea and vomiting because the former symptoms are due to catecholamine
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activity whereas the latter symptoms are due to augmented vagal stimulation. There
are also gender differences in AMI presentations: nausea, back pain, dizziness, and
palpitations are more common in women, who usually also display a greater number
of symptoms than men.14
The diagnosis of AMI must be therefore confirmed using blood tests,
electrocardiography (ECG), and imaging test. Acute myocardial infarctions are
schematically divided into two types on the basis of ECG results: ST-elevated and
non-ST-elevated. An occlusive thrombus complicating a high-grade stenosis would
arrest the blood flow and cause ST-segment elevation myocardial infarction (STEMI).
Acute coronary syndromes without ST-segment elevation (NSTEMI) would result
from an incomplete or transient obstruction of flow in the culprit coronary artery at a
site of critical stenosis.2,12
The latest universal definition of AMI for diagnostic purposes (2007) is as follows:
troponin T elevation ≥0.035 ng/ml (i.e. above the 99th percentile of the upper
reference limit with a coefficient of variation <10%) with at least one of the
following: symptoms of ischaemia; ECG evidence of AMI (acute ischaemic changes or
development of pathological Q waves); imaging evidence of new loss of viable
myocardium.15,16
Cardiac troponins are regulatory proteins that control the calcium-mediated
contraction from within the myocyte (heart muscle cell). The troponin complex
consists of three subunits: troponin T, troponin I, and troponin C. Troponins are not
normally present in the plasma of healthy individuals. The role of Troponin T is to
bind to a filament called tropomyosin in order to enhance its interaction with
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another filament called actin that is responsible for contraction. Contraction happens
when the two filaments can slide reciprocally levering on bridges that link them.
When cellular necrosis happens, the contents of the myocyte, including Troponin T,
are released into the capillaries and from here they reach the main blood stream.
There is a rapid early release of plasma Troponin T after ischaemic injury, which
peaks at 12–24 hours, and may remain raised for more than two weeks. The
detection of Troponin T in the plasma inevitably indicates cardiac cell damage.17
Increased blood concentrations of troponin T can be seen in a variety of diseases
other than AMI, such as sepsis, hypovolemia, atrial fibrillation, heart failure,
pulmonary embolism, myocarditis, myocardial contusion, renal failure, stroke, toxic
injury, severe cardiac overload, and others. Thus, while negative troponin T may be
useful to "rule out" an AMI, there are limitations of using troponin T to "rule in" an
AMI, especially in patients with low clinical likelihood of IHD, because troponin T is
highly indicative of myocardial injury, which nonetheless can be the result of AMI but
also of other conditions. In epidemiological terms, troponin T has great sensitivity but
medium/low specificity for AMI when the other diagnostic criteria for AMI are not
met. As a consequence, if troponin T testing is applied indiscriminately in broad
populations with a low pre-test probability of AMI, the positive predictive value for
AMI (i.e. the probability of having an AMI if the test is positive) is greatly diminished.
In clinical settings, troponin T is measured using standard assays that have a lower
detection limit of 10 ng/L,18 and a diagnostic threshold of 35 ng/L.15,16 However, high-
sensitivity assays have now been developed with a lower detection limit of 3 ng/L.19–
21 With the advent of high-sensitivity assays, causes of troponin T elevation not
related to heart disease have become common findings in patients with chest pain
35
and in those with acute or chronic systemic disorders. However, troponin T elevation
in the absence of heart disease still retains significant prognostic value, and screening
may be justified on this basis. Indeed, troponin T elevations in a variety of settings
predict cardiac events, and worse short- and long-term survival, independently of the
underlying disease, and also in disease-free people. The reasons for this increase in
morbidity and mortality are currently poorly understood, and the clinical conditions
leading to Troponin T release in patients who do not have any chronic or acute
disease, and the appropriate diagnostic and therapeutic strategies for these
individuals, are largely unknown.22
Although Troponin I is not currently used for the diagnosis of AMI, this other
component of the troponin complex, measured with a high-sensitivity assay, is also
an independent predictor of cardiovascular events and might support selection of at
risk individuals.23
Treatment
In STEMIs nearly half of the potentially salvageable myocardium is lost within 1 hour
of the coronary artery being occluded, and two-thirds are lost within 3 hours. Apart
from resuscitation from any cardiac arrest, the highest priority in managing STEMI is
to restore an adequate coronary blood flow as quickly as possible. In the 1980s and
1990s, the best way to restore flow was to administer a fibrinolytic drug (i.e. a drug
that is able to dissolve the fibrin clot occurred following plaque rupture causing
ischaemia). This treatment is called thrombolysis (i.e. the breakdown of a thrombus).
However, fibrinolysis is not suitable for use in all people because of bleeding
complications. In around 20-30% of individuals, fibrinolysis failed to result in
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coronary reperfusion, and in a minority (1.0%) its administration caused
haemorrhagic stroke. To improve outcomes, attention turned to mechanical
techniques to restore coronary flow (for example, coronary angioplasty, thrombus
extraction catheters and stenting). These techniques are grouped under the umbrella
term of primary percutaneous coronary intervention (primary PCI). Primary PCI is
both feasible and cost effective and is the treatment of choice for STEMI, providing it
can be delivered in a timely fashion. PCI is one of the two coronary revascularisation
techniques currently used in the treatment of ischaemic heart disease, the other
being coronary artery bypass grafting (CABG). PCI involves non-surgical widening of
the coronary artery, using a balloon catheter to dilate the artery from within. A
metallic stent is usually placed in the artery after dilatation. Antiplatelet agents are
also used. Stents may be either bare metal or drug-eluting. The coronary artery is
accessed with a method called angiography: a long, thin, flexible tube called a
catheter is threaded into an artery in the arm or leg, and the tip is advanced through
the arterial system into the coronaries. The catheter is firstly used to administer an X-
ray contrast agent that enables the X-ray imaging on the coronaries in order to
diagnose and locate stenosis. The catheter is then used to mechanically remove the
obstruction and insert the stent.
Alternatively, CABG is a type of open-heart surgery that is usually performed with the
heart stopped, necessitating the usage of cardiopulmonary bypass, although
techniques are available to perform CABG on a beating heart, which is called "off-
pump" surgery. In CABG the stenosis in not resolved but by-passed: a blood vessel is
taken from the chest, leg, or arm of the patient and used to bypass a narrowed or
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blocked coronary artery. PCI is preferred to CABG, although CABG is superior to PCI in
some conditions, for example for some patients with multivessel IHD.24–27
Although NSTEMIs result from incomplete and often undetectable stenosis and their
consequences on the vitality of the myocardium are often less severe than for
STEMIs, patients presenting with NSTEMI are also tested with angiography and
eventually treated with primary PCI.25,28
It has to be noted that gender and SES have been studied independently as factors
influencing the care and outcomes after IHD, and it was found that they are
influential, partly through barriers in timely access to PCI, with women and low-
income people being more likely to be excluded from appropriate care. Moreover a
recent study evaluated the combined effect of gender and SES, and demonstrated
that the association between SES and both care and outcomes in IHD differs in men
versus women: low-income women seem to be particularly vulnerable in terms of
access to PCI and short-term mortality after IHD.29
Epidemiology and risk factors
According to 2010 data, IHD is the leading cause of death worldwide resulting in
more than seven million deaths per year, with an increasing trend over the last
twenty years.30 The incidence of AMI has decreased in the United Kingdom over the
past three decades and currently there are about 100,000 heart attacks on average in
the UK every year.31 In England around 11% of men and 15% of women who were
admitted to hospital with an AMI in 2010 died within 30 days. In Scotland, case
fatality rates were higher, with 12% of men and 19% of women admitted with an AMI
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dying within 30 days.32 Prevalence studies indicate that around 1 million men and
nearly 500,000 women have had an AMI in the UK.33
The conventional risk factors for AMI are older age, male gender, hypertension,
smoking, hypercholesterolaemia, and diabetes.34
 Hypertension. Hypertension is defined as a consistently elevated blood
pressure over a certain threshold. The British Hypertension Society has set
the threshold as 140 mmHg for systolic blood pressure and 90 mmHg for
diastolic blood pressure.35 According to the Health Survey for England, the
prevalence of hypertension in 2012 was 31% among men and 27% among
women, remaining at a similar level over the last few years.36
 Smoking. Regarding cigarette smoking, among men there has been an
increase in the proportion of who have never regularly smoked cigarettes
(from 39% in 1993 to 51% in 2012). Correspondingly, the proportion of men
who are current smokers declined overall from 28% 1993 to 22% in 2012.
The proportion of women who have never regularly smoked increased from
52% in 1993 to 61% in 2012, while the proportion of current smokers
decreased overall in the same period, falling from 26% to 18%. The
proportion of men and women who smoked 20 or more cigarettes per day
has fallen: from 11% of men in 1993 to 5% in 2012 and from 8% women to
3% over the same time period.36
 Hypercholesterolaemia. Hypercholesterolaemia is the presence of high
levels of cholesterol in the blood. Since cholesterol is insoluble in water, it is
transported in the blood plasma within protein particles (lipoproteins).
Lipoproteins are classified by their density: very low density lipoprotein
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(VLDL), intermediate density lipoprotein (IDL), low density lipoprotein (LDL)
and high density lipoprotein (HDL). All the lipoproteins carry cholesterol, but
elevated levels of the lipoproteins other than HDL, particularly LDL-
cholesterol, are associated with an increased risk of atherosclerosis and IHD
coronary heart disease. In contrast higher levels of HDL cholesterol are
protective. Elevated levels of non-HDL cholesterol and LDL in the blood may
be a consequence of diet, obesity, genetic diseases (such as LDL receptor
mutations in familial hypercholesterolemia), or the presence of other
diseases such as diabetes and an underactive thyroid. The term
hypercholesterolaemia has been recently replaced by the term
dyslipidaemia, meaning that the ratio between offensive and protective
plasma lipids is more important that absolute values of the offensive ones.37–
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 Diabetes. Diabetes mellitus is a condition characterised by an elevated
concentration of glucose, a type of sugar, in the blood (hyperglycaemia).
There are two types of diabetes. Type 1 diabetes is particularly prevalent in
younger non-obese individuals and is mainly due to autoimmune
mechanisms that destroy the islets of Langerhans, which are the regions of
the pancreas that contain insulin-producing cells. The hormone insulin has an
antidiabetic effect because it removes blood sugar by promoting its entrance
into the cells and its conversion into storage lipids. Type 2 diabetes is more
prevalent in older and obese individuals and has a more complex
pathophysiology: it results from insulin resistance, a condition in which cells
fail to use insulin properly. In order to try to maintain glucose tolerance, this
reduction in insulin sensitivity causes an increased release of insulin. The
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resulting hyperinsulinaemia and hyperglycaemia contribute to the
development of atherosclerosis through hypertension, endothelial
dysfunction, dyslipidaemia, and inflammation. At its final stages, type 2
diabetes may also manifest an absolute insulin deficiency. Type 2 diabetes is
a direct risk factor for IHD because the excess amount of glucose in the blood
can lead to non-enzymatic glycosylation of plasma proteins that form high-
volume molecules that can produce a mechanical damage to the arteries.1,2
Not only can diabetes produce inflammation but inflammation can also be a
promoting factor for the genesis of diabetes.40 In England, the prevalence of
doctor-diagnosed diabetes increased between 1994 and 2012 from 2.9% to
6.7% among men and from 1.9% to 4.9% among women.36
 Gender. It has been recognised over the past years that women form a
distinct subpopulation within patients with IHD, which is markedly more
common in men than in women. Cardiovascular disease develops 7 to 10
years later in women than in men on average, but after midlife it has a
sharper increase with age among women. Many reasons have been proposed
for this phenomenon, although there is no definitive explanation. There are
some risk factors that are unique to women, such as preeclampsia and
menopause for example (oestrogen may have a protective role against IHD).
Furthermore, non-gender-specific risk factors also play a role for the gender
differences in IHD incidence: many risk factors are more prevalent in one
gender, and the significance and the relative weighting of these risk factors
are different between men and women. For instance, at younger ages (<50
years) smoking is more deleterious in women than in men; women with
diabetes are at greater risk for cardiovascular complications than their male
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counterparts; and low HDL cholesterol implicates a higher IHD risk in women
than in men.41–44 As a consequence, widely-used IHD risk scores, such as the
Framingham, the Joint British Societies & British National Formulary, the
Assign, and the Q-Risk 2 for example, are indeed gender specific.34,45–47
Regarding non-conventional risk factors, growing evidence indicates that in heart
disease, elevated circulating inflammatory markers, in particular C-reactive protein
(CRP) and Interleukin-6 (IL-6), predict an unfavourable course, independent of the
severity of the atherosclerotic or ischemic burden. Thus, inflammation represents
one potential novel pathophysiological mechanism of heart disease that may furnish
a new target for therapy.7,11,12
The next three sections (1.4-1.6) I will describe some other non-conventional risk
factors for heart disease that are relevant to my research aims. I will go through the
different types of mental adversity and then illustrate the mechanisms that link them
with heart disease. As the reader will note, inflammation plays a central role.
Afterwards, I will discuss the effect of socioeconomic status on human health.
1.4 Mental stress
The term stress comes from the Latin term strictus which means strained,
compressed. Even before there was an understanding of the biological process of
stress, researchers have been interested in how it might influence health and
therefore the study of stress and disease has a long history.48
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Under the expression of mental stress I have included several types of psychosocial
conditions that can be schematically divided into three main themes, i.e. chronic
stressors, mood factors, and social relationships:49
1. Chronic psychological distress
a. Work stress
i. High-demand/low-control
ii. Effort-reward imbalance
b. Family conflicts and care giving
c. Low emotional support
d. Financial strain
2. Mood and behavioural factors
a. Depression
b. Anxiety
c. Hostility and anger
d. Optimism
e. Positive thinking
f. Hopelessness/Helplessness
3. Social relationships
a. Social cohesion
b. Social support
c. Social network
d. Neighbourhood problems
The above conditions do not have well-defined boundaries and hence each condition
can be pertinent to more than one theme.
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Factors such as job strain, social network, and others can be measured objectively,
even though they are often measured by self-report, and can therefore mark
someone’s objective exposure to stress, whereas some other factors such as
depression, anxiety, and others are rather subjective mental representations, and
can be thus considered as markers of individual response and adaptation to stress. A
description of all the different elements of mental stress goes beyond the aims of this
dissertation.
Mental stress is therefore a multi-dimensional concept and can be considered as a
subjective state as well as a biological phenomenon. There are several strategies for
studying mental stress as a risk factor for cardiovascular disease:50
 Animal research. Research on animals has provided many important insights
into the role of mental stress. There are many advantages of using this
approach: animals can be experimentally subjected to stronger stressors
than humans; the period of time that goes from the inducement of stress
and the development of cardiovascular disease is shorter than in humans;
information and selection bias that are typical of human studies can be
avoided (e.g. no losses to follow-up); histological, anatomical, and autoptical
methods make disease ascertainment very accurate as well as describe
complete aetiological processes; genetic and environmental factors that may
confound the results can be standardised. The disadvantages of animal
research are the following: experimental animals must be employed with
care and utilised under ethically rigorous conditions; direct inferences to
humans cannot be made; some kinds of stressor are difficult to investigate
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(e.g. depression); important cofactors such as socio-economic status cannot
be included into the models.50
 Laboratory studies in humans. As a biological phenomenon, mental stress
can be studied in laboratory-based experiments where nonspecific biological
markers of activation that are influenced by stress are evoked in human
participants in response to behavioural simulation.49 The standardised stimuli
can assume various forms, e.g. problem-solving tasks or emotionally
demanding social interactions, the crucial element being that conditions are
perceived as stressful, challenging, and involving. These tests elicit consistent
physiological responses with good test-retest reliability in many biological
measures including blood pressure, heart rate, and inflammatory and
haemostatic variables.50 This approach has several compelling advantages:
the experimental design can be used with randomisation to different
conditions, eliminating the effect of known and unknown confounding
factors; given the very short period of time between exposure and monitored
outcomes (markers of activation) and the environmentally controlled
conditions, issues such as of information bias (e.g. changes in stress exposure
and losses to follow-up) become irrelevant; stratification or restriction for
specific groups of people (e.g. people with or without certain diseases) is
efficient and accurate. On the other hand, mental stress testing in humans
has some limitations: although these biological responses to stress are
associated with future cardiovascular events, real clinical outcomes are not
measured; although the stimuli always precede the recorded biological
outcomes, these studies have cross-sectional nature and in some cases (e.g.
if there is no random allocation to stimuli) the possibility of reverse causality
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cannot be ruled out; only short-term biological responses can be recorded,
whereas chronic stressors may elicit different response patterns because of
habituation, adaptation, and chronic disturbances in autonomic or
neuroendocrine regulation. In order to address this issue, laboratory stress
testing has been increasingly complemented by naturalistic and ambulatory
methods.50
 Naturalistic and ambulatory methods. These studies involve the
measurement of biological factors continuously or intermittently during
everyday life and take several forms, such as Holter monitors for cardiac
function and ambulatory blood pressure monitors for example. These
methods have the advantage that the biological activity is assessed under
natural conditions. The dynamic covariation between everyday activities,
emotions, and biology can also be evaluated. The disadvantages are: the
range of biological markers that can be assessed is relatively narrow (blood
pressure, heart rate variability, physical activity, and salivary cortisol are
amongst the commonest measures); the measurement techniques need to
be relatively unobtrusive, so as not to interfere with ongoing activities, and
this typically rules out blood sampling; there are factors that influence
biological function in everyday life that need to be taken into account such as
time of the day, cigarette smoking, food and caffeine intake, sleep, and
physical activity; participants may change their behaviour because they are
aware that they are being monitored.50
 Observational epidemiological studies. As a subjective state, mental stress
can be studied in large-scale population-based surveys using validated
questionnaires.51,52 These often take the form of longitudinal observational
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cohort or population studies, in which large, preferably representative,
populations are screened to ensure they do not already suffer from the
outcome condition under investigation (e.g. IHD), the measurement of the
exposure variable (e.g. anxiety, depression, etc.) is then carried out along
with other variables that are known to influence the outcome (possible
confounders) or interact with the exposure, and then the population is
followed up in time (usually many years) and the occurrence of the outcome
is monitored. The main advantages of these kind of studies are: they can
have actual clinical events as main outcome variables; they are usually large
in sample size and therefore they are able to capture relatively small effect
sizes (provided that some other conditions are met, e.g. limited information
bias, sufficient number of events, etc.); the issue of reverse causality can
usually be addressed (although not completely) by excluding participants
who experienced the outcome event soon after their study recruitment and
who may had been already in the initial phases of the disease at the time.
These types of studies have of course limitations: longitudinal studies usually
take many years before sufficient number of events occur to obtain statistical
evidence (unless one would opt for a case-control design, in which case the
retrospective nature of the study would pose major limitations such as recall
bias, selection bias, and reverse causality for example); they are usually very
expensive in terms of human and financial resources; the exposure variable
in usually measured only at baseline (i.e. there are no repeated observations)
and one cannot be sure that the initial condition is stable throughout the
follow-up period (information bias, misclassification); possible confounding
factors are also measured only at baseline and their quantification can be
47
inaccurate (usually many cofactors are measured in these questionnaires,
which often take a long time to be completed, diminishing participants’
compliance) or they may be even unknown, rendering that statistical
adjustment at the data analysis stage inefficient when not impossible
(residual confounding).50
 Prevention and treatment studies. There are psychological and behavioural
methods aimed at decreasing mental stress. These methods can be
experimented on participants, even with randomisation against placebo or
against each other, to ascertain their effect on disease incidence. However
there are limitations for these kinds of trials. To study the association
between mental stress reduction and IHD prevention for example, one would
firstly implement an efficacy trial (explanatory trial) to get a precise and
robust quantification of the risk reduction determined under ideal,
experimentally-controlled conditions. Afterwards, an effectiveness trial
(pragmatic trial) should complement the results, by testing the stress
reduction method in everyday, real life circumstances. Efficacy trials are
typically focused on restricted categories of patients (and therefore have
good internal validity but poor generalisability) whereas effectiveness trials
are focused on wide categories, for the general public. There are several
steps that must occur for an efficacious intervention to be effective in clinical
practice, and therefore an efficacy trial can often overestimate an
intervention’s effect when implemented in clinical practice. In other words,
efficacy trials answer the question “can it work?”, whereas effectiveness
trials answer the question “does it work?”. The combination of those two
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type of trials that form a continuum is rarely applicable in psychological and
behavioural interventions, especially in the cardiovascular domain.50,53
As part of the present thesis I have designed and conducted studies on human
participants using two of the above-mentioned approaches: laboratory-based
experiments and epidemiological cohorts.
In the next sections, we will see how mental stress is increasingly becoming
recognised as a risk factor for IHD in acute conditions, when sudden stressful events
trigger acute IHD events, as well as in chronic conditions, when poor adaptation to
recurrent daily stressors produces a pathophysiological substratum for IHD. Although
the mechanisms underlying these associations have not been completely clarified,
inflammation plays a central role and therefore proinflammatory factors, cortisol
levels, haemostatic processes and endothelial function factors have been identified
as key mediators.54–58
The neuroendocrine system
By endocrine system we refer to the group of glands that secrete hormones directly
into the main blood stream of the circulatory system, through which they reach
distant target organs. The major endocrine glands include the hypothalamus, the
hypophysis (pituitary gland), the thyroid and parathyroid glands, the adrenal gland,
the pineal gland, the ovaries and the testes, and the pancreas. However many other
organs have endocrine activity, such as the gastrointestinal tract, the skin, the heart,
etc. The metabolic activities of the target organs or cells depend on the stimulus they
receive from the hormones. Glands not only influence effector cells but also
influence each other. For example, the hypothalamus produces the thyrotropin-
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releasing hormone (TRH), which stimulates the release of thyroid-stimulating
hormone (TSH) from the hypophysis, which stimulates thyroxine (T4) and
triiodothyronine (T3) synthesis and release from the thyroid. Similarly, the
corticotropin-releasing hormone (CRH) released by the hypothalamus stimulates the
release of the adrenocorticotropic hormone (ACTH) from the hypophysis, which
stimulates corticosteroid (glucocorticoid and mineralcorticoid) and androgen
synthesis and release from the adrenal gland.
The secretory activity of the endocrine glands is constantly controlled by complex
regulatory systems that adjust hormonal circulating levels to the metabolic needs of
the effector cells. This regulation can happen through negative feedback
mechanisms, whereby parts of the body that function as stimuli for the
determination of certain conditions are inhibited by the status of the conditions they
promote, achieving an automatic self-regulation. For example, the hormones that are
produced by the adrenal cortex (cortisol), by the thyroid (T3 and T4), and by the
gonads (testosterone, oestrogen, and progesterone) in response to hypophyseal
stimulus, regulate their own production by acting at the hypothalamic-pituitary level
on the excretion of their releasing factors (ACTH, TSH, and LH [Luteinizing Hormone]),
i.e. the negative feedback works in such a way that the response (e.g. cortisol)
inhibits its releasing factor (e.g. ACTH). Therefore, the increase in circulating cortisol
inhibits ACTH secretion and, vice versa, the decrease in circulating levels of cortisol
augments ACTH secretion. However, the regulatory mechanisms are more complex
than it may appear from the example above, since usually many factors concur to the
control of each hormone. Moreover, the hormones produced by peripheral glands
give negative feedback not only to the hypophysis but also to hypothalamic and even
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supra-hypothalamic structures (e.g. endorphinergic neurones in the hippocampus, as
well as in the frontal and parietal lobes of the brain). Further complexity is given by
the fact that in some cases there is a positive feedback, and that sometimes it is not
hormone concentration that works as controller but a function regulated by the
hormone (e.g. parathyroid hormone for circulating ionised calcium concentration).1,59
The secretory activity of each endocrine gland is therefore integrated in a system or
axis (e.g. the CRH-ACTH-cortisol axis, the THR-TSH-thyroid hormones axis, etc.),
whereby an axis has to be considered as a functional unit and not as a mechanic
cascade with hierarchical ordering. Therefore, for each axis, the central nervous
system (CNS) and the effector cells have to be seen as two terminals, and the
hypothalamus as their fulcrum.1,59
The CNS regulates endocrine activity in response to stimuli that can be external (e.g.
mental stress) and internal (e.g. metabolic variation in osmolarity) through
neurotransmitters (e.g. central monoamines, GABA [γ-aminobutyric acid], etc.) and 
neuromodulators (e.g. cerebral neuropeptides) that act at the hypothalamic-pituitary
level. Peripherally, some substances that are derived from cellular metabolic activity
intervene in hormonal regulation with several direct or indirect mechanisms that aim
at keeping internal conditions stable and constant (homeostasis) in response to
different types of stimuli that tend to modify them. The relationship between the
CNS and endocrine system can be therefore framed within the more complex
interaction between the external and internal environment (Figure 1.7).
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Figure 1.7. A diagram for the interaction between the external and internal environment of the
human body.
External environment
↓ 
CNS ↔ Endocrine system 
↓ 
Internal homeostasis
The hypothalamic-pituitary system is the core of the connections between the CNS
and the endocrine glands and can be regarded as the most important and complex
regulating system for homeostasis. In fact, monoaminergic and peptidergic cells
come in contact just in the hypothalamus. Monoaminergic cells are nerve cells that
produce neurotransmitters (noradrenalin, dopamine, serotonin, etc.) that act locally.
Peptidergic cells are instead real transducers between the nervous and the endocrine
system, because they can be activated by neurotransmitters just like the standard
nervous cells are, but in response to the nervous stimulus they produce peptides that
are biologically active and that are secreted in the hypothalamic-hypophyseal portal
vessels. These are the so-called hypothalamic-hypophyseal peptidic hormones (TRH,
somatostatin, GnRH [gonadotropin-releasing hormone], etc.), that reach the
adenohypophysis (anterior pituitary gland) through the portal vessels and bind to
specific receptors belonging to secreting cells (thyrotrophic, gonadotrophic,
somatotrophic cells, etc.). Some hypothalamic hormones stimulate (“releasing
hormones” or “releasing factors”) and some others inhibit (“inhibiting hormones” or
“inhibiting factors”) the release of their respective hormones from
adenohypophyseal cells. The hormones that are pertinent to the posterior pituitary
gland (neurohypophysis), such as arginine-vasopressin (AVP) and oxytocin, are
instead produced in the neurons of the supraoptic and paraventricular nuclei of the
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hypothalamus and reach the neurohypophysis through the axons of the cells that
have produced them. They are accumulated in the neurohypophysis and then
released in the main blood stream. However, hypophyseal responses to releasing or
inhibiting factors cannot be seen as simple monophasic triggers because they are
modulated by additional neuropeptides and hormones.1,59
We have seen how complex the relationship between hypothalamus and hypophysis
is, but the relationship between the CNS and hypothalamus is even more complex.
The CNS interacts with the hypothalamus through the activation or inhibition of
several systems based on neurotransmitters (noradrenergic, dopaminergic,
serotoninergic, etc.), but, while the single peptidergic cells of the hypothalamus
synthetize only one releasing or inhibiting hormone and are grouped in well-defined
areas on the basis of their secretory activity, each neurotransmitter produced by the
monoaminergic cells can stimulate different parts of the hypothalamus for the
production of different neurohormones. For example, the dopaminergic system
inhibits the release of prolactin but stimulates the release of growth hormone (GH).
Furthermore, the activity of the hypothalamic cells producing hypophysiotrophic
hormones is controlled by more than one kind of neurotransmitter. For example, the
CRH-ACTH-cortisol axis is inhibited by the noradrenergic system and stimulated by
the serotoninergic and dopaminergic systems. Therefore, the complexity of the
connection between CNS and hypothalamus, between mind and body, is given by
this many-to-many system of relationships, where one stimulus can have many
responses and one response can be evoked by many stimuli.1,59
I have focused on the CNS because the hypothalamus is located inside the brain.
However, the parts of the nervous system that consists of the nerves and ganglia
53
outside of the brain and the spinal cord are also very important. These form the
peripheral nervous system (PNS), which can be divided into the somatic nervous
system and the autonomic nervous system (ANS). The main function of the PNS is to
connect the CNS to the limbs and organs, essentially serving as a communication
relay going back and forth between the brain and the extremities. The ANS is
particularly relevant in the study of mental stress because it acts as a control system
that functions largely below the level of consciousness to control visceral functions,
including heart rate, vasoconstriction, digestion, respiratory rate, etc. Most
autonomous functions are involuntary but they can often work in conjunction with
the somatic nervous system which provides voluntary control. The ANS is divided into
three main sub-systems: the parasympathetic nervous system and the sympathetic
nervous system, and the enteric nervous system. Depending on the circumstances,
these sub-systems may operate independently of each other or interact co-
operatively. The sympathetic nervous system is often considered the "fight or flight"
system (increased metabolism, heart rate, vascular tone, respiration rate, etc.), while
the parasympathetic nervous system is often considered the "rest and digest" or
"feed and breed" system. In many cases, but not always, these two subsystems have
"opposite" actions where one system activates a physiological response and the
other inhibits it. There are two kinds of neurons involved in the transmission of any
signal through the sympathetic system: pre- and post-ganglionic. The shorter
preganglionic neurons originate from the thoracolumbar region of the spinal cord
(levels T1–L2, specifically) and travel to a ganglion where they synapse with a
postganglionic neuron. From there, the long postganglionic neurons extend across
most of the body and can reach any tissue where they release noradrenaline, which
activates adrenergic receptors on the peripheral target tissues. The activation of
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target tissue receptors causes the effects associated with the sympathetic system.
Moreover, the neurons can reach and activate the adrenal gland itself, which
develops in tandem with the sympathetic nervous system and can be seen as a
particular type of sympathetic ganglion. Within the medulla (inner part) of the
adrenal gland, pre-ganglionic neurons synapse with chromaffin cells, stimulating the
release of noradrenaline and adrenaline directly into the blood (endocrine effect).
Therefore the CNS, the PNS, and the endocrine system can work as a whole
integrated system.1,59
I have described how the neuroendocrine system regulates the basal or tonic
activities of the various axes in relation to the metabolic needs on the body
(homeostasis). Nonetheless, neuroendocrine connections are also indispensable for
the maintenance of the secretory rhythms that characterise the activity of the body,
the so-called circadian rhythms. For instance, cortisol shows a strong diurnal pattern,
GH and PRL can influence the sleep–wake rhythm, etc. When the frequency of the
peaks, or the amplitude of the pulses, goes beyond certain limits the normal activity
of an axis stops. So there is another form of negative feedback: in many endocrine
systems the pattern of hormonal secretion is as important as the absolute
concentration. Therefore the integrity of the nervous system is important even to
control hormonal variations, for example when ACTH is suddenly released and,
consequently, cortisol circulating levels are increased in response to mental stress.1,59
Stress response can be considered as one of the biological phenomena that are most
indicative of the connections between the nervous and the endocrine systems. Acute
mental stressors can induce hypertension, tachycardia, the release of cortisol,
catecholamines, GH, and PRL that are typical of behaviours such as escape, defence,
55
anger, etc. These responses are considered as forms of adaptation, because they are
meant to nullify the effect of the stressor.1,59
CRH induces the release of ACTH and therefore cortisol, but also of catecholamines
with the interplay of the ANS, and can also produce hyperglycaemia and
haemodynamic variations that are typical of acute stress stimulation. CRH-secreting
neurons have been identified not only in the hypothalamus, but also in areas
correlated with sympathetic and behavioural activity such as the limbic system and
the mesencephalon (midbrain). CRH can be therefore considered one of the most
important mediators of stress that is able to activate metabolic, circulatory,
endocrine, and behavioural responses.1,59
Neuroendocrine-immune interactions
While the endocrine system is responsible for internal homeostasis, the role of the
immune system is to counteract external agents such as bacteria, viruses, other
germs, and proteins. However, some neuropeptides, peptide hormones, and
hormonal receptors that are typical of the endocrine system are expressed also by
immune cells. These cells not only respond to non-self agents with immunoglobulins
but also with several peptides including cytokines (lymphokines and monokines) and
some hormones and peptides that are usually associated with endocrine activity.1,59
Furthermore, the hypophyseal hormones that are produced by the lymphocytes are
regulated by the same factors that regulate the activity of the hypophysis. For
example, ACTH production by the lymphocytes is suppressed by glucocorticoids and
stimulated by CRH, whereas the production of GH is stimulated by GHRH (growth-
hormone-releasing hormone) and suppressed by somatostatin. Cytokines regulate
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the differentiation, the proliferation, and the function of other immune cells, but also
influence other tissues and systems such as fever, protein and lipid metabolism in
muscles, and neuroendocrine function. For example, Interleukin 1 (IL-1) stimulates
the release of CRH at the hypothalamus.1,59
Importantly, during inflammation cytokines are not only released locally but also in
the main blood stream and can influence neuroendocrine function by acting on the
encephalon and/or on the hypothalamus and/or directly on the pituitary gland. Some
endocrine cells are also able to synthetize cytokines.1,59
Therefore, the nervous system can modulate immune function through the
hypothalamic-pituitary-peripheral gland system and the autonomic nervous system.
The hypothalamic-pituitary-adrenal (HPA) system is one of the most important
because the production of glucocorticoids by the adrenal gland has a considerable
suppressive effect on immune function by decreasing the rate of lymphocyte
proliferation, as well as the production of immunoglobulin, cytokines, and mediators
of inflammation such as leukotrienes. The anti-inflammatory action of the
glucocorticoids that are used in clinical practice is based on the inhibitory effects that
I have described. Therefore the HPA response to stress can modulate immune
function and its inflammatory components, including those that influence vessel
permeability. The fact that some products of the inflammation such as interleukin 6
(IL-6) can activate the HPA axis is indicative of the existence a negative feedback that
controls inflammation. Since the HPA axis is controlled by the nervous system we
have to think about a psycho-neuro-endocrine-immune system.1,59
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In summary, mental stress is able to alter the HPA axis, which regulates many body
processes, including the immune system and inflammation.54–57 Mental stress
initiates the release of cortisol by activating corticotrophin releasing factor and
arginine vasopressin neurons in the paraventricular nucleus of the hypothalamus,60
and this leads to the release of adrenocorticotrophic hormone from the pituitary
gland, which triggers the release of glucocorticoids from the adrenal glands.
Moreover, known cross-talk between the brain and the immune system includes the
sympathetic-adrenal-medullary axis, which controls stress-induced catecholamine
release in support of the fight-or-flight reflex.1,59,61,62
Other dynamics
Other dynamics may operate for the association between mental stress and IHD.63
Abnormalities in serotonergic function may influence atherogenesis. Serotonin is a
neurotransmitter found in the CNS and is critical in the regulation of mood,
emotions, and behavior. Serotonin is also found in the platelets which release
serotonin when they bind to a clot, where the neurotransmitter serves as a
vasoconstrictor and helps to regulate haemostasis and blood clotting. Therefore,
serotonin has vasoactive properties and is involved in thrombogenesis and platelet
activation, and hence both central and peripheral serotonergic mechanisms influence
thrombovascular processes.64–66 It is interesting to note that the serotonin that is
found in the platelets is primarily secreted by the enterochromaffin cells of the
gastrointestinal tract, which is innervated by the PNS, where the neurotransmitter is
used to regulate intestinal movements, and then it moves into the platelets.
Preclinical investigations and clinical studies indicate that depression is associated
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with serotonergic dysfunction in the central nervous system and in peripheral
circulating platelets.67–69 Depressed patients, especially those with high levels of
anxiety, showed serotonin-stimulated increases in platelet intracellular calcium,
which is involved in platelet activation and maintenance of blood pressure.70 Other
chronic stressors such as anxiety can also produce alterations in serotonin levels and
function, and serotonergic dysregulation plays a critical role in aggressive behavior
and impulsivity and may be associated with high levels of anger and hostility.71,72
Current hostility and lifetime history of aggressive behavior in adults with major
depression have been associated with high levels of platelet serotonin,73 and
increasing levels of hopelessness have been associated with high whole blood
serotonin levels in a population-based sample of older adults.63
A study on mice has recently ascertained the role of mental stress on hematopoietic
stem cells. Apparently stress increases proliferation of hematopoietic stem cells, i.e.
the most primitive hematopoietic progenitors, giving rise to higher levels of disease-
promoting inflammatory leukocytes. It has also been found that chronic stress
induces monocytosis and neutrophilia in humans. While investigating the source of
leukocytosis in mice, it was discovered that stress activates upstream hematopoietic
stem cells. Under conditions of chronic variable stress in mice, sympathetic nerve
fibres released surplus noradrenaline, which signalled bone marrow niche cells to
decrease CXCL12 levels through the β3-adrenergic receptor. Consequently, 
hematopoietic stem cell proliferation was elevated, leading to an increased output of
neutrophils and inflammatory monocytes. When atherosclerosis-prone Apoe−/− mice 
were subjected to chronic stress, accelerated haematopoiesis promoted plaque
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features associated with vulnerable lesions that cause myocardial infarction in
humans.74
Biological markers of mental stress
The key markers of dysregulation related to mental stress that are relevant to
cardiovascular disease are: blood pressure, heart rate variability, cortisol, C-reactive
protein (CRP), IL-6, von Willebrand factor (vWF), MCP-1, and fibrinogen:54–57,75,76
 Blood pressure. The physical pressure that the blood mass exerts on the
walls of the arteries is measured in millimetres of mercury (mmHg) and is
recorded as two figures: systolic pressure, i.e. the pressure of the blood
when the heart beats to pump blood out, and diastolic pressure, i.e. the
pressure of the blood when the heart rests in between beats, which reflects
how strongly the arteries are resisting blood flow. A blood pressure reading
below 140/90mmHg is considered to be normal.1
 Heart rate variability is the physiological phenomenon of variation in the
time interval between heartbeats. It is measured by the variation in the beat-
to-beat interval, usually within electrocardiographic sessions.1
 Cortisol is a glucocorticoid hormone that is part of the steroid family. It is
produced by the adrenal cortex, specifically in the zona fasciculata. Its
primary functions are to increase blood sugar through gluconeogenesis,
suppress the immune system, and enhance the metabolism of lipids,
proteins, and carbohydrates.1
 CRP is an acute phase protein (i.e. it is released into the plasma in response
to inflammation) that is synthesised by the liver in response to factors
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released by macrophages and adipocytes (fat cells). Its physiological role is to
bind to phosphocholine expressed on the surface of dead or dying cells (and
some types of bacteria) in order to activate the complement system (a part
of the immune system). CRP secretion is stimulated by proinflammatory
cytokines, in particular IL-6. CRP is one of the most widely studied
inflammatory markers.1
 IL-6 is secreted by T cells and macrophages to stimulate immune response
during infections and traumas, leading to inflammation. It is an endogenous
pyrogen capable of inducing fever in people with autoimmune diseases or
infections. More recent studies show that adipocytes are also able to
produce IL-6.77
 vWF is produced by endothelial cells and bone marrow cells, and is a blood
glycoprotein involved in haemostasis, which is the process which causes
haemorrhage (bleeding) to stop. Its primary function is binding to other
proteins and specific cells during the formation of a blood clot. vWF is
important in platelet adhesion.78
 Chemokines (chemotactic cytokines) are small heparin-binding proteins that
constitute a large family of peptides structurally related to cytokines, whose
main function is to regulate cell trafficking. Chemokines play a major role in
selectively recruiting monocytes, neutrophils, and lymphocytes. MCP-1 is a
chemokine that regulates the migration and infiltration of monocytes,
memory T lymphocytes, and natural killer (NK) cells. MCP-1 is produced by
many cell types, including endothelial, fibroblasts, epithelial, smooth muscle,
mesangial, astrocytic, monocytic, and microglial cells. These cells are
important for antiviral immune responses in the peripheral circulation and in
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tissues. However, monocyte/macrophages are found to be the major source
of MCP-1, which is responsible for their migration from the blood stream
across the vascular endothelium.79
 Fibrinogen is a plasma protein produced by the liver and is a major
coagulation factor. It is a positive acute-phase reactant protein, i.e. its
concentration increases with inflammation, and it is traditionally considered
as a risk factor for IHD because it promotes formation of thrombus.80,81
1.5 Epidemiological studies of mental stress and ischaemic heart
disease
Epidemiological studies about the relationship between mental stress and IHD have
been conducted with regards to specific aspects of stress and specific cardiovascular
diseases.
 Work stress. The positive association between high work stress and IHD
incidence has been recently clarified in an individual-level meta-analysis from
13 European cohort studies (1985-2006) of men and women who did not
have any IHD and were employed at the time of baseline assessment, with a
total sample size of about 200,000. The authors screened published and
unpublished data to avoid publication bias. Job strain was measured with
questions from a validated job-content questionnaire and demand-control
questionnaire, which were included in the baseline self-report questionnaire
of all studies. The authors defined the binary exposure variable as job strain
(high demands and low control) versus no strain (all other combinations, e.g.
high demands but also high control, low demands and low control, etc.). The
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authors obtained information about incident coronary heart disease during
the follow-up time from national hospital admission and death registries in
all studies. Individuals were defined as having incident IHD according to the
type and time of diagnosis of their first disease event. The hazard ratio (HR)
for job strain versus no job strain was found to be 1.23 (95% confidence
interval [CI] 1.10-1.37), which means that the incidence rate of IHD was on
average the 23% higher on those who had reported job strain .82
 Anxiety. The link between anxiety IHD has a long history and it has been now
accepted by the scientific community.83–87 For example, a recent meta-
analysis assessed the association between a comprehensive set of common
anxiety constructs (including anxiety, panic, phobia, post-traumatic stress,
and worry) and incident IHD. The included studies were prospective in
nature, following a nonpsychiatric cohort of initially healthy persons over
time. Studies had to include at least one self-report or interview-based
assessment of anxiety symptoms or anxiety disorder at baseline (e.g., post-
traumatic stress disorder, tension, worry, phobic anxiety, panic, or
generalized anxiety disorder), and had to monitor the incidence of IHD. The
mean follow-up period was about eleven years. Anxious persons were at
higher risk of IHD (HR =1.26; 95%CI =1.15-1.38; P <0.001).88 Moreover, a
prospective cohort study evaluated the effect of generalised anxiety disorder
on cardiovascular prognosis, i.e. in subsequent cardiovascular events after
the first one. After having followed up about a thousand outpatients with
stable IHD for six years on average (patients were interviewed on an annual
basis), it was found that patients with anxiety were more likely to experience
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a relapse or worsening of the disease (HR =1.74; 95%CI= 1.13-2.67; P
=0.01).89
 Social relationships. Although some studies show no associations with
disease,90 the overwhelming consensus is that positive social factors do
protect against heart disease to some extent.63,91–93 For example, in a recent
meta-analysis of prospective studies on loneliness and social isolation, the
pooled relative risk for social isolation or loneliness and first IHD event across
the 9 studies identified was 1.5 (95%CI =1.2-1.9).57
 Anger and hostility. Investigations into the effects of anger and hostility on
risk for CVD have a long history. Early psychoanalytic and psychodynamic
literature described episodes of anger, hostility, or other strong emotions or
personality characteristics, such as aggressiveness and a need to be hard-
driving and tough-minded, in patients with heart disease or hypertension.
These observations, together with the need to provide a clearer definition
and assessment of what was deemed “coronary-prone behavior,” motivated
work in the 1950s and 1960s on what came to be called the Type A behavior
pattern. On the basis of observations of their own cardiac patients,
Rosenman & Friedman described the Type A individual as one who was
exceedingly hard-driving and ambitious, competitive, time-urgent, and
unusually quick-tempered and tightly wound. Their initial work suggested
that Type A men and women had higher cholesterol levels and greater
evidence of IHD, compared with those who were “Type B”.94 In the past two
decades, numerous studies have investigated hostility and anger, measured
with various instruments, in relation to risk of hypertension, stroke, and IHD
morbidity and mortality, with both positive and null findings. However, a
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meta-analytic review of 45 studies published in 1996 concluded that hostility
is an independent risk factor for IHD and all-cause mortality.95 A number of
studies investigating hostility and/or anger and incident CVD have been
published since then; the majority reported positive associations.63
 Depression and other mood factors. Over the past 40 years more than 60
prospective studies have examined the link between established indices of
depression and IHD. Despite differences in samples, duration of follow-up,
and assessment of depression and depressive symptoms, these studies have
demonstrated relatively consistent results and the literature continues to
support both an etiologic and a prognostic role for depression.96 For
example, a recent systematic literature review on depression and adverse
medical outcomes after IHD (all-cause mortality, cardiac mortality, and
nonfatal events) that included 57 studies, concluded that despite the
heterogeneity of published studies, the preponderance of evidence supports
the recommendation to elevate depression to the status of a risk factor for
adverse medical outcomes in patients with IHD.97 Hopelessness is one
symptom of depression that appears to have particularly adverse effects on
health. A single item on hopelessness extrapolated from a multi-item
measure of depressed affect predicted a more than two fold risk of fatal and
nonfatal IHD and was a stronger predictor than the complete measure.98 In
the San Antonio Heart Study, high levels of hopelessness predicted all-cause
and CVD mortality in Mexican Americans and Caucasians.99 Everson and
colleagues found that hopelessness predicted a two fold increase in
cardiovascular mortality, AMI, and all-cause mortality over six years of
follow-up in a population sample of middle-aged Finnish men from the
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Kuopio Ischemic Heart Disease study, after controlling for demographic
characteristics, cardiovascular risk factors, and overall depressive
symptoms.100 Furthermore hopelessness was related to accelerated
progression of intimal-medial thickening in the carotid arteries and threefold
greater risk of incident hypertension over four years in the KIHD study.101,102
Combination of stressors. Stress sources can be studied in combination. For
example, a systematic review and meta-analysis of the association between
perceived stress and incident IHD at >6 months was carried out combining
observational cohort studies that measured self-reported perceived stress from
different sources, i.e. work stress, marital conflicts, financial strain, and emotional
stress. The meta-analysis yielded an aggregate risk ratio of 1.27 (95% CI =1.12-1.45)
for the magnitude of the relation between high perceived stress and incident IHD.103
There are however limitations to the studies that I have reported. Often mental
stress measures are not objectively assessed but are self-reported, with issues of
information bias. They are observational studies, and therefore there may be
unknown factors confounding the results. Confounding happens when an unknown
and therefore unmeasured risk factor for the outcome under study is associated with
the exposure under investigation, and therefore it can be an alternative explanation
for the supposed exposure-outcome association. Some residual confounding can also
come from known factors, if they have been measured without sufficient accuracy
and precision. Furthermore, although these observational studies had prospective
nature, the issue of reverse causality cannot be ruled out (early stages of the disease
causing mental stress). These issues could be addressed by implementing
randomised controlled trials (RCTs), in which the exposure variable is randomly
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allocated to study participants (RCT have many other features, such as blindness for
example, but the description of those features goes beyond the aims of this
dissertation). Well-designed RCTs can eliminate the issues of known and unknown
confounding factors as well as of reverse causality.
There have been some RCTs carried out to study the association between mental
stress and IHD. The disadvantage of RCTs is that they are more expensive than
observational studies and therefore tend to have smaller sample sizes, and thus they
are not able to detect small effect sizes and therefore are not very effective for
relatively rare events such as AMI and cardiovascular mortality. For example, in a
double-blind, placebo-controlled randomised trial conducted in 40 outpatient
cardiology centres and psychiatry clinics in the United States, Europe, Canada, and
Australia, 369 patients with major depressive disorder and who had recent AMI or
unstable angina were randomly assigned to receive sertraline (a drug used to treat
depression) with the aim of assessing drug safety by measuring the change in left
ventricular ejection fraction. The drug resulted to be safe and effective for the
treatment of recurrent depression in patients with IHD and in secondary analyses, it
was also found that the incidence of severe cardiovascular adverse events was 14.5%
with sertraline and 22.4% with placebo, but this results was not statistically
significant (P >0.05).104 Furthermore, a RCT with about 2,400 AMI patients, evaluated
the effect of cognitive behavior therapy that was designed to tackle depression and
low-perceived social support towards mortality or recurrent AMI, and it was found
that the intervention did not increase event-free survival.105
A meta-analysis of 21 aetiological and 34 prognostic cohort studies on the effect of
depression on IHD was explicitly set out to estimate the contribution of confounding,
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reverse causality and other biases.106 The authors argued that several biases are likely
to lead to an overestimation of the depression–IHD association. For example they
found some evidence of publication bias, with smaller negative aetiological studies
missing. Furthermore, no adjustment for coronary risk factors could be included for
nearly half of the aetiological studies, and in these studies, the adjusted effect was
systematically lower than the unadjusted effects in studies which also reported
adjusted differences. This suggests that adjustment for IHD risk factors was
selectively reported in studies which had stronger effects, and therefore, had
adjustment been available in all aetiological studies, the overall adjusted depression
effect would have been weaker. When adjustment was carried out, it seldom
included all the major IHD risk factors. Many studies omitted adjustments for IHD risk
factors known to be associated with depression such as smoking, exercise, BMI, and
alcohol. Time-dependent covariates, to allow for change in health behaviours during
follow-up, were very rarely used. The authors also noted that the healthy population
studies tended to remove patients with prevalent IHD at baseline, but this does not
preclude the possibility of reverse causality. Coronary disease commonly presents
with chronic angina, or non-specific chest pain (which were seldom explicitly
excluded) and this may lead to depression, but many studies made limited or no
attempt to remove such patients from analyses. Among those without symptoms of
chest pain, depression might initiate atherosclerosis de novo or accelerate the
progression of underlying atherosclerosis. Consistent with the latter possibility, the
authors found that the strongest effect of depression on IHD incidence was found in
early periods of follow-up. In prognosis studies, it was found no evidence that more
severe depression (as indicated by either lower prevalence of depression or clinical
assessment) had stronger associations with prognosis than less severe depression.
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This is consistent with depression being a consequence of ill-heath rather than an
adverse prognostic risk factor. Selection bias and information bias (in particular
differential misclassification, i.e. a type of measurement error that distorts the
results) were also considered by the authors with the following arguments. Higher
effects were found when depression was assessed clinically rather than defined by
symptom scales in aetiological studies. Studies with clinical assessment are likely to
have a higher proportion of more severely depressed patients in their exposed group
than studies with detection by symptom scale, suggesting that more severe
depression carries a higher risk of IHD. Moreover, studies with a lower prevalence of
depression at baseline also reported higher effect estimates. Although true
underlying prevalence of depression will vary between study populations, it is
plausible that a lower prevalence of depression also denotes more severe
depression, supporting the findings on the mode of assessment. In other words, if
study participants with non-severe forms of depression and who were at lower risk of
developing IHD were wrongly categorised as not having depression or even excluded
from the study, the effect of depression on IHD would be overestimated.106 Some of
the mood and behavioural conditions that are linked with IHD appear to be different
or sometimes opposite from each other. Anxiety and depression are an example of
that. Anxiety is an unpleasant state that is often accompanied by nervous behaviour
and a feeling of worry that usually lead to overreaction to normal situations, whereas
depression is a persistent sadness or low mood with associated loss of interest in
activities and often failure to react to situations. In spite of those dissimilarities, both
conditions are positively associated with higher chances of IHD. It has been argued
that affective dispositions can overlap and that a general disposition toward negative
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affectivity may be more important for disease risk than any specific negative
affect.107
Furthermore, it is highly likely that the psychosocial risk factors described above do
not work in isolation and that there is a resultant clustering of psychosocial risk
factors, which produces an interactive pathophysiological effect, potentially greater
than the effect of the factors added together. For example, people experiencing
severe work stress may also become anxious or depressed; or, slightly abnormal
levels of work stress may be particularly harmful for depressed or anxious people, for
whom the deleterious effect of stress may be amplified. Moreover, psychosocial
variables converge with conventional CVD risk factors (such as smoking for example)
which compound the effect further.63,108
Mental stress may not only converge with classic heart disease risk factors, but also
with low socioeconomic status (SES). For example, Steptoe and Marmot (2003)
devised a scale aggregating chronic stress exposure and available social resources to
investigate the cumulative effect of psychosocial adversity on quality of life. Using a
Whitehall II sample of men and women, the PAVIX (Psychosocial Adversity and
Vulnerability Index) was associated with depression and hostility and correlated with
SES.109
1.6 Socioeconomic status
The study of the relationships between SES and health has a long scientific history.
Since the time of rapid industrialisation and migration of the population into urban
areas in Europe, observers have noted links between poor health and adverse living
conditions associated with poverty. In the past few centuries, carefully-conducted
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studies documented disease associations with poverty using early statistical
approaches, e.g. mapping cases within geographical areas, comparing diseased and
healthy groups on living conditions. Medicine, epidemiology, sociology, demography,
and economics are only some of the disciplines that participated in establishing the
strong and consistent gradients between SES and health. Across diverse health
outcomes, individuals who are less educated, have lower-status jobs, who earn less
or no income are at greater risk for poor health than their higher-SES counterparts.
The associations extend from relatively minor illnesses, e.g. headaches, to serious
and life-threatening diseases, e.g. coronary heart disease, to early mortality, and are
apparent across the life course. Individually and in aggregate, across the life course,
time, and space, a vast number of studies have shown how socioeconomic
disadvantage is related to poorer health.110
SES is an umbrella term for a range of indicators and interconnected concepts that
are key to understanding inequalities in health. SES is therefore related to numerous
exposures, resources, and susceptibilities that may affect health. There is no single
best indicator of SES suitable for all study aims and applicable at all time-points in all
settings. Each indicator measures different, often related aspects of socioeconomic
stratification and may be more or less relevant to different health outcomes and at
different stages in the life course. The choice of SES measure(s) should ideally be
informed by consideration of the specific research question and the proposed
mechanisms linking SES to the outcome. This is the case when SES is the exposure of
interest as well as when it is being considered as a confounding/mediating/modifying
factor. If the central interest is to show the existence of a socioeconomic gradient in
a particular health outcome then the choice of indicator may not be crucial.
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However, even in a case such as this, using different indicators of SES may result in
gradients of varying slopes. Furthermore, while a single measure of SES may show an
association with a health outcome, it will not encompass the entirety of the effect of
SES on health. This issue is of particular importance when SES is a potential
confounding/mediating/modifying factor. Multiple SES indicators, preferably
measured across the life course, will be needed to avoid residual confounding, or
mediation, or effect modification, by unmeasured socioeconomic circumstances.111–
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A description of the theoretical basis, measurement, interpretation, strengths, and
limitations of each SES indicator goes beyond the aims of this dissertation, and I will
just note that the markers of SES that are typically used in medical research are:111–116
1. Occupational status
2. Level of education
3. Individual or household income
4. Social deprivation
5. Neighbourhood deprivation
Socioeconomic status has therefore different components: it can be an indicator for
an individual’s rank or prestige in relation to others (i.e. the “social” component of
SES) and/or can describe access to material and social resources and goods (i.e. the
economic component), and/or can be correlated to an individual’s education level
and consequently to his/her psychological skills. Therefore, many factors may
contribute to generate SES disparities in health, and among the most prominent
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candidates are limited access to appropriate health care, poor health-related
behaviours, and mental stress.111–116
Health care systems are vital determinant of health. Their dedicated resources are
often too scarce and/or misused in developing and developed countries.117 In 2008
the general director of the World Health Organisation declared: “no one should be
denied access to life-saving or health-promoting interventions for unfair reasons,
including those with economic, social, or political causes.”118 Health care is
inequitably distributed around the world and the pattern of inequity in utilisation is
pronounced in low- and middle-income countries but is also present in high-income
countries. The so-called ‘inverse care law’, in which the poor consistently gain less
from health services than the better off, is visible in every country across the
globe.119
In the United States of America (USA), ethnic minorities are more likely to be
diagnosed with late-stage breast cancer and colorectal cancer than whites and
patients in lower socioeconomic strata are less likely to receive recommended
diabetic services and more likely to be hospitalised for diabetes and its
complications. Inequalities in health care are related to a host of socioeconomic and
cultural factors, including income, ethnicity, gender, and rural/urban residency in the
USA.120 In China, low socioeconomic status is closely associated with poor secondary
prevention in patients at high risk of IHD: among patients affected by IHD who are
very likely to experience a new IHD event, secondary prevention was prescribed less
in low SES patients.121 In a systematic comparison of hospital quality indicators in the
USA and United Kingdom (UK) with regards to IHD patient in need of surgical or
minimally-invasive treatment procedures such as CABG and PCI, low SES strata were
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less likely to be treated in a timely fashion and were assigned to longer waiting
lists.122 Despite differences between the USA third-party payer health system and the
UK socialised one, each country faces the same SES inequalities regarding waiting
times.122 Similar results have been found in other countries such as Sweden,123
Finland,124 and Denmark.125 Moreover, in a historical cohort study with ecological
analysis comprising about 8,000 patients with new-onset stable chest pain but no
known cardiac history, it was found that those from low SES were less likely to be
referred to chest pain clinics.126 Furthermore, using hospital administrative data for
all patients admitted to any English public hospital, a survey of about 200,000 stroke
patients found that least socio-economically deprived patients appeared to have
more chance of being selected for appropriate brain scan.127 Nevertheless there are
some contrasting results. Using the data from the Whitehall II prospective cohort
study, about 10,000 civil servants were followed up for over 15 years. Service
employment grade was used as a measure of individual socioeconomic position, and
the need for cardiac care was determined by the presence of angina, myocardial
infarction, and coronary risk factors. The use of exercise electrocardiography,
coronary angiography, and coronary revascularisation procedures and secondary
prevention drugs were the main outcome measures, and there was no evidence that
low SES was associated with lower use of cardiac procedures or drugs, independently
of clinical need.128
As we have seen, the treatment for IHD is one of the most studied indicators of
health inequality. This is mainly because IHD is the most common cause of death in
the developed world and there are internationally-recognised guidelines for its
appropriate treatment.129
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Behaviours such as smoking, food choice, physical inactivity, and alcohol
consumption are well recognised determinants of health.130
There is a SES gradient in health-related behaviours - with low SES groups being more
likely to make unhealthy choices - an effect that has been consistently described in
population surveys.131–133 Moreover, Wardle & Steptoe (2003), while confirming that
high SES sectors of the population are less likely to make unhealthy choices,
demonstrated that low SES is associated with less health consciousness (being able to
distinguish between the healthy and the unhealthy choices), stronger beliefs in the
influence of chance on health, less thinking about the future, and lower life
expectancies. These attitudinal factors are in turn associated with unhealthy
behavioural choices.134
As a consequence, health-related behaviours may be considered as important
mediators between SES and health (cardiovascular health in particular): low SES
people are more likely to make unhealthy choices which in turn put them at higher
risk of CVD and mortality.135,136
Nonetheless, the socioeconomic gradient in healthy behaviours may be different
between developed and developing countries. In an analysis that I carried out in
collaboration with colleagues in Thailand and Australia of an international
comparison of representative samples from Thailand and England with about 40,000
participants, I found that, while mental stress was consistently associated with low
SES in both countries, in Thailand there was a flat slope (in men), or even a negative
slope (in women) for the association between SES and healthy behaviour, with Thai
females being less likely to have unhealthy behaviours when they were in low SES.137
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The next section will describe how mental stress can interact with SES for the
determination of IHD.
1.7 The reserve capacity model
We have seen how mental stress is becoming increasingly recognised as a risk factor
and trigger for IHD events54,55,57 and how SES is also a recognised determinant of
health status: the lower a person’s SES the worse his or her health.113,138,139 In
particular, low SES is associated with high risk of IHD in developed countries such as
England.140,141
I have mentioned that mental stress may be one of the mediators between SES and
IHD. However there are inconsistent findings in the literature on this matter with
consequent limited support for a mediating role of stress. For example, some studies
report either no relationship between SES and stress142,143 or, even more surprisingly,
an opposite association such that higher stress was found to be present in more
advantaged SES groups.144 While it has been proposed that different aspects of
chronic work stress contribute to the relationship between SES and health outcomes
such as IHD,145,146 some studies investigating whether various forms of stress
contribute to SES-health associations have produced null findings.147,148 Moreover,
whereas some studies have identified support for an intermediate role of negative
emotions, including depression and anxiety, in connecting SES with health
outcomes,147,149 other studies have failed to provide evidence for these
pathways.150,151
The relatively weak support for an intermediary role of stress stimulated the
researchers Gallo and Matthews to hypothesise their reserve capacity model.110,152
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This model focuses on interpersonal and intrapersonal resources as modifiers of the
effect of environmental demands and stresses on emotional and physiological
responses. From this perspective, on the one hand low-SES environments foster
greater exposure to frequent and intense harmful or threatening situations and
fewer rewarding or potentially beneficial situations, which in turn, are believed to
have direct negative effect on emotional experiences. On the other hand, low-SES
individuals maintain a smaller bank of resources (tangible, interpersonal, and
intrapersonal) to deal with stressful events when compared to their higher-SES
counterparts.
Resources banks, termed reserve capacity, may be low in low-SES circumstances for
two reasons:
1. Low-SES individuals are exposed over the life course to more situations that
require the use of resources.
2. The environment of low-SES people prevents the development and
replenishment of resources to be kept in reserve.
Hence, because individuals of low SES have fewer stress-dampening resources, which
are further reduced by enduring or repeated stress exposures, they are likely to show
increased responsiveness when faced with challenges and demands.110,152
Figure 1.8 shows a diagram for the reserve capacity model for the dynamic
associations among environments of low SES, stressful experiences, psychosocial
resources, emotion and cognition, and biological and behavioral pathways predicting
morbidity and mortality over time. Dashed lines depict possible reciprocal influences.
Arrow A depicts the direct influence of SES on exposure to stressful experiences.
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Arrow B indicates the direct impact of stressful experiences on emotion and
cognition. Arrow E shows the effects of stress on intermediate pathways
hypothesized to affect health outcomes. Arrow C shows that socioeconomic
environments condition and shape the bank of resources (i.e., the reserve capacity)
available to manage stress. Arrow D shows that the reserve capacity represents a
potential moderator of the association between stress and cognitive–emotional
factors. Arrow E indicates the direct impact of cognitive–emotional factors on
intermediate pathways and Arrow F on intermediate pathways to illness and death.
Figure 1.8. A diagram for the reserve capacity model.
In synthesis, people in higher SES categories may have greater economic, social, and
psychological resources and better coping strategies for dealing with adversity, and
therefore mental stress may not be considered as a mediator between SES and
health but it may interact with SES, such that the effect of mental stress on health is
modified by SES, so that measures of association between mental stress and health
HPA: hypothalamic-pituitary-adrenocortical axis.
SAM: sympathetic adrenal-medullary axis.
Adapted from Matthews KA, Gallo LC, Taylor SE. Ann N Y Acad Sci. 2010 Feb;1186:146-73.
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may differ according to categories of SES. In other words, low-SES may be an
amplifier of the detrimental effect that mental stress exerts on human health.
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Chapter 2 - Aim of the study
The aim of this thesis was to analyse the combined association of mental stress and
low SES with the risk of acute myocardial infarction, with an emphasis on the
interaction between the two risk factors. I hypothesized that SES can operate as an
amplifier of mental stress, such that when both risk factors are present the resulting
effect on the risk of AMI is not the mere sum of the two (additive effect) but that
some extra risk may appear (multiplicative effect). In other words, I hypothesized
that the effect of mental stress on AMI would be greater in lower than higher SES
groups.
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Chapter 3 - Systematic literature review
The present systematic literature review has been carried out to check whether my
research hypothesis had been already addressed, in order not to duplicate existing
evidence, and hence it was not designed to produce a synthesis of knowledge.
Therefore I aimed at retrieving works that had explicitly hypothesised the existence
of an interaction between mental stress and SES and a priori, and I deliberately
neglected secondary results from subgroup analyses. In fact, it has been shown that
post hoc subgroup analysis can lead to false positive results simply due to chance.153
3.1 Methods
I systematically searched the databases Medline and Embase for relevant articles. I
used the following MeSH terms (for Medline) or Emtree terms (for Embase) to
identify articles that were relevant to my research hypothesis (the search was
restricted to major topics):
1. Behavior and Behavior Mechanisms
2. Socioeconomic Factors
3. Cardiovascular Diseases
The three groups were combined using the Boolean logic term “AND”.
The Mesh/Emtree term Behavior and Behavior Mechanisms includes behavioural and
affective concepts such as depression and psychological distress, emotions such as
anxiety and hostility, and psychosocial concepts such as family conflict, psychosocial
deprivation, and social distance, and many other psychosocial conditions. The
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Mesh/Emtree term Cardiovascular Diseases can include all cardiovascular diseases
that may share common pathophysiology with AMI. I have therefore deliberately
chosen broad entry terms to make my search as sensitive as possible. In addition, I
have performed a free-text search on the same databases using the entry terms
described in Table 3.1. Entry terms within each group were combined using the
Boolean logic term “OR”, whereas the groups were combined together using “AND”.
This search was restricted to titles and abstracts.
Table 3.1. Free-text entry terms for the systematic literature review.
Mental stress SES CVD Interaction
• (mental OR psychological
OR psychosocial OR
perceived OR work OR job)
AND (stress OR distress OR
stressor* OR strain)
• (socioeconomic OR social
OR economic OR
occupational OR
employment) AND (status
OR class* OR position* OR
deprivation OR grade* OR
type*)
• (cardiovascular OR cardiac
OR heart) AND disease*
• interact*
• modif*
• "coronary artery disease" • buffer*
• "coronary heart disease" • amplif*
• ("high demand") OR ("low
control") OR ("effort
reward")
• "ischaemic heart disease" • synerg*
• income • infarction • multipli*
• (family OR marital) AND
(conflict OR status)
• education OR "educational
level" • angina • additi*
• neighbourhood OR area • stroke • subgroup*
• "care giving" • strat*
• depression • attenuat*
• anxiety • moderat*
• hostility
• optimism
• hopelessness
• helplessness
• "positive thinking"
• "social support"
• "social network"
The asterisk (*) represent truncation, i.e. the search considers all words starting with the text before the asterisk. For
example class* = class, classes, classification, etc. Double quotes indicate exact phrase searching. Hyphenation gives
the same results of non-hyphenation; e.g. high demand = high-demand.
The identified articles were then screened for eligibility by reading their titles and
abstracts. Among the articles that passed this screening, a further screening was
applied by reading their full text. The present systematic review was conducted and
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reported according to the PRISMA (Preferred Reporting Items for Systematic reviews
and Meta-Analyses) guidance.154
3.2 Results
1,906 hits were obtained after combining all searches and after excluding duplicate
articles, although only 35 passed the title/abstract screening and only eleven articles
were included in the review (Figure 3.1).
Figure 3.1. Adapted PRISMA flowchart
Records after duplicates removed
(n =1,906)
↓ 
Records screened in title
→ 
Records excluded
(n =1,906) (n =1,424)
↓ 
Records screened in abstract
→ 
Records excluded
(n =482) (n =447)
↓ 
Records screened in full-text
→ 
Records excluded
(n =35) (n =24)
↓ 
Records included in the review
(n =11)
The description of each study is presented in chronological order below.
Kuper and Marmot in 2003 conducted a cohort study on around 10,000 British civil
servants followed up for about eleven years (Whitehall II study). They have
considered job strain as the main exposure variable, which was defined as the
combination between low control and high demand and was measured using
questionnaires. Incident IHD was the main outcome variable and it was ascertained
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using either the National Health Service Central Registry for fatal events or
questionnaires and clinical records for non-fatal events. SES was considered as a
potential effect modifier and indexed using occupational grades grouped into three
categories: clerical, professional, and administrative. While confirming the role of job
strain for the determination of IHD, the authors concluded that there was no effect
modification by employment grade.155
Toivanen et al. (2008) developed a register-based cohort study of nearly 3.5 million
Swedish workers, and studied the effect of job control on fatal stroke, taking into
account socioeconomic status. They used population registry data from the 1990
Swedish Census that were linked to the national Cause-of-Death Registry (1990 to
1995). Occupational holders 25 to 64 years of age in 1990 who did not emigrate
during the follow-up period were included. The exposure variable was not measured
at the individual level but imputed using external data, i.e. mean job control
exposures stratified by gender and age groups have been estimated based on the
Swedish Surveys of Working Conditions (nearly 50,000 respondents) for the period
1989 to 1997 for 320 occupational families (3-digit Nordic Occupational Classification
Codes), and information from this job exposure matrix was used to impute exposures
to each occupational code in the census. It was found that the association between
job control and fatal stroke was significant only for lower non-manual jobs.156
Janszky et al. (2010) studied the association between depression or anxiety and heart
disease within a cohort study of about 50,000 men recruited in their adolescence
who were followed up for an average time period of 37 years. All the conscripts were
seen by a psychologist for a structured interview and depression and anxiety was
diagnosed according to International Classification of Diseases. SES was measured at
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baseline and was indexed using self-reported information about the type of
occupation that the head of the household had during participants’ childhood.
Hospitalization and mortality for IHD were identified by the Swedish health registers.
The authors considered SES as a potential effect modifier and did not find any
positive results in stratified analyses.157
Toivanen (2011) further evaluated the interplay between work stress and
socioeconomic position in relation to health. Data from the Swedish Level of Living
Survey provided a representative sample of the working population in Sweden
including women and men in a variety of occupations. The surveys were carried out
through personal interviews and the questions covered a wide spectrum of living and
working conditions. At each measurement point, the surveys comprised a random
sample of roughly 2,600 persons from the Swedish population. Job strain was defined
as having high psychological demands and low job control and self-reported health
was the main outcome. Occupational class was used as the indicator of
socioeconomic position and was categorised into five groups: unskilled manuals,
skilled manuals, lower non-manuals, intermediate non-manuals, and higher non-
manuals. The variable was further categorised into lower socioeconomic position
(manual classes) and higher socioeconomic position (non-manuals). Interaction was
studied by comparing odds ratios for work stress across strata of socioeconomic
position, and assessed by calculating the synergy index.158 A synergy index with a
value greater than one implies synergism, whereas a value below one indicates
antagonism concerning the influence of work stress and low SES on health. Following
this method, a composite variable with four categories was computed for each work
stress model combining work stress and SES: those exposed to work stress and low
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SES, work stress but not low SES, low SES but not work stress, and neither work stress
nor SES. The authors concluded that the joint influence of work stress and low SES on
health was additive rather than multiplicative.159
Tsutsumi et al (2011) studied the effect of occupational stress on stroke across
occupational classes for about 6400 Japanese workers, with an average follow-up of
11 years, and found an interaction between stress and work class. Data were
acquired from routine mass screening examinations for cardiovascular diseases in the
aged. Two categories of occupation (white-collar and blue-collar) and two categories
of position (manager and non-manager) were used to reflect the occupational classes
related to SES. Occupational stress was evaluated at baseline using a Japanese
version of the Demand-Control Questionnaire from the WHO-MONICA Psychosocial
Study Questionnaire. During the follow-up participants were contacted annually by
direct interview or telephone/letter to determine their health status. Participants
were asked if they had suffered a stroke or cardiovascular disease after enrolling.
They were asked which hospital they attended and when, to ascertain the incidence
of these diseases. When an incident case was suspected, all the medical records were
reviewed and duplicate computer tomography films or magnetic resonance imaging
films for these patients were obtained. The outcome was also measured using
mortality records and specific causes of mortality were determined for all
participants using the Cause-of-Death Register found at the public health centre
located in each community. The findings show a significantly higher risk of incident
stroke in men with high job strain among blue-collar workers and those in non-
managerial jobs, but not among white-collar workers or those in managerial
positions. The opposite trends were observed in women, i.e. significant elevated risks
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among white-collar and managerial workers, but not among blue-collar workers or
those in non-managerial positions.160
Suadicani et al. (2011) used data from the Copenhagen Male Study that was
established in 1970–1971. At 14 companies in Copenhagen, covering the railway,
public road construction, military, post, telephone, customs, national bank, and the
medical industry, all men aged 40 to 59 years were asked to participate in the study.
The final sample size comprised about 4,900 men. The examination consisted of a
questionnaire, a short interview, and a clinical examination. The following questions
were used to mark psychological pressure at work and leisure: “Are you under
psychological pressure when performing your work? Do you take sedatives or sleep
medicine? Are you under psychological pressure in your leisure time?” Answer
options were: “Rarely”, “Regularly”, or “Never”. The men were divided into five SES
classes according to a system based on education level and job position in terms of
number of subordinates. Information on death diagnoses within the period 1970-71
to end of 2001 was obtained from official national registers. Also hospitalisation due
to stroke identified in the National Hospital Register between 1977 and 2001 was
used. The result was that regular psychological work pressure is a highly prevalent
and independent risk factor for stroke among men in higher SES classes, while no
association to stroke risk was found among low SES men.161
Mittag et al. (2012) evaluated whether the association between depressive
symptoms and ischemic heart disease in older adults is moderated by education,
using data from a health survey commissioned by the U.S. government. The baseline
cohort included a sample of about 64,000 older adults who had not reported IHD,
who were then followed up for around two years. Depression was assessed by three
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items: “In the past year, have you had two weeks or more during which you felt sad,
blue or depressed; or when you lost interest or pleasure in things that you usually
cared about or enjoyed? In the past year, have you felt depressed or sad much of the
time? Have you ever had two years or more in your life when you felt depressed or
sad most days, even if you felt ok sometimes?’’ Positive responses to any of these
items were taken as an indication of depressive symptoms or episodes in the past.
Education was assessed by this item: “What is the highest grade or level of school
that you have completed?” Possible answers were: “less than high school education;
high school education; greater than high school education.” IHD was assessed by two
questions: “Has a doctor ever told you that you had angina pectoris or coronary
artery disease? Has a doctor ever told you that you had a myocardial infarction or
heart attack?” If any of these items were answered positively the existence of IHD
was assumed. The authors concluded that the association of depressive symptoms
and IHD in older adults is not moderated by education.162
Wiernik et al. (2013) tested whether occupational status moderates the association
between current perceived stress and high blood pressure with a cross-sectional
design. Resting blood pressure was measured in about 120,000 adults aged ≥30 years 
without history of cardiovascular and renal disease and not on either psychotropic or
antihypertensive treatment that attended a medical centre for a medical check-up in
Paris, France. Perceived stress in the past month was measured with the French
version of the 4-item Perceived Stress Scale. Occupational status was categorized in 6
classes: (1) high (e.g. managers); (2) medium (e.g. clerks or first-line supervisors); (3)
low (e.g. blue collar workers); (4) unemployed participants (i.e. seeking employment);
(5) participants without a paid occupation (e.g. housewives); and (6) others (e.g.
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artisans). The interaction between occupational status and perceived stress was
significant (P <0.001). In analyses stratified by occupational categories, perceived
stress was negatively associated with high BP among participants of high
occupational status, but positively associated among those of low occupational
status and among the unemployed.163
Redmond et al. (2013) recruited about 24,000 community dwelling participants
residing in the continental United States. Baseline data collection was completed
using computer-assisted telephone interviews to collect medical history, functional 
status, health behaviours, and psychosocial measures. In-home examinations were 
conducted by trained health care professionals using standardised, quality-controlled 
protocols to collect physiologic measures. The primary independent variable was
baseline perceived stress, as assessed by a 4-item version of the Perceived Stress 
Scale. SES variables included education (less than high school, high school graduate,
some college, college graduate) and household annual income (<$20 000; $20 000 to
$34 000; $35 000 to $74 000; ≥$75 000). During the a mean follow-up of 4.2 years, 
living participants or their proxies were contacted every 6 months by telephone with
retrieval of medical records for reported hospitalisations. Deaths were detected by
report of next-of-kin or through online sources (e.g. Social Security Death Index) or 
the National Death Index. Proxies or next-of-kin were interviewed about the 
circumstances surrounding death including the presence of chest pain. Death
certificates, medical records, and autopsy reports were obtained to adjudicate cause
of death and cardiovascular outcomes. The results showed that high stress was
associated with greater risks of IHD and death for individuals with low but not high
income.164
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Kermott et al (2013) studied 325 high-income patients undergoing comprehensive
health assessment in a cross-sectional manner. Stress was assessed using the
validated Self-Rated Stress instrument. Coronary artery calcification served to assess
the degree of atherosclerosis. Although in the study there was no comparison group
(low SES), it was concluded that stress did not play a role in early IHD when focusing
on a population in higher socioeconomic strata.165
In a cross-sectional study, Schreier et al. (2014) tested whether family chaos
influences adolescents' inflammatory profiles and whether adolescents from low SES
environments are at higher risk for experiencing adverse inflammatory profiles from
living in chaotic family environments. A total of 244 families with an adolescent aged
13 to 16 years participated. Parents completed measures of family SES and family
chaos. Both systemic inflammation and stimulated proinflammatory cytokine
production in response to bacterial challenge were assessed in adolescents. The
results suggest that SES moderates the detrimental effect of family chaos on systemic
inflammation and on stimulated proinflammatory cytokine production in
adolescents, such that a chaotic family environment is positively associated with
greater systemic inflammation and greater stimulated proinflammatory cytokine
production in adolescents as family SES declines.166
3.3 Discussion
I have shown that there is a gap in medical knowledge with regards to the interaction
between mental stress and SES for the determination of cardiovascular disease
outcomes such as AMI, and this research hypothesis has no definitive answer. Out of
the eleven studies included in the review, five found an interaction, four found no
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interaction, one study on male population found an inverse interaction, with high-SES
participants being more vulnerable to stress, and one study found positive
interaction in men and inverse in women. Moreover, there was considerable
variation in study design and quality among the articles. For example, some studies
did not have IHD as an outcome although they had diseases or conditions that are
linked with or have common pathophysiology compared to IHD; some did not have
prospective nature and one did not have a comparison group; in many cases a formal
statistical test for interaction was not performed; and sometimes variables were
measured using non-validated methods or with low precision.
The methods that I have used for this literature review are not as exhaustive as those
that are usually used for the purpose of knowledge synthesis and meta-analysis. For
example I did not search the grey literature, I did not perform any sort of hand
searches, and I did not deal with the issue of publication bias. I have however already
specified that this literature review was produced only to check whether my research
hypothesis had already been fully addressed, in order not to duplicate existing
evidence. Given the lack of definitive evidence that I have found, the rest of this
dissertation will describe the three studies that I have implemented to test my
research hypothesis.
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Chapter 4 - Structure of the thesis
My thesis is based on original medical research carried out since January 2011 at
University College London, department of Epidemiology and Public Health,
Psychobiology group. The research that I have carried out to test my research
hypothesis resulted in the publication of the following studies in peer-reviewed
international medical journals:
 Lazzarino AI, Hamer M, Gaze D, Collinson P, Steptoe A. The association
between cortisol response to mental stress and high-sensitivity cardiac
troponin T plasma concentration in healthy adults. Journal of American
College of Cardiology (JACC). 2013 Oct 29; 62 (18): 1694-701.
 Lazzarino AI, Hamer M, Stamatakis E, Steptoe A. Low socioeconomic status
and psychological distress as synergistic predictors of mortality from stroke
and coronary heart disease. Psychosomatic Medicine. 2013 Apr; 75 (3): 311-
6.
 Lazzarino AI, Hamer M, Stamatakis E, Steptoe A. The combined association of
psychological distress and socioeconomic status with all-cause mortality: a
national cohort study. Journal of American Medical Association (JAMA)
Internal Medicine. 2013 Jan 14; 173 (1): 22-7.
Moreover the following journal article is in preparation:
 Lazzarino AI, Fourkala EO, Steptoe A, Menon U. The interaction between
psychosocial and socioeconomic factors for the incidence of cardiovascular
disease in women.
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In Chapter 5 I will describe my first study, which is about the association between
cortisol response to mental stress and high-sensitivity cardiac troponin T plasma
concentration in healthy adults, which I have published in the Journal of American
College of Cardiology (JACC). Although it was completed more recently than others, I
have decided to present it first because it is a laboratory study carried out on
selected participants and gives an insight into the pathophysiology of heart disease.
In Chapter 6 I will show the methods and the results from my other two published
studies, which are observational longitudinal studies that were set out to test my
research hypothesis on a wider population. In Chapter 7 I will describe another
observational longitudinal study carried out to test the same research hypothesis
while changing key study design features as well as the reference population.
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Chapter 5 - Study 1: The association between cortisol
response to mental stress and high-sensitivity cardiac
troponin T plasma concentration in healthy adults
5.1 Introduction
Mental stress is becoming increasingly recognised as a risk factor and trigger for
cardiovascular disease (CVD) events.54,55,167 Stress can be studied in several ways
including epidemiological studies, laboratory based psychophysiological testing, and
animal research. Psychophysiological testing allows mechanisms to be studied by
measuring biological responses to standardized behavioural challenge. Stress
markers relevant to CVD include pro-inflammatory factors, cortisol, heart rate
variability, and haemostatic processes.56,168 Mental stress initiates the release of
cortisol by activating corticotrophin releasing factor and arginine vasopressin
neurons in the paraventricular nucleus of the hypothalamus.60 This leads to the
release of adrenocorticotrophic hormone from the pituitary gland, which triggers
release of glucocorticoids from adrenal glands. Cortisol has attracted relatively little
attention as a mechanism linking stress and CVD. However, several population
studies have demonstrated associations between diurnal cortisol patterns and
subclinical atherosclerosis.169,170
Atherosclerosis, a fundamental precursor of CVD, can be defined as the thickening
and hardening of the arterial walls due to the deposition of lipids within the walls.
After the initial stage, atherosclerosis becomes irreversible and atherosclerotic
plaques can become calcified. At advanced stage, atherosclerotic plaques can cause
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progressive stenosis and ischaemia by blocking the blood flow in the arteries, or they
can determine sudden and often more dangerous ischemia if they break and form a
thrombus. Atherosclerosis was traditionally considered as a passive process of lipid
accumulation, a sort of passive trapping and retention of cholesterol-rich lipoproteins
within the arterial wall, while we now acknowledge that inflammation plays and
active and central role in the pathophysiology of this condition. Inflammation
participates in all stages of atherosclerosis, from the initial fatty streak formation, to
atherosclerotic plaque formation, and to ulceration and thrombus formation. For
that reasons, studies about the etiology of heart disease must include measurements
of markers of atherosclerosis, such as coronary artery calcification for example, and
indexes of inflammation such as C-reactive protein (CRP), Inteleukin-6 (IL-6), together
with other more conventional risk factors for CVD such as blood pressure, serum
lipids, diabetes, etc.7–9
A flatter slope in the decline of cortisol levels across the day (thought to be a marker
of chronic stress) is associated with an increased risk of CVD mortality in British civil
servants,171 while 24hr urinary cortisol was associated with CVD death in the
InCHIANTI prospective cohort study of older people,172 and serum cortisol level were
found to be a cardiac event risk predictor in patients with chronic heart failure and
that cardiac event prediction based on cortisol levels was influenced by oxidative
stress.173 Recent data from our laboratory has shown that heightened increases in
salivary cortisol following standardized mental stress tests in healthy older
individuals are associated with greater coronary artery calcification (CAC), and with
CAC progression over 3 years.174,175
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Cardiac troponin T (CTnT) is a plasma protein routinely used for the diagnosis of
acute myocardial infarction (AMI).15,16 In clinical settings cTnT is measured using
standard assays that have a lower detection limit of 10 ng/L,18 and a diagnostic
threshold of 35 ng/L.15,16 However, high-sensitivity assays have now been developed
(HS-CTnT) with an even lower detection limit of 3 ng/L.19–21
Cardiac troponins are regulatory proteins that control the calcium-mediated
contraction from within the myocyte (heart muscle cell). The troponin complex
consists of three subunits: troponin T, troponin I, and troponin C. Troponins are not
normally present in the plasma of healthy individuals. The role of Troponin T is to
bind to a filament called tropomyosin in order to enhance its interaction with
another filament called actin that is responsible for contraction. Contraction happens
when the two filaments can slide reciprocally levering on bridges that link them.
When cellular necrosis happens, the contents of the myocyte, including Troponin T,
are released into the capillaries and from here they reach the main blood stream.
There is a rapid early release of plasma Troponin T after ischaemic injury, which
peaks at 12–24 hours, and may remain raised for more than two weeks. The
detection of Troponin T in the plasma inevitably indicates cardiac cell damage.17
In healthy people not fulfilling any diagnostic criterion for AMI, greater HS-CTnT is
associated with a greater incidence of structural and functional heart disease,
cardiovascular mortality, and all-cause mortality.176,177 Among patients undergoing
noncardiac surgery, the post-operative increase in HS-CTnT plasma concentration
was associated with increased 30-day mortality.178 In a study of community-derived
perimenopausal women, HS-CTnT was associated with long-term mortality,
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independently of amino-terminal pro-B-type natriuretic peptide and other risk
factors.179
Research Hypothesis
Cortisol is associated with coronary atherosclerosis, although whether this hormone
plays a role in structural and functional cardiac disease remains unclear. The aim our
study was therefore to provide further insight into the role of cortisol in CVD by
examining the association between cortisol responses to mental stress and HS-CTnT
concentrations in healthy older individuals without history of CVD, taking into
account underlying coronary atherosclerosis (CAC) as well as inflammatory factors
relevant to CVD . We hypothesized that high cortisol responders are individuals who
are hyper-reactive to mental stress. If these responses are elicited on a regular basis
over many years, they might lead to chronic elevation in HS-CTnT concentration in
the circulating blood. In addition, we attempted to determine whether the
association between cortisol response to mental stress and HS-CTnT concentration is
homogeneous across SES groups or not.
5.2 Methods
Study Design
Our study involved participants drawn from the Whitehall II epidemiological cohort180
for psychophysiological testing between 2006 and 2008. Whitehall II is a prospective
epidemiological study of 10,308 London-based civil servants recruited in 1985-1988
when aged 35-55 years to investigate demographic, psychosocial, and biological risk
factors for IHD.180 The criteria for entry into our study included no history or
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objective signs of clinical or subclinical CVD, no previous diagnosis or treatment for
hypertension, inflammatory diseases, allergies, or kidney disease. CVD was defined as
prior myocardial infarction, stable or unstable angina, revascularization procedure,
heart failure, transitory ischaemic attack, stroke, or electrocardiographic
abnormalities (resting 12-lead electrocardiograms were taken). This information was
confirmed by a telephone interview and verified from clinical data collected from the
previous seven phases of the Whitehall II study. Volunteers were of white European
origin, aged 53–76 years, and 56.5% were in full-time employment. Selection was
stratified by grade of employment (current or most recent) to include higher and
lower socioeconomic status participants. From the initially invited participants (n
=1,169), 27.6% were not eligible (mainly because of prescribed medications) and
25.9% declined to take part. Participants were prohibited from using any anti-
histamine or anti-inflammatory medication 7 days before testing and were
rescheduled if they reported colds or other infections on the day of testing.
Participants gave full informed consent to participate in the study and ethical
approval was obtained from the UCLH committee on the Ethics of Human Research.
Sample size calculation
This study is based on secondary analysis of data gathered for another study having a
slightly different research hypothesis (it concerned SES differences in stress
responsivity174). The original aim was to select 100 men and 100 women from each of
three grades of employment (lower, intermediate, and higher) reaching a total
sample size of 600. The invited people were chosen from the Whitehall II database
using stratified random sampling.
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Data Collection
Psychophysiological Testing
We carried out psychophysiological stress testing in either the morning or afternoon
in a light temperature-controlled laboratory. This procedure was based on a protocol
previously used in Psychobiology Group laboratory at UCL.181 Participants were
instructed to refrain from drinking caffeinated beverages or smoking for at least 2 h
before the study and not to have performed vigorous physical activity or consumed
alcohol the previous evening. After a 30 min rest period, baseline blood pressure
(using an automated UA-779 digital monitor) and a saliva sample were taken. Two
behavioural tasks, designed to induce mental stress, were then administered in
random order. The tasks were a computerized version of the Stroop task and mirror
tracing, both of which have been used extensively in psychophysiological research.182
The tasks each lasted for 5 min. Saliva samples were collected immediately before
and after the tasks and then at 20, 45, and 75 min post-stress for the assessment of
salivary cortisol, and the present analysis concerns the measures taken immediately
before and after the tests. The samples were collected using Salivettes (Sarsted,
Leicester, UK), which were stored at -30oC until analysis. Levels of cortisol were
assessed using a time resolved immunoassay with fluorescence detection, at the
University of Dresden. The intra- and inter-assay coefficients of variation were less
than 8%.
Cardiac Troponin T
Non-fasting blood samples were collected in EDTA tubes and centrifuged
immediately at 2500 rpm for 10 min at room temperature. Plasma was removed
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from the tube and aliquoted into 0.5 ml portions and stored at 80 ⁰C until analysis. 
We measured cardiac troponin T concentrations 75 min after the end of the mental
stress test using a highly sensitive assay on an automated platform (Elecsys-2010
Troponin T hs STAT, Roche Diagnostics), with a lower detection limit of 3 ng/L and a
reported 99th percentile value in apparently healthy individuals of 13.5 ng/L, at
which the CV is 9%, confirmed by in house studies.19–21
Covariates
We assayed baseline plasma IL-6 using a Quantikine® high sensitivity two-site
enzyme-linked immunosorbent assay (ELISA) from R&D Systems (Oxford, UK). The
sensitivity of the assay ranged from 0.016 to 0.110 pg/ml and the intra and inter
assay CVs of 7.3% and 7.7% respectively. Baseline C-reactive protein (CRP) was
measured using high-sensitivity ELISA (R&D Systems, Oxford, UK).
The assessment of coronary artery calcification (CAC) was performed using electron
beam computed tomography (GE Imatron C-150, San Francisco, CA, USA).183 In brief,
40 contiguous 3 mm slices were obtained during a single breath-hold starting at the
carina and proceeding to the level of the diaphragm. Scan time was 100 ms/slice,
synchronized to 40% of the R-R interval. Agatston and volumetric calcium scores
were calculated to quantify the extent of CAC by a single experienced investigator
blinded to the psychophysiological and clinical data on an Aquarius workstation
(TeraRecon Inc., San Mateo, CA, USA). Since calcified volume was very highly
correlated with Agatston score (Spearman’s rho =0.99), we present data for Agatston
score only.
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Participants reported current smoking levels, weekly alcohol intake (units per week),
and hours of moderate or vigorous physical activity per week. We measured height
and weight in light clothing for the calculation of body mass index (BMI). Fasting
blood samples were taken during a separate clinical assessment. Total and high-
density lipoprotein (HDL) cholesterol and triglycerides were measured within 72 h in
serum stored at 4oC using enzymatic colorimetric methods.184 Low-density
lipoprotein (LDL) cholesterol was derived using the Friedewald equation.185 Glucose
homeostasis was assessed from glycated haemoglobin (HbA1C) concentration,
assayed using boronate affinity chromatography, a combination of boronate affinity
and liquid chromatography.
SES was indexed according to the latest employment grade of the individual. We
obtained information on grade of employment by asking all participants to give their
civil service grade title. On the basis of salary the civil service identifies twelve non-
industrial grades which, in order of decreasing salary, comprise seven "unified
grades", and senior executive officer (SEO), higher executive officer (HEO), executive
officer (EO), clerical officer, and clerical assistant. Other professional and technical
staff are assigned by the civil service to one of these grades on the basis of salary. For
analysis, we have combined unified grades 1-7 into one group and the bottom two
clerical grades into another, thus producing three categories: higher (administrative),
intermediate (professional and executive), and lower (clerical).180
Data Analysis
Data were cleaned before the analysis: inconsistent, duplicate, outlier, and missing
values were checked, as well as digit preferences. Normality of each continuous
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variable was checked using histograms and Shapiro–Wilk tests. We quantified the
cortisol response to stress by subtracting the values of salivary cortisol concentration
measured immediately after the behavioural tasks from the baseline. The resulting
measure was normally distributed and for the main analyses it was transformed into
a binary variable using a cut point at the value of 4 nmol/L, which corresponds to the
mean value (0.54 nmol/L) plus 1 s.d. (3.47 nmol/L). HS-CTnT was highly right-skewed
and for 83.3% of the sample it was undetectable (below the lower detection limit of 3
ng/L) and so it was transformed into a binary variable (detectable vs undetectable).
Agatston score (CAC) had a right-skewed distribution and for some analyses was
transformed into a binary variable by cutting at the value of zero (0 vs >0) or 100
(<100 vs ≥100). This threshold was based on the St Francis Heart Study that 
demonstrated maximum sensitivity and specificity for detecting cardiovascular
events at a threshold calcium score ≥ 100.186
Analytic strategy
We described the study sample according to the exposure (salivary cortisol response
to stress tasks) and the outcome (plasma detectable HS-CTnT) variables. Triglycerides
and CRP had right-skewed distributions and were described using geometric means.
Afterwards, we used multiple logistic regression to model the association between
cortisol stress response and odds of detectable HS-CTnT. Cortisol responses may
differ according to baseline cortisol levels and time of testing, so these parameters
were included as covariates. We also adjusted for age, gender, and smoking because
they are related to CVD and may confound the association between cortisol reactivity
and CVD. For example, people who experience mental stress may be more likely to
be smokers and/or may tend to smoke more; smoking is a risk factor for CVD and
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therefore it may be an alternative explanation for a supposed positive association
between stress and CVD. A similar argument can be applied for age and gender:
males or the elderly may experience more stress and we know that they are at
greater risk of CVD then their counterparts. Additionally, we took into account
clinical variables that are known to be linked with CVD such as systolic blood
pressure, total cholesterol/HDL ratio, and glycated haemoglobin (HbA1c). These are
well known risk factors for CVD and they may mediate the association between
mental stress and CVD; for example, mental stress may produce an increase in blood
pressure, which would then increase CVD risk, or mental stress may negatively
influence people’s eating habits, which would then produce dysregulated metabolic
profiles leading to CVD. From this perspective, the adjustment for mediating factors
would not be appropriate because it would nullify a true effect of mental stress on
HS-CTnT. On the other hand, should the estimates remain unchanged after these
adjustments, it would be an interesting finding, plausibly meaning that mental stress
operates on different pathways. Moreover, we adjusted for CRP and IL-6 to account
for vascular inflammation, which is also a possible confounder (inflamed people may
overreact to normal stress and may also be at higher risk of CVD) or a mediator.
Finally, we examined whether the association between cortisol reactivity and HS-
CTnT was independent of underlying coronary atherosclerosis using several
approaches. We firstly adjusted for CAC score as a binary variable using both cut-
points separately (0 and 100). However, adjusting for a continuous factor using a
binary variable can lead to residual confounding and therefore we carried out a sub-
analysis of participants with no detectable coronary calcification. This approach
reduces the power of the analysis (smaller sample size) but is more efficient for the
purpose of eliminating the confounding effect. Similarly, we then restricted the
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analysis to participants with positive CAC scores, and in this case we further adjusted
for CAC score as a log-linear variable, because the variable showed a right-skewed
distribution. It is theoretically possible that atherosclerosis operates as confounding
factor, if for example people who know they have atherosclerosis may be more
worried about their health status and have an overreaction to our stress tests. But
this is not likely to have happened because all our participants were asymptomatic
and were blind to the test results. However, we included CAC into our analysis to
assess the mediating role of atherosclerosis, given that there are many cases of
myocardial infarctions with normal coronary arteries187 and that there may exist non-
atherosclerotic pathophysiologic components even in infarctions with damaged
arteries; therefore we were interested in testing the effect of mental stress on HS-
CTnT independently of coronary atherosclerosis.
The interaction between stress response and SES was assessed using the Likelihood
Ratio Test (LRT) in two separate models, one without any adjustment and one with
full adjustment. The analysis strategy was as follows: we ran a model for HS-CTnT
detection with stress response and SES as exposure variables, and eventually the
other covariates; the model was then repeated adding in an interaction parameter
between stress and SES; the estimates from this second model were then compared
with the estimates from the initial model using the LRT. In order for this test to be
valid, the comparison has to be made on the same group of individuals (missing
values can distort the results) and this assumption was always satisfied.
Departure from linearity of each continuous variable in the final model was tested
using the following procedure: 1) cut-offs were chosen to subdivide the sample
equally in four or five categories; 2) the presence of an adequate number of
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outcomes in each category was checked; 3) the final model was run assuming the
variable to be categorical (three or four odds ratios were generated); 4) the final
model was run assuming the variable to be ordered categorical (one odds ratio was
generated); 5) the two models were compared using the LRT. Furthermore, the odds
ratios for categorical variables were plotted to have a visual impression of the
trend.188
We carried out several sensitivity analyses. We tested other two different methods of
quantification: in order to test of dose-response associations, we analysed the
cortisol response as a continuous variable and we also calculated cortisol responses
as the ratio between the post-stress and baseline values and tested the resulting
variable as a linear variable. We checked the association separately for man and
women. As for the multiple adjustments, we further included additional variables
such as physical activity, BMI, alcohol consumption, diastolic blood pressure,
triglycerides, and LDL, which were not included in the principal analyses. We did not
carry out any additional analysis on missing values (e.g. multiple imputations)
because they were minimal.
5.3 Results
A total of 543 people participated in the study, but 34 (6.3%) had missing information
for HS-CTnT and one had a HS-CTnT value >35 ng/L (limit for AMI diagnosis) and were
therefore excluded. The final analytic sample comprised 508 participants (mean age
of 62.9 years [s.d. =5.7] and 55.1% males). The excluded participants did not differ
significantly from the main sample in any covariates. The sample is described
according to cortisol stress response in Table 5.1 and according to HS-CTnT
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categories in Table 5.2. The prevalence of detectable HS-CTnT was 16.7%. Older and
male participants were more likely to have detectable HS-CTnT and higher salivary
cortisol responses to stress tasks. HS-CTnT, cortisol response, and CAC appeared to
be associated with each other: participants with detectable levels of HS-CTnT were
more likely to have higher cortisol responses and CAC (Table 5.2), and participants
having high cortisol responses were more likely to have CAC ≥100 (Table 5.1). 
Participants with cortisol responses <4 nmol/L were more likely to be smokers and
those with detectable levels of HS-CTnT had higher IL-6 plasma concentrations
(Tables 5.1 and 5.2). Baseline cortisol was not associated with HS-CTnT either in
bivariate or multivariate models.
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Table 5.1. Study 1 - Characteristics of the sample by categories of cortisol response to laboratory
standard mental stress tasks.
Factor and category
Salivary cortisol response
P value< 4 nmol/L ≥ 4 nmol/L 
(n =459) (n =35)
Age (mean years ± s.d.) 62.8 ±5.6 64.7 ±6.4 0.055
Male 54.5% n=250 71.4% n=25 0.056
Lab session in the morning 39.2% n=180 41.2% n=14 0.823
Current smoker 5.5% n=25 0.0% n=0 <0.001
Latest grade of employment
0.071
Higher 38.1% n=175 51.4% n=18
Intermediate 39.4% n=181 37.1% n=13
Lower 22.4% n=103 11.4% n=4
Alcohol consumption
0.943
No alcohol 15.5% n=71 17.1% n=6
Below recommended levels 71.2% n=327 68.6% n=24
Above recommended levels 13.3% n=61 14.3% n=5
Hours of physical activity per week
0.727
<1 hour 23.3% n=107 17.1% n=6
1-4 hours 32.4% n=149 42.9% n=15
5-7 hours 23.3% n=107 14.3% n=5
>7 hours 21.0% n=97 25.7% n=9
Body Mass Index (mean Kg/m2 ± s.d.) 25.8 ±3.8 25.8 ±4.4 0.931
Systolic blood pressure (mean mmHg ± s.d.) 128.9 ±15.6 130.2 ±15.5 0.628
Diastolic blood pressure (mean mmHg ± s.d.) 69.7 ±8.6 70.6 ±9.8 0.534
Glycated haemoglobin (mean % ± s.d.) 5.4 ±0.4 5.4 ±0.4 0.984
Triglycerides (geometric mean g/L ± s.d.) 1.2 ±1.6 1.1 ±1.7 0.431
HDL (mean mmol/L ± s.d.) 1.7 ±0.5 1.6 ±0.4 0.527
LDL (mean mmol/L ± s.d.) 3.0 ±0.9 3.1 ±0.9 0.628
Total cholesterol (mean mmol/L ± s.d.) 5.3 ±0.9 5.3 ±0.9 0.977
C-reactive protein at baseline (geometric mean mg/L ± s.d.) 1.0 ±2.7 1.2 ±3.2 0.610
IL-6 at baseline (mean pg/ml ± s.d.) 1.3 ±0.8 1.6 ±0.9 0.716
Agatston coronary calcium score
0.037
None 44.7% n=205 31.4% n=11
<100 32.5% n=149 28.6% n=10
<400 14.2% n=65 25.7% n=9
400+ 8.7% n=40 14.3% n=5
Agatston coronary calcium score >100 22.9% n=105 40.0% n=14 0.025
HS-cTnT detectable, i.e. >3 ng/L 14.8% n=68 40.0% n=14 <0.001
P values were computed using univariate logistic regression (Wald test). Ordered categorical variables such as latest
grade of employment, alcohol consumption, hours of physical activity per week, and Agatston coronary calcium score
were treated as linear (test for trend).
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Table 5.2. Study 1 - Characteristics of the study sample by categories of high-sensitivity cardiac
troponin T plasma concentration.
Factor and Category
HS-cTnT
P valueUndetectable Detectable
(N = 423) (N = 85)
HS-cTnT (geometric mean ng/L ± s.d.) - - 6.3 ±1.7
Age (mean years ± s.d.) 62.1 ±5.1 67.2 ±6.4 <0.001
Male 51.1% n=216 75.3% n=64 <0.001
Lab session in the morning 39.8% n=168 35.9% n=31 0.522
Current smoker 5.4% n=23 3.5% n=3 0.470
Latest grade of employment
0.190
Higher 40.2% n=170 31.8% n=27
Intermediate 38.5% n=163 43.5% n=37
Lower 21.3% n=90 24.7% n=21
Alcohol consumption
0.201
No alcohol 15.1% n=64 20.0% n=17
Below recommended levels 70.9% n=300 69.4% n=59
Above recommended levels 14.0% n=59 10.6% n=9
Hours of physical activity per week
0.481
<1 hour 23.1% n=98 22.6% n=19
1-4 hours 33.0% n=140 32.1% n=27
5-7 hours 23.8% n=101 17.9% n=15
>7 hours 20.2% n=85 27.4% n=23
Body Mass Index (mean Kg/m2 ± s.d.) 25.8 ±3.9 26.2 ±3.8 0.436
Systolic blood pressure (mean mmHg ± s.d.) 128.5 ±15.3 131.8 ±17.4 0.082
Diastolic blood pressure (mean mmHg ± s.d.) 69.5 ±8.5 70.7 ±9.7 0.262
Glycated haemoglobin (mean % ± s.d.) 5.5 ±0.4 5.5 ±0.8 0.516
Triglycerides (geometric mean g/L ± s.d.) 1.2 ±1.6 1.1 ±1.6 0.047
HDL (mean mmol/L ± s.d.) 1.7 ±0.5 1.6 ±0.4 0.293
LDL (mean mmol/L ± s.d.) 3 ±0.8 2.9 ±0.9 0.243
Total cholesterol (mean mmol/L ± s.d.) 5.3 ±0.9 5.1 ±1.0 0.024
Salivary cortisol at baseline (mean nmol/L ± s.d.) 6.5 ±4.4 7.0 ±4.2 0.321
Salivary cortisol response (mean nmol/L ± s.d.) 0.3 ±2.9 1.7 ±5.5 0.004
Salivary cortisol response ≥ 4 nmol/L 5.1% n=22 17.1% n=15 <0.001
C-reactive protein at baseline (geometric mean mg/L
± s.d.) 1.0 ±2.7 1.2 ±3.2 0.088
IL-6 at baseline (mean pg/ml ± s.d.) 1.3 ±0.8 1.6 ±0.9 0.003
Agatston coronary calcium score
<0.001
None 47.3% n=200 25.9% n=22
<100 32.9% n=139 28.2% n=24
<400 13.2% n=56 22.4% n=19
400+ 6.6% n=28 23.5% n=20
Agatston coronary calcium score >100 19.9% n=84 45.9% n=39 <0.001
P values were computed using univariate logistic regression (Wald test). Ordered categorical variables such as latest
grade of employment, alcohol consumption, hours of physical activity per week, and Agatston coronary calcium score
were treated as linear (test for trend).
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Table 5.3 shows the results of multiple logistic regression models. We found a robust
association between cortisol response and detectable HS-CTnT (OR =3.83; 95%CI
=1.86-7.90; P <0.001). After adjustment for demographic variables and cardiovascular
risk factors the association between cortisol response and detectable HS-CTnT did
not differ from the unadjusted analysis. After further adjustments for CRP and IL-6
the association remained (OR =3.75; 95%CI =1.50-9.37; P =0.005). The adjustment for
CAC score as a binary variable did not change the effect estimates. When we
restricted the analysis to participants without detectable coronary calcification, the
evidence of association remained in spite of the 40% drop in sample size (N =222; OR
=4.83.; 95%CI =1.24-18.83; P =0.023). When the analysis was restricted to
participants with coronary calcification and adjusted for Agatston CAC score as a log-
linear variable, the association between cortisol stress responses and troponin T
concentration remained (N =286; OR =6.19; 95%CI =1.87-20.55; P =0.003) (Table 5.3).
Table 5.4 shows the results of a fully-adjusted model. The odds of detectable plasma
concentration of HS-CTnT were increased in men, in the elderly, and in people with
high levels of CRP. Coronary calcification and IL-6 lost the significance that they had
shown at the univariate analysis.
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Table 5.3. Study 1 - Multiple logistic regression models for the association between salivary cortisol
response to standard laboratory mental stress tasks and plasma detectable high-sensitivity cardiac
troponin T.
Model for detectable HS-cTnT (binary outcome)
OR for cortisol
response
(binary
exposure)
P (95% CI)
1. Crude association 3.83 <0.001 (1.86 7.90)
2. Adjusted for baseline salivary cortisol (pre-task) and time of the
session (am or pm) 3.68 0.001 (1.75 7.76)
3. With further adjustment for age and gender 2.75 0.021 (1.16 6.49)
4. With further adjustment for smoking, systolic blood pressure,
total cholesterol/HDL ratio, and glycated haemoglobin 3.38 0.007 (1.39 8.22)
5. With further adjustment for CRP and IL-6 3.75 0.005 (1.50 9.37)
6a. With further adjustment for coronary calcification score, treated
as a binary variable with cut-off at 0 3.74 0.005 (1.49 9.36)
6b. Same as model 7a but the cut-off was set at 100 3.74 0.005 (1.49 9.35)
6c. Model 6 was restricted to participants without coronary
calcification (CAC score = 0, N=222) 4.83 0.023 (1.24 18.83)
6d. Model 6 was restricted to participants with coronary calcification
(CAC score > 0, N=286) for which score it was further adjusted using
a log-linear variable*
6.19 0.003 (1.87 20.55)
*Positive CAC score values had a right-skewed log-linear distribution.
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Table 5.4. Study 1 - Multivariate logistic regression model for the odds of plasma detectable high-
sensitivity cardiac troponin T (full output).
Factor OR (95%CI) P
Salivary cortisol response to standard laboratory mental stress tasks
(binary exposure) 3.74 (1.49 9.36) 0.005
Baseline salivary cortisol 1.03 (0.96 1.10) 0.386
Testing session in the morning 1.10 (0.58 2.10) 0.768
Age 1.19 (1.12 1.25) <0.001
Gender male 4.85 (2.33 10.10) <0.001
Smoker 1.30 (0.32 5.32) 0.712
Systolic blood pressure 1.00 (0.98 1.01) 0.637
Total cholesterol / HDL ratio 0.80 (0.58 1.09) 0.153
Glycated haemoglobin 0.93 (0.41 2.12) 0.870
IL-6 1.11 (0.76 1.63) 0.585
CRP 1.18 (1.03 1.36) 0.020
Coronary calcification score, treated as a binary variable with cut-off at 0 1.29 (0.66 2.50) 0.455
This is the full output for model 6a in Table 5.3.
In sensitivity analyses the results remained unchanged after further adjustment for
physical activity, BMI, alcohol consumption, diastolic blood pressure, triglycerides,
and LDL cholesterol. We also performed sensitivity analyses using different
approaches to quantify the cortisol stress response although the same pattern of
results emerged. For example, after treating the stress response as a linear
proportional change in cortisol, the fully-adjusted OR for HS-CTnT was 1.38 (95%CI
=1.10-1.73; P =0.005) for each unit increase in change. The results were similar
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between men and women. The results from the sensitivity analyses are presented in
Appendix 1.
Table 5.5 shows the results from the interaction analysis. In the crude model, the
stratification by SES showed a trend such that the OR of stress response for HS-CTnT
was very low in people from higher-SES categories (OR =1.03; 95%CI 0.11-9.68),
higher in people from intermediate positions (OR =5.22; 95%CI =1.81-15.09), and
much higher in people from lower SES circumstances (OR =6.11; 95%CI =1.92-19.52).
A similar trend was found for the adjusted model: the OR in higher SES people was
1.75 (95%CI =0.13-23.74); in intermediate SES people was 3.86 (95%CI =0.94-15.79);
and in lower SES people was 13.00 (95%CI =2.72-62.17). Nevertheless the Likelihood
Ratio test P value for interaction was not significant for either model (0.562 and
0.698).
Table 5.5. Study 1 - Interaction analysis.
Strata of SES Odds ratio (95%CI) of high vs low (referent) mental stressand detectable HS-cTnT
Crude Adjusted*
In participants where SES = Higher 1.03 (0.11 9.68) 1.75 (0.13 23.74)
In participants where SES = Intermediate 5.22 (1.81 15.09) 3.86 (0.94 15.79)
In participants where SES = Lower 6.11 (1.92 19.52) 13.00 (2.72 62.17)
Likelihood Ratio Test P value 0.562 0.698
*Adjusted for baseline salivary cortisol (pre-task), time of the session (am or pm), age, gender, smoking, systolic
blood pressure, total cholesterol/HDL ratio, glycated haemoglobin, CRP, IL-6 and coronary calcification score, treated
as a binary variable with cut-off at 0. This model is parallel to model 6a in Table 5.3.
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5.4 Discussion
Our results suggest that in healthy participants with no history of CVD, a heightened
cortisol response to mental stress is associated with detectable concentrations of
circulating cardiac troponin T when measured using a high-sensitivity assay. These
findings add to previous data from our laboratory that demonstrate an association
between cortisol reactivity and CAC.174,175 However, importantly, while this study
confirms the findings from other work that stress responsivity is associated with
increased CAC,174 the association between cortisol stress responses and circulating
cardiac troponin T was independent of CAC, a reliable indicator of sub-clinical
coronary atherosclerosis. Therefore, cortisol may be involved in structural and
functional adaptations to the heart as well as in the atherosclerotic process.
The prevalence of detectable HS-CTnT in our British sample was 16.7%, which is
similar to levels reported (15.7%) in a nationally-representative CVD-free population
sample in USA .176
To our knowledge, this is the first study to examine the association between mental
stress and cardiac troponin T in humans. Our data are consistent with research on
stress-induced Takotsubo cardiomyopathy, in which emotional stress increases
troponin and cortisol levels in the absence of coronary artery disease.189,190 Our data
also agree with that of Caligiuri et al. who showed that behavioural stress in
laboratory animals increases troponin.191 Although stress responses seem to be
positively correlated with troponin, evidence for a direct or indirect glucocorticoid
modulation of troponin is still scarce. The troponin gene contains a transcription
factor binding site192,193 previously shown to bind the activated glucocorticoid
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receptor.194 Despite the presence of this binding site, the effect of glucocorticoids on
troponin levels does not seem to be via direct modulation of gene expression.195–199
Cortisol has a strong diurnal pattern that can cause difficulties in the interpretation of
the data; we dealt with this issue by considering stress response as the difference
between the post-test and pre-test measurement, and by adjusting for cortisol
baseline level and daytime of testing at the data analysis stage. We also performed
sensitivity analyses using different approaches to quantify the cortisol stress
response although the same pattern of results emerged. It is possible that the
cortisol response to stress contributes to the increased levels of troponin T observed
here by several indirect mechanisms. First, oxidative stress could play a role in
cortisol induced troponin release.200,201 Supporting this hypothesis, the temporal
change in serum troponin matches the increase in the concentration of myocardial
malondialhehyde, a marker of free radical lipid peroxidation.202 Second, stress
induced cortisol levels could increase troponin levels by modulating ion channels. For
example, dexamethasone, a synthetic glucocorticoid, significantly increases the L-
type Ca2+ currents in neonatal rat cardiomyocytes203 and accelerates myocyte
spontaneous contractions.204 Finally, cortisol responses to stress could induce
troponin levels by potentiation of adrenergic signalling. Corticosteroids potentiate
adrenergic signalling and increase muscle contraction and cardiomyocyte
hypertrophy.205 Corticosteroid-potentiated adrenergic signalling increases
mineralocorticoid and glucocorticoid receptor expression and function in
cardiomyocytes.205
Detectable HS-CTnT is associated with noncardiac conditions such as severe renal
disease206,207 and, theoretically, our results could be due to confounding if patients
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with renal disease are more likely to test positive at mental stress tests. However, it
is unlikely that this mechanism underlies our results since the study participants were
free from any chronic conditions at the time of testing, as explained in the Methods
section.
The effect of stress-related cortisol release on cardiomyocytes may be mediated by
atherosclerosis and consequent ischaemia, although the adjustments for CAC, which
is a recognised index of atherosclerosis, did not attenuate the findings. CAC and HS-
CTnT do not appear to lie on the same causal pathway since their effect was not
diminished by mutual adjustment, in spite of being correlated with each other. Thus
cortisol might have acted through indirect effects as described above.
Non-calcified coronary plaques are less detectable using cardiac computerized
tomography and that may partly explain why CAC did not attenuate the association
between cortisol and HS-CTnT. However, there is a direct relationship between the
number of calcified plaques present and total plaque burden, and CAC correlates
highly with the severity of coronary artery disease, so the absence of calcification
implies that there is probably little significant coronary artery disease.208 On the
other hand, it has been argued that raised troponin T may be due to occult or
undetected plaque rupture209 and it is known that plaque rupture is a relatively
common event that is usually not followed by an acute cardiac event.210 This process
may have operated in our patients with minimal CAC score levels and detectable HS-
CTnT.
A single measure of plasma HS-CTnT concentration cannot be regarded as a robust
test if it is not stable in time, i.e. if it shows remarkable intra-individual short-term
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variation. However, the results from the ARIC study showed that HS-CTnT intra-
individual variability over 6 weeks is almost null, with a correlation coefficient of
0.94.211 Thus, although our study collected HS-CTnT after a brief and moderately
stressful behavioral challenge, it is improbable that troponin T was released in
response to this task. To the contrary, we hypothesized that high cortisol responders
are individuals who are hyper-reactive to mental stress in everyday life. If these
responses are elicited on a regular basis over extended periods of time, they might
lead to chronic elevation in HS-CTnT concentration.
This is a cross-sectional study and therefore we cannot determine the causal
sequence. Heightened cortisol stress responsivity may contribute to early signs of
CVD, or people at an early stage of cardiac disease may be more prone to disturbed
stress responses. In fact, cardiac troponins are the most sensitive and specific
biochemical markers of myocardial damage,212 but their elevation can be due to a
variety of reasons such as pericarditis, myocarditis, pulmonary embolism, and
other.213 However, it is unlikely that the undetected presence of those conditions can
explain our findings since no participants reported any symptoms or signs of cardiac
disease, had any previous diagnosis or treatment for hypertension, inflammatory
disease or allergies, and did not show any electrocardiographic indications of CHD on
tests carried out over more than 20 years in the Whitehall II study. Moreover, we
found a strong association both in people with and without coronary calcification,
which is consistent with another study showing that HS-CTnT is predictive of CVD in
healthy people and also of secondary events in CVD-patients.214 It is interesting to
note that detectable levels of HS-CTnT were associated with salivary cortisol
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response to stress test but not with its baseline levels (pre-test), corroborating its
relationship with stress-induced neuroendocrine dysregulation.
The analysis of interaction did not give significant results in terms of P value, and
therefore we cannot reject the null hypothesis of no interaction between SES and
mental stress for the determination of IHD. However, this study may be
underpowered for such analysis, since the sample size was calculated on the basis of
another research question that did not consider any specific interaction analysis,
while it is known that statistical tests for interaction are generally low in power.215
Moreover, both the crude and the adjusted analysis showed a trend such that the
amount of increased risk of HS-CTnT positivity for people with higher stress
responses was very low in people from higher-SES categories, higher in people from
intermediate positions, and much higher in people from lower SES circumstances.
This clear trend comes out in favour of an existing interaction, which is consistent
with my main research hypothesis.
In conclusion, heightened cortisol responses to mental stress were associated with
detectable levels of cardiac troponin T using high-sensitivity assays in the plasma of
healthy people. Heightened stress-induced cortisol release may increase the risk of
CHD through several pathways, including atherosclerotic processes, or other indirect
effects on the cardiomyocytes. Further research is needed to understand the role of
psychosocial stress in the pathophysiology of cardiac cell damage. Further research is
also necessary to ascertain the role of socioeconomic status as an effect modifier of
the association between mental stress and CHD.
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Chapter 6 - Study 2: The combined association of mental
stress and socioeconomic status with all-cause mortality
and ischaemic heart disease mortality: a national cohort
study
6.1 Introduction
Mental stress is a term that incorporates a number of psychological risk factors
including depressive symptoms, anxiety, and social dysfunction. These psychological
constructs are becoming increasingly recognised as risk factors for mortality and
trigger for ischemic heart disease (IHD) events.54,55,167 Socio-economic status (SES) is
also a recognised determinant of health status: in developed countries, the lower a
person’s SES the worse his or her health. Even in the most affluent countries, people
who are in lower SES levels have considerable shorter life expectancies and more
disease than people who are in higher SES levels,112,113,139 and low SES is associated
with high risk of IHD and death in developed countries such as England.141
In Chapter 1.7, we hypothesized that when both risk factors are present (high levels
of mental stress and low levels of SES), the resulting effect on health outcomes is not
additive, but that there is a multiplicative effect. This hypothesis was stimulated by
concepts such as the reserve capacity model of Gallo and Matthews, which
postulates that lower-SES individuals have fewer interpersonal and intrapersonal
resources to manage stressful events than do more affluent individuals.110 In other
words, people in higher SES categories may have greater economic, social, and
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psychological resources and better coping strategies for dealing with adversity.110
These assets may be acquired through learning or better access to resources.
Consequently, it can be argued that when both risk factors are present (high levels of
mental stress and low levels of SES) the resulting effect on mortality is not the mere
sum of the two (additive effect) but that some extra risk may appear (multiplicative
effect). We therefore hypothesized that SES can operate as an amplifier of mental
stress and that the effect of mental stress on mortality would be greater in lower
than higher SES groups. As a consequence, there may be vulnerable populations of
adults that are more susceptible to the detrimental effects of mental stress and have
unmet care needs.
Identifying people who are more vulnerable to the health consequences of mental
stress may have clinical and public health implications. For example, questionnaires
such as the GHQ-12 could be of value in systematic screening at the family doctor
level, aimed at improving the recognition rate of common mental disorders for
reducing the risk of cardiovascular disease and other fatal conditions.
Research Hypothesis
The aim of this study was to analyse the association of mental stress and low SES on
the incidence of all-cause mortality and ischaemic heart disease (IHD) mortality with
an emphasis on the interaction between the two risk factors.
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6.2 Methods
Study design and variable selection
The analysis was based on the Health Survey for England (HSE), a nationally
representative, general population-based study, recruiting individuals living in private
households in England using stratified random sampling.216 The HSE comprises a
series of annual surveys beginning in 1991, and is designed to provide regular
information on various aspects of the nation's health. It has a set of core
measurements that are included every year: general health; SES; height; weight;
blood pressure; health behaviours such as smoking, alcohol consumption, and
physical activity; blood and saliva parameters. Psychosocial factors such as mental
stress and social relationships are also assessed during the household visits, during
which information is collected using Computer-Assisted Personal Interviewing (CAPI).
Trained interviewers collect information about physician-diagnosed cardiovascular
disease and diabetes, and measure height and weight. In a separate household visit,
trained nurses collect blood samples, and measure resting blood pressure using a
digital monitor (Omron HEM-907, Omron Healthcare Inc).216 Diabetes was defined
from a self-reported clinician’s diagnosis. Hypertension was defined from the clinical
blood pressure reading using the conventional criteria (above 140/90 mmHg) or from
a self-reported clinician’s diagnosis, or prescribed anti-hypertensive medication.
Smoking was self-reported as well as physical activity (defined as the number of
sessions of moderate or vigorous physical activity per week excluding domestic
activity). Body Mass Index (BMI) was defined from height and weight as Kg/m2.
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We pooled HSE years 1994 to 2004 and used all participants aged 35 or more to
constitute a baseline sample for a cohort study. We have chosen to exclude younger
people because they are at much lower risk of heart disease, which typically requires
decades from the establishment of risk factors to the incidence of hard events. So, if
on the one hand we have produced a decrease in statistical power by reducing the
sample size, on the other hand we have increased the precision of the estimates by
including only people who are at plausible risk of cardiac events. Consenting study
members were linked to Office for National Statistics (ONS) mortality data, which
record and certify all deaths in the UK. Information about their status was obtained
up to 28th February 2008 (non-informative censoring date). Our main outcomes were
mortality from any cause and from IHD. Classification of the underlying cause of
death was based on information collected from the death certificate together with
any additional information provided subsequently by the certifying doctor (e.g.,
secondary death cause). Diagnoses for primary cause of death was recorded using
the International Classification of Diseases, Ninth (ICD-9) and Tenth (ICD-10)
Revisions. Cardiovascular disease codes were 390-459 for ICD-9 and I01-I99 for ICD-
10, which were further categorised into coronary heart disease (410-414 [ICD-9] and
I20-I25 [ICD-10]) and cerebrovascular diseases (430-438 [ICD-9] and I60-I69 [ICD-10]).
Patients with history of stroke (including Transitory Ischaemic Attack), IHD (including
angina), and any other cardiovascular disease or cancer at baseline were excluded
from the analysis on the basis of electronic records and of individual nurse visits
trained ad hoc. The variables hypertension and physical activity were planned to be
recorded only in years 1994, 1997 (physical activity only), 1998, 1999, 2003, and
2004. We have therefore excluded those variables from the main multivariate
analyses.
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We used the profession of the individual as an indicator of SES. The Registrar
General’s Social class is a social classification system that attempts to classify groups
on the basis of employment, based on characteristics such as career prospects,
autonomy, and mode of payment and period of notice.217 The Health Survey for
England uses the six category system in which informants are classified as managerial
and professional, intermediate, small employers and own account workers, lower
supervisory and technical, and semi-routine and routine occupations. For some
analyses we further collapsed the six categories into three (1 = professional or
managerial position; 2 = skilled manual or non-manual workers; 3 = semi-routine or
unskilled workers). The classification is based on data from the head of the
household. If this person was unemployed at the time of the survey the classification
was based on their most recent employment.216
We used the General Health Questionnaire (GHQ-12) to measure mental stress.218
The GHQ-12 is generally considered to be a unidimensional scale,219 and it consists of
twelve items relating to anxiety, depression, social dysfunction, and loss of
confidence. Interpretation of the answers is based on a four point response scale
scored using a bimodal method (symptom present: 'not at all' = 0, 'same as usual' = 0,
'more than usual' = 1 and 'much more than usual' = 1). The questionnaire therefore
gives a score for mental stress that goes from zero to twelve. At the analysis stage,
the variable GHQ-12 can be used as ordered categorical (0 = low stress; 1-3 =
medium stress; 4+ = high stress) or as binary (0-3 = low stress; 4+ = high stress).218 A
full GHQ-12 questionnaire form is shown in Appendix 2.
Study participants gave full informed consent, and ethical approval was obtained
from the London Research Ethics Committee.
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Data analysis
Data were cleaned before the analysis: inconsistent, duplicate, outlier, and missing
values were checked, as well as digit preferences. Normality of each continuous
variable was checked using histograms and Shapiro–Wilk tests. The proportion of
participants who died within the follow-up period was calculated as well as the crude
incidence rate for the cohort.
Data were analysed using Cox-Regression with follow-up time (in months) as the time
scale. We constructed a multiple Cox-Regression model for the association of GHQ-
12 (ordered categorical with three categories), age (per one-year linear increase),
gender (binary), current smoking (binary), BMI (linear for IHD mortality and
categorical for all-cause mortality with cut-offs at <18.5; 18.5-29.9[reference]; 30+),
and diabetes (binary), with the outcome using the forward step-wise approach, i.e.
the variables were sequentially added to an ‘empty’ (intercept only) model one at a
time giving priority to those that had shown the strongest evidence of association at
the univariate stage (smallest P value). At each round the importance of the added
variable was assessed according to changes in the rate ratios, Wald tests and
Likelihood Ratio tests (LRT) P values (cut off = 0.05) of all variables in the model. If a
variable lost significance we removed it from the model. After having fitted the final
model, we checked the proportional hazards assumption and the departure from
linearity.
The proportional hazards assumption has been assessed as follows: data has been
split with the Lexis Expansion method according to follow-up time (cut-offs at 2, 4,
and 6 years), and tests for departure from proportional hazards assumption were
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carried out assessing the presence of interaction between follow-up time and each
variable. Furthermore, Nelson-Aalen plots were displayed to have a visual impression
of the proportionality.188 An example of a Nelson-Aalen plot is shown in Appendix 4.
Departure from linearity of each continuous variable in the final model was tested
using the following procedure: 1) cut-offs were chosen to subdivide the sample
equally in four or five categories; 2) the presence of an adequate number of
outcomes in each category was checked; 3) the final model was run assuming the
variable to be categorical (three or four hazard ratios were generated); 4) the final
model was run assuming the variable to be ordered categorical (one hazard ratio was
generated); 5) the two models were compared using the Likelihood Ratio Test (LRT).
Furthermore, the hazard ratios for categorical variables were plotted to have a visual
impression of the trend.188 The variable GHQ-12 showed a better linear trend when
in the form of ordered categorical than when in the form of continuous, and
therefore the categorisation was preferred. BMI showed a J-shape association with
all-cause mortality and a linear association with IHD-mortality.
Finally, interaction between SES and GHQ-12 was assessed using the Likelihood Ratio
Test (LRT) in three separate models, one without any adjustment, one with
adjustment for age and gender, and one with further adjustment for smoking, BMI,
physical activity, diabetes, and hypertension. The analysis strategy was as follows: we
ran a model with SES, GHQ-12 (binary scores 0-3 vs 4+), and eventually the other
covariates; the model was then repeated adding in an interaction parameter
between SES and GHQ-12; the estimates from this second model were then
compared with the estimates from the initial model using the LRT. In order for this
test to be valid, the comparison has to be made on the same group of individuals
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(missing values can distort the results) and this assumption was always satisfied. We
tested for the interaction using another strategy: a new variable was calculated as
the multiplication between SES (three categories) and GHQ-12 (three categories).
The variable therefore had possible values ranging from zero to nine and was
included as a covariate in the adjusted model.
We have carried out several sensitivity analyses: we restricted the multivariate
analyses to those years that included data collection for the variables hypertension
and physical activity (n =35,090) and added those variables into the models; the
entire analysis was repeated separately for men and women; we excluded
participants who experienced an outcome within one year from recruitment to
minimize the chances of reverse causality; participants who had missing values for
GHQ-12 were slightly older compared to responders, and it is arguable that they may
tend to have higher levels of mental stress, and therefore we have rerun the main
interaction analysis after recoding those missing values with valid values scoring 4
(cut-off for high stress).
6.3 Results
The initial study sample consisted of 96,605 adults, although 10.4% (n=10,065) did
not consent to mortality follow up and were therefore removed from any analysis.
Non-consenting adults had similar characteristics compared to consenting adults.
5,864 (6.8%) participants had history of stroke or IHD, or had another prevalent
cardiovascular disease or cancer at baseline and were therefore excluded. Out of the
resulting 80,676 participants, 15.4% had missing values for mental stress and 2.6%
for SES. Participants with GHQ-12 missing values were slightly older compared with
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those who completed the GHQ-12 questionnaire (56.4 vs 55.1 years; P < 0.001),
whereas the gender structures of the two subgroups were similar (males = 45.4% vs
44.8%; P = 0.234). Six participants were lost during the follow-up and 27 were
excluded from the analysis because they experienced an outcome within one month
from recruitment. The final analytic sample comprised 66,518 participants. The
measures of hypertension and physical activity had about 40% missing values.
The participants were followed up for a mean of 8.2 years (s.d. =3.4; median =7.9).
During this period, 1,007 (1.5%) died of an IHD event, and 7,875 (11.8%) died for any
cause. The crude incidence rates for IHD and all-cause mortality were 1.85 (95%CI =
1.74-1.97) and 14.49 (95%CI = 14.17-14.81) per 1,000 person-years. The two
outcomes have shown very similar patterns in all analyses.
Tables 6.1 and 6.2 show the baseline characteristics of the sample. On average,
14.4% of the sample reported mental stress based on the established cut point of
GHQ-12 score  4. Participants from lower occupational classes were older, less likely
to be male, had higher GHQ-12 score, and were more likely to be smokers. Both
mental stress and low SES were associated with increased mortality rates, as were
diabetes, hypertension, and smoking. Physical activity was associated with lower risk
of mortality. Both groups of people with BMI values of less than 18.5 or more than 30
had higher mortality rates than people with BMI values between 18.5 and 30
(reference category), although this non-linear pattern was not evident for IHD
mortality. Therefore I have used a categorical BMI variable for the analysis of all-
cause mortality and the native linear BMI variable for IHD mortality.
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Table 6.1. Study 2 - Sample description and unadjusted hazard ratios, 95% confidence intervals, and P
values for all-cause mortality.
Factor and category at the beginning
of the follow-up
All-cause mortality within the follow-
up time
HR (95%CI) P
Yes No
(n =7,875) (n =58,643)
Male 49.7% n=3,912 44.9% n=26,326 1.19 (1.14 1.24) <0.001
Age (mean ± s.d.) 72.1 ±12.1 52.5 ±12.4 1.11 (1.11 1.11) <0.001
Age
5.88(2) (5.64 6.12) <0.001
35-49 5.8% n=460 46.5% n=27,287
50-64 16.9% n=1,328 34.2% n=20,044
65+ 77.3% n=6,087 19.3% n=11,318
Socio-Economic Status based on professional category
1.20(2) (1.18 1.22) <0.001
1 - High 24.5% n=1,932 35.1% n=20,566
2 - Medium 45.8% n=3,605 42.9% n=25,158
3 - Low 29.7% n=2,338 22.0% n=12,919
GHQ-12 Score (mean ± s.d.) 1.7 ±2.8 1.4 ±2.6 1.04 (1.03 1.05) <0.001
GHQ-12 Score
1.30(4) (1.25 1.36) <0.001
0 54.3% n=4,275 62.0% n=36,341
1-3 27.6% n=2,172 24.1% n=14,133
4+ 18.1% n=1,428 13.9% n=8,169
Smoking
1.54(2) (1.47 1.61) <0.001
20+ 8.6% n=679 8.9% n=5,237
1-19 15.0% n=1,180 13.8% n=8,116
Ex 44.3% n=3,489 34.6% n=20,290
Never 32.1% n=2,526 42.6% n=24,994
Body Mass Index Kg/m2 ± s.d.)
<18.5 1.9% n=150 0.6% n=352 3.56 (2.97 4.27) <0.001
18.5-30 56.0% n=4,410 66.4% n=38,939 1(5)
30+ 42.1% n=3,315 33.0% n=19,352 1.13 (1.08 1.19) <0.001
Physical activity(1) (mean ± s.d.) 0.6 ±1.9 1.6 ±2.8 0.80 (0.78 0.81) <0.001
Diabetes 6.7% n=531 2.6% n=1,530 2.78 (2.54 3.03) <0.001
Hypertension(6) 29.4% n=2,313 17.5% n=10,259 1.85 (1.73 1.98) <0.001
Hazard ratios, 95% confidence intervals, and P values were computed using unadjusted Cox regression. (1) Number of
sessions of moderate or vigorous physical activity per week excluding domestic activity. N=39,610. (2) Per one-
category increase. (3) Treated as binary: 4+ versus 0-3. (4) Treated as binary: current smokers versus ex- or never-
smokers. (5) Reference category. (6) N=35,090
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Table 6.2. Study 2 - Sample description and unadjusted hazard ratios, 95% confidence intervals, and P
values for IHD mortality.
Factor and category at the beginning
of the follow-up
IHD mortality within the follow-up
time
HR (95%CI) P
Yes No
(n =1,007) (n =65,511)
Male 57.8% n=582 45.3% n=29,656 1.65 (1.45 1.87) <0.001
Age (mean years ± s.d.) 71.9 ±11.6 54.6 ±13.8 1.11 (1.11 1.12) <0.001
Age in years
6.36(2) (5.66 7.15) <0.001
35-49 5.8% n=58 42.3% n=27,685
50-64 15.5% n=156 32.4% n=21,212
65+ 78.8% n=793 25.4% n=16,614
Socio-Economic Status based on professional category
1.28(2) (1.18 1.39) <0.001
1 - High 24.6% n=248 34.0% n=22,254
2 - Medium 47.8% n=481 43.2% n=28,281
3 - Low 27.6% n=278 22.9% n=14,976
GHQ-12 score (mean ± s.d.) 1.6 ±2.6 1.4 ±2.6 1.03 (1.01 1.05) 0.009
GHQ-12 score
1.19(3) (1.10 1.28) <0.001
0 53.4% n=538 61.2% n=40,080
1-3 29.4% n=296 24.4% n=16,011
4+ 17.2% n=173 14.4% n=9,420
Smoking
1.65(4) (1.45 1.89) <0.001
20+ 8.6% n=87 8.9% n=5,830
1-19 14.2% n=143 14.0% n=9,158
Ex 46.5% n=468 35.6% n=23,315
Never 30.7% n=309 41.5% n=27,213
Body Mass Index (mean Kg/m2 ± s.d.) 27.5 ±4.6 27.1 ±4.7 1.03 (1.01 1.04) 0.001
Physical Activity(1) (mean ± s.d.) 0.6 ±1.9 1.5 ±2.8 0.79 (0.75 0.84) <0.001
Diabetes 10.8% n=109 3.0% n=1,952 4.86 (3.98 5.93) <0.001
Hypertension(5) 29.8% n=300 18.8% n=12,293 1.89 (1.57 2.28) <0.001
Hazard ratios, 95% confidence intervals, and P values were computed using unadjusted Cox regression. (1) Number of
sessions of moderate or vigorous physical activity per week excluding domestic activity. N=39,610. (2) Per one-
category increase. (3) Treated as binary: 4+ versus 0-3. (4) Treated as binary: current smokers versus ex- or never-
smokers. (5) N=35,090
Tables 6.3 and 6.4 show the results from the multivariate analysis performed using
Cox-Regression. GHQ-12 was associated with higher mortality rates (HR for one
category increase out of three total categories=1.23; 95%CI =1.19-1.27; P <0.001)
after having adjusted for age, gender, smoking, BMI, and diabetes, all of which also
were independent predictors of all-cause and IHD mortality.
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Table 6.3. Study 2 - Multivariate Cox regression model showing hazard ratios, 95% confidence
intervals, and P values for all-cause mortality.
Factor at the beginning of the follow-up
Mutually-adjusted all-cause mortality
HR (95%CI) P
One category increase in GHQ-12 (3 categories in
total) 1.23 (1.19 1.27) <0.001
Gender male 1.44 (1.37 1.51) <0.001
One-year increase in age 1.11 (1.11 1.11) <0.001
Current smoking 1.51 (1.43 1.59) <0.001
BMI <18.5 versus BMI 18.5-29.9 2.66 (2.27 3.12) <0.001
BMI 30+ versus BMI 18.5-29.9 1.07 (1.02 1.15) 0.008
Diabetes 1.60 (1.44 1.76) <0.001
Table 6.4. Study 2 - Multivariate Cox regression model showing hazard ratios, 95% confidence
intervals, and P values for IHD mortality.
Factor at the beginning of the follow-up
Mutually-adjusted IHD mortality
HR (95%CI) P
One category increase in GHQ-12 (3 categories in
total) 1.25 (1.14 1.38) <0.001
Gender male 2.02 (1.75 2.34) <0.001
One-year increase in age 1.12 (1.11 1.12) <0.001
Current smoking 1.50 (1.29 1.75) <0.001
Unit increase in BMI 1.03 (1.01 1.04) 0.002
Diabetes 2.55 (2.03 3.21) <0.001
Tables 6.5 and 6.6 present the results of an analysis focused on the interaction
between SES and GHQ-12, i.e. it shows crude and adjusted hazard ratios of GHQ-12
on mortality, stratified by SES. After adjusting for age, gender, smoking, BMI, and
diabetes, there was a significant interaction showing that mental stress
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demonstrated stronger associations with mortality in lower SES participants (LRT P
for all-cause mortality= 0.012, for IHD mortality =0.048).
Table 6.5. Study 2 - Multivariate Cox regression models showing crude and adjusted hazard ratios and
95% confidence intervals for the association between psychological distress and all-cause mortality
stratified by socioeconomic status.
Strata of SES Hazard ratio (95%CI) of high vs low (referent) psychological distress forall-cause mortality
Crude Adjusted for age andgender Multi-adjusted*
In participants where SES = High 1.18 (1.07 1.29) 1.26 (1.18 1.34) 1.22 (1.13 1.31)
In participants where SES = Medium 1.32 (1.23 1.41) 1.37 (1.27 1.49) 1.33 (1.21 1.45)
In participants where SES = Low 1.36 (1.25 1.47) 1.46 (1.33 1.59) 1.36 (1.23 1.51)
Likelihood Ratio Test P value 0.004 0.001 0.012
* Adjusted for age, gender, smoking, BMI, and diabetes. Low Psychological Distress = GHQ-12 score < 4; High
Psychological Distress = GHQ-12 score ≥ 4. High SES = professional/managerial positions; medium SES = skilled 
manual/non-manual workers; low SES = semi-routine/unskilled workers.
Table 6.6. Study 2 - Multivariate Cox regression models showing crude and adjusted hazard ratios and
95% confidence intervals for the association between psychological distress and IHD mortality
stratified by socioeconomic status.
Strata of SES Hazard ratio (95%CI) of high vs low (referent) psychological distress for
IHD mortality
Crude Adjusted for age andgender Multi-adjusted*
In participants where SES = High 0.88 (0.64 1.21) 1.43 (1.04 1.98) 1.22 (0.83 1.81)
In participants where SES = Medium 1.29 (1.02 1.63) 1.52 (1.20 1.92) 1.38 (1.05 1.83)
In participants where SES = Low 1.48 (1.13 1.94) 1.63 (1.24 2.14) 1.47 (1.06 2.02)
Likelihood Ratio Test P value 0.009 0.023 0.048
* Adjusted for age, gender, smoking, BMI, and diabetes. Low Psychological Distress = GHQ-12 score < 4; High
Psychological Distress = GHQ-12 score ≥ 4. High SES = Professional/managerial positions; Medium SES = Skilled 
manual/non-manual workers; Low SES = Semi-routine/unskilled workers.
Table 6.7 and 6.8 describe the results from multivariate Cox regression models in
which the interaction between SES and GHQ-12 was included as a covariate that was
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previously created by multiplying SES (3 categories) and GHQ-12 (3 categories)
together. After adjusting for all variables in the model, the incidence of all-cause
mortality was on average increased by six percent when participants experienced
medium exposure from both factors and twelve percent when they experienced high
exposure (HR =1.06, 95%CI =1.01-1.10, P =0.021). Similarly, the incidence of IHD
mortality was on average increased by three percent when participants experienced
medium exposure from both factors and six percent when they experienced high
exposure (HR =1.03, 95%CI =1.01-1.05, P =0.047). These augmented risks have to be
summed to the risks that the two factors exert by themselves.
Table 6.7. Study 2 - Multivariate Cox regression model showing hazard ratios, 95% confidence
intervals, and P values for all-cause mortality.
Factor at the beginning of the follow-up
Mutually-adjusted all-cause mortality
HR (95%CI) P
Unit increase in GHQ-12 (3 categories) 1.38 (1.26 1.50) <0.001
Unit increase in SES going from high to low (3 categories) 1.21 (1.16 1.26) <0.001
Interaction SESxGHQ-12 (3x3) 1.06 (1.01 1.10) 0.021
Gender male 1.47 (1.40 1.54) <0.001
One-year increase in age 1.11 (1.11 1.11) <0.001
Current smoking 1.42 (1.35 1.49) <0.001
BMI <18.5 versus BMI 18.5-29.9 2.39 (2.04 2.80) <0.001
BMI 30+ versus BMI 18.5-29.9 1.08 (1.02 1.15) 0.008
Diabetes 1.62 (1.48 1.77) <0.001
The interaction between SES and GHQ-12 was calculated manually.
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Table 6.8. Study 2 - Multivariate Cox regression model showing hazard ratios, 95% confidence
intervals, and P values for IHD mortality.
Factor at the beginning of the follow-up
Mutually-adjusted IHD mortality
HR (95%CI) P
Unit increase in GHQ-12 (3 categories) 1.19 (1.14 1.38) <0.001
Unit increase in SES going from high to low (3 categories) 1.15 (1.14 1.16) <0.001
Interaction SESxGHQ-12 (3x3) 1.03 (1.01 1.05) 0.047
Gender male 2.13 (1.84 2.47) <0.001
One-year increase in age 1.12 (1.11 1.12) <0.001
Current smoking 1.49 (1.27 1.74) <0.001
Unit increase in BMI 1.02 (1.01 1.04) 0.003
Diabetes 2.53 (2.01 3.18) <0.001
The interaction between SES and GHQ-12 was calculated manually.
Figure 6.1 shows a graph that gives a visual representation of the concept of
interaction. In that example, study participants have been divided according to three
categories of mental stress levels (X-axis), and incidence of IHD-mortality (Y-axis), and
were stratified by three categories of socioeconomic status (diagonal lines). The
slopes of the lines represent the effect of mental stress on IHD-mortality; the steeper
the line is, the stronger the effect. The slopes of the three lines (the three strata of
socioeconomic status) are different from each other. The likelihood ratio test
challenges the null hypothesis of no difference in the slope between any lines. Since
the test gave a very significant result (P <0.001), we can reject the null hypothesis
and acknowledge the existence of an interaction between mental stress and
socioeconomic status. It has to be noted that the 95% confidence intervals for each
point in the graph do not overlap with each other, strengthening the findings further.
However, an interaction can exist and can be detected by the LRT even when the
confidence intervals overlap.
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Figure 6.1. Study 2 - Age- and sex-adjusted hazard ratios for IHD-cause mortality as a function of
mental stress for each stratum of socioeconomic status.
The reference category (hazard ratio =1) included participants with low mental stress and a high SES
level. Whiskers represent 95% confidence intervals. Likelihood ratio test P value <0.001. Low mental
stress = GHQ-12 score 0; Medium mental stress = GHQ-12 scores 1-3; High mental stress = GHQ-12
score 4+. High SES = Professional/managerial positions; Medium SES = Skilled manual/non-manual
workers; Low SES = Semi-routine/unskilled workers.
The sensitivity analyses showed a pattern of results that was similar to that found in
the main analyses, with no differences in the key interactions (Appendix 3).
6.4 Discussion
We have shown that the association between mental stress and either IHD or all-
cause mortality differs according to socio-economic status. Low SES operates as an
amplifier of the detrimental effect of mental stress on either IHD or all-cause
mortality.
The differential impact of psychological stress on health outcomes across SES groups
has not been directly investigated before in a large prospective observational study,
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but there is limited evidence concerning exposure to specific sources of stress. For
example, in a study of Japanese workers, job strain was associated with a higher risk
of stroke in men from lower occupational classes but not in higher status white-collar
and managerial workers.160 Similarly, in a register-based cohort study of nearly 3.5
million Swedish men and women, low job control was a risk factor for stroke in
women working in lower manual jobs but not in higher status non-manual
occupations.156 Given that lower SES groups are more likely to be exposed to greater
adversity and stress, several studies have also examined if occupational stress might
explain the social gradient in IHD risk. However, in a cohort of Finnish public sector
workers, job demands alone or in combination with job control suppressed rather
than explained socioeconomic differences in cerebrovascular disease.220
The explanations of why people from disadvantaged backgrounds are more
vulnerable to stress than those from higher SES groups are poorly understood.
However, people from higher SES might have better coping strategies and larger
support networks together with greater biobehavioral and economic resources for
dealing with adversity.221 In addition, higher SES groups demonstrate more effective
recovery in cardiovascular and biological parameters following acute stress, which
might over time contribute to IHD pathology.222,223
Smoking, BMI, hypertension, diabetes, and physical inactivity are also known risk
factors for IHD or all-cause mortality. We took these factors into account but we
cannot rule out the possibility of residual confounding by the measured or by other
unmeasured variables. Nevertheless, these factors may be on the causal pathway
between SES or mental stress and the outcomes, so adjusting for them could
diminish the effect of the two main exposure variables and make their interaction
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less detectable. Under this perspective, the more appropriate analysis to look at
would be the age- and gender-adjusted one.
BMI showed a J-shape association with all-cause mortality, with both under-weight
and obese people having higher mortality rates than normal-weight people, but had
a linear trend of association with IHD mortality. Our results are compatible with the
existing literature on this topic.224
One limitation of the present study is a lack of follow up data on mental stress, so we
were unable to account for the effects of changes in distress over time. The GHQ-12
is not designed to assess specific aspects of mental health such as anxiety and
depression. However, measuring symptoms of anxiety, depression, and dysfunction
as a unidimensional construct of mental stress is particularly relevant in community-
based samples, such as ours, as mental health problems in the community are
frequently characterized by shifting patterns of symptoms that resist precise clinical
classification.225 It has also been argued that the different manifestations of mental
stress are not distinctive in their associations with cardiovascular disease
outcomes.107
Other indicators of SES might have been used, such as educational level or gross
annual income. Occupational class was preferred since it is an indicator of current
socio-economic circumstances, whereas education is typically completed early in life
and partly dictates life-course trajectories.226 As for annual household income, the
HSE has relatively low response rate, like many other population surveys (about 50%
of households had no valid data).
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The HSE does not unfortunately include measures of specific sources of life stress
such as work stress, domestic strain, caregiver burden, or social isolation consistently
over the different years. We do not therefore know whether the elevations in mental
stress were responses to adverse life conditions or enduring traits.
Since we have used mortality records, our results are not generalizable to non-fatal
cardiac events. Our cohort was made of people who were free from any
cardiovascular disease, including angina, at baseline. Therefore, our results are
applicable only to those types of heart attacks that are fatal at their first
manifestation, which may have different pathophysiology compared to those events
that begin with less severe symptoms.
It has been argued that mortality records may underestimate the incidence of acute
myocardial infarction, unless combined with other sources (e.g. Hospital Episode
Statistics).227 This may account for our findings if mortality records were more
accurate for people with higher susceptibility to mental stress, increasing the
proportion of such people in our dataset in an artificial way, and therefore distorting
the results. This is very unlikely because any inaccuracies in the mortality records
probably occurred independently from the interactions that we have focused on.
These types of biases are called non-differential or non-informative because they do
not distort the results but they just “dilute” them, i.e. they decrease the statistical
power. In light of this, our results acquire even more robustness.
Another issue comes from the fact that some of our participants may have died in a
foreign country and therefore the ONS may have not recorded their death or may
have done so with a misleading delay. Again, it is unlikely that these missing data
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happened less frequently for people with higher susceptibility to mental stress,
rendering these people more present in our dataset and therefore explaining for our
results.
In conclusion, the effect of mental stress on all-cause mortality is more pronounced
in people from lower than higher socio-economic status groups, but further research
is required to confirm our results.
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Chapter 7 - Study 3: The interaction between psychosocial
and socioeconomic factors for the incidence of ischemic
heart disease in women
7.1 Introduction
Psychosocial factors are thought to have an influence on physical health status and
in particular on the genesis of cardiovascular disease (CVD).54,55,167 The psychosocial
factors that are relevant include exposure to different forms of life stress (such as
work stress and caregiver burden), aspects of impoverished social relationships
including low social support and social isolation, and psychological features such as
depression and hostility. We have recently argued that the magnitude of the effect
that stress exerts on IHD incidence may vary with socio-economic status (SES), in
such a way that people from disadvantaged backgrounds are more vulnerable to
stress, which consequently has larger effects on their physical health.228,229 This
hypothesis was stimulated by concepts such as the reserve capacity model of
Matthews and Gallo, which postulates that lower-SES individuals have fewer
interpersonal and intrapersonal resources to manage stressful events that do more
affluent individuals.110
Our previous cohort studies (described in Chapter 6) that found a robust interaction
between stress and SES had the following design features: participants were drawn
from the Health Survey for England database, which comprises a series of annual
nationally-representative surveys on the health status of men and women leaving in
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private households in England; baseline sample recruitment spanned years 1994-
2004; stress was measured in terms of psychological distress using the 12-item
General Health Questionnaire; SES was indexed using the occupation of the
individual (or of the head of the household); the study outcomes were fatal IHD
events and overall mortality and were assessed using mortality records from the
Office of National Statistics; and follow-up times were relatively long (8 years on
average).228,229
In the present study we wanted to challenge our previous findings by testing the
same research hypothesis after changing the study design in some key factors
including the reference population, the dataset analysed, the time period during
which data were collected, the index of SES, the measure of psychosocial adversity,
the data source from which clinical outcomes were extracted, the severity of
outcome events (non-fatal IHD events instead of fatal), and the follow-up time
resolution and duration (shorter follow-up times reduce the possibility of information
bias due to change in psychosocial adversities over time). Because of the strong
evidence that depression is a risk factor for future IHD,106,230,231 we tested exposure to
the related construct of hopelessness/helplessness. Hopeless/helplessness has more
recently attracted attention as it has been argued that this specific psychosocial trait
may play a more direct role in the process of IHD development than overall
depressive symptoms.75,101,102,232 Attempts to assess SES-specific prevalence of
depressive disorders have been made but no studies have focused on the differential
effect that depression has on IHD by categories of SES.233 Research carried out in this
field has predominantly involved men, so we deliberately tested our hypotheses in a
large cohort study of middle-aged and older women.
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7.2 Methods
Participants’ recruitment
This cohort study involved participants from the United Kingdom Collaborative Trial
of Ovarian Cancer Screening (UKCTOCS). The UKCTOCS is a multicentre randomised
controlled trial of ovarian cancer screening in the general population. The trial invited
1.2 million women of whom 202,638 were randomised through 13 trial centres
located in NHS Hospitals in England, Wales and Northern Ireland. Eligibility criteria
included (a) age between 50 and 74 years and (b) postmenopausal status defined as
>12 months amenorrhea, following a natural or surgical menopause or >12 months
of hormone replacement therapy commenced for menopausal symptoms. The
exclusion criteria were: (a) history of bilateral oophorectomy, (b) active non-ovarian
malignancy (women with a past history of malignancy were eligible if they had no
documented persistent or recurrent disease), (c) increased risk of ovarian cancer
because of familial predisposition and (d) previous history of ovarian cancer. At
recruitment, women completed a baseline questionnaire and written consent was
obtained which included use of their data in secondary studies. Women were then
randomised in a 2:1:1 ratio to: (1) a control group with no intervention (101,359) (2)
a multimodal group with annual screening with CA125 (50,640) (3) an ultrasound
group with annual screening with ultrasound (50,639).234 Women who had been on
the trial for at least 3.5 years following randomisation were sent a follow-up
questionnaire and constitute the baseline sample of the present study. Therefore, for
the purpose of the present study, the cohort follow-up started at the time of
questionnaire completion, which happened from July 2005 to December 2012. The
data for these analyses were made available through a collaboration with Professor
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Usha Menon, Professor of Gynaecological Cancer at the Institute of Women’s Heath,
University College London.
Measurement of hopelessness/helplessness
The baseline questionnaire included questions on demographics and current health
since randomisation. In addition, participants were asked to complete a 2-item
measure of hopelessness and helplessness (HH): (1) “The future seems to me to be
hopeful and I believe that things are changing for the better.” (2) “I feel that it is
possible to reach the goals I would like to strive for.” These items followed the 2-item
scale of Everson et al.100 with the only change being that they were phrased positively
rather than negatively (“The future seems to me to be hopeless…”), to avoid
reactions of distress observed with the negatively phrased HH scale.235 There were 5
categories of response ratings ranging from 1-absolutely agree, 2-somewhat agree,
3-cannot say, 4-somewhat disagree, to 5-absolutely disagree. The scores of both
items were added together to give a HH total score ranging from two to ten, where
high scores indicate higher levels of hopelessness/helplessness. This measure has
been recently validated in a cohort study on 2,413 postmenopausal women. The HH
index correlated 0.87 with the Beck Hopelessness Scale after correction for
attenuation and its association with the Centre for Epidemiological Studies
Depression Scale mirrored that seen with the Beck Hopelessness Scale. There was no
change in mean scores on the HH measures with repeat testing, and the test–retest
reliability was good (intraclass correlation =0.72).235
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Measurement of socio-economic status
We applied the Index of Multiple Deprivation v.2010 (IMD) as a marker of socio-
economic status using participants’ home postcode. The IMD is a geographically-
based measure of multiple deprivation built on the principle of distinct domains of
deprivation which can be recognised and measured separately in small communities
and then combined, using appropriate weights, into a single overall index of multiple
deprivation. This can then be used to rank every small area in England according to
the deprivation experienced by the people living there (one area includes around
1,500 people). Each domain represents a specific form of deprivation and is in turn
measured using a number of indicators. Seven distinct domains form the IMD:
income; employment; health; education; barriers to housing and services; living
environment; crime.236 The score is unidimensional and values range from less than
one to more than eighty, with higher scores indicating higher deprivation and deciles
being typically used as units of measurement.237
Covariates
The questionnaire included demographic and clinical measures such as education,
smoking, body height and weight, blood pressure, blood lipid profile, diabetes,
rheumatoid arthritis, osteoarthritis, and osteoporosis. The body mass index (BMI)
was calculated at the data analysis stage from self-reported height and weight as
Kg/m2.
142
Outcome measurement
The study outcome was non-fatal acute ischemic heart disease event (IHD) and we
used Hospital Episode Statistics records (HES) to measure their incidence with a
resolution of one day. The HES is a data warehouse containing details of all
admissions, outpatient appointments, and A&E attendances at public NHS hospitals
in England.238 The primary cause of hospitalisation was ascertained using the
International Classification of Diseases produced by the World Health Organization,
versions ten (ICD10) or nine (ICD9), as for some years the older version was used. The
codes for IHD were I20 to I25 for ICD10, or 410 to 414 for ICD9. The codes for stroke
were I60 to I69 for ICD10, or 430 to 438 ICD9. The end of the follow-up was set at 31st
March 2010 (non-informative censoring date).
Data analysis
Out of the 202,638 British post-menopausal women who have been recruited in the
UKCTOCS trial, we excluded those who have not stayed in the trial for at least 3.5
years following randomisation and were therefore not sent the questionnaire
containing the HH index, our main exposure variable. We have also excluded
individuals who had already experienced heart disease or cerebrovascular disease.
This information was derived by inspecting primary and secondary diagnostic fields of
HES hospital for admissions that occurred before baseline questionnaire completion
using ICD codes indicating IHD or stroke (same codes as above), and by using the self-
reported health status information included in the questionnaire. We have also
excluded participants with prevalent cancer using the same procedure (ICD10 codes
from C00 to D48 and ICD9 codes from 140 to 239). Moreover, since the IMD only
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considers England and not the whole United Kingdom, the analysis was restricted to
English residents. Our final analytical baseline sample therefore comprised 80,197
individuals. Unfortunately we are not aware of the number of people excluded for
each unmet condition.
The final dataset was cleaned before the main analyses with respect to inconsistent
and missing values, duplicates, outliers, digit preference, and normality of continuous
variables. Normality of each continuous variable was checked using histograms and
Shapiro–Wilk tests. The proportion of participants who died within the follow-up
period was calculated as well as the crude incidence rate for the cohort.
For the purpose of the interaction analysis, we transformed the
hopelessness/helplessness values (subtracted two points from each value) so that
they could range from zero (no HH) to eight (maximum HH) and measured IMD in
deciles ranging from zero (no socio-economic deprivation) to nine (maximum
deprivation). For data presentation purpose, we cut HH values into a binary variable:
low HH (scores 0 to 2) versus medium/high HH (scores 3 to 8). Since the HH index is a
relatively novel measure in medical research, a histogram describing its frequency
distribution is reported in Appendix 6. The index follows a normal distribution.
We used Cox proportional hazards regression with time-scale in days to model the
hazard ratios (HR) of developing IHD as a function of HH adjusting for all other
available covariates such as age, education, smoking, high blood pressure,
osteoarthritis, osteoporosis, diabetes, and BMI, which all showed potential
confounding effects by being associated with both the main exposure variable and
the outcome variable. The only covariate that did not show potential confounding
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effect was rheumatoid arthritis, which was excluded from the multivariate analysis.
Diabetes and education level were not associated with the outcome after the
multiple adjustments, and they were therefore removed from the model. Estimates
for the other covariates did not change after their removal.
The proportional hazards assumption has been assessed as follows: data has been
split with the Lexis Expansion method according to follow-up time (cut-offs at 1, 1.5,
and 2 years), and tests for departure from proportional hazards assumption were
carried out assessing the presence of interaction between follow-up time and each
variable. Furthermore, Nelson-Aalen plots were displayed to have a visual impression
of the proportionality, as in Chapter 6.188 An example of a Nelson-Aalen plot is shown
in Appendix 4.
Departure from linearity of each continuous variable in the final model was tested
using the following procedure: 1) cut-offs were chosen to subdivide the sample
equally in four or five categories; 2) the presence of an adequate number of
outcomes in each category was checked; 3) the final model was run assuming the
variable to be categorical (three or four hazard ratios were generated); 4) the final
model was run assuming the variable to be ordered categorical (one hazard ratio was
generated); 5) the two models were compared using the likelihood ratio test (LRT).
Furthermore, the hazard ratios for categorical variables were plotted to have a visual
impression of the trend.188
The interaction between IMD and HH was evaluated using the following approach:
the raw values of IMD were firstly divided into three tertiles; we then run a model
with HH and tertiles of IMD as main covariates; the model was then repeated after
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adding in an interaction term between the main covariates; finally the estimates
from the second model were compared with the estimates from the first one using
the LRT. In order for this test to be valid, the comparison has to be made on the same
group of individuals (missing values can distort the results) and this assumption was
always satisfied. This approach was used in four models using different adjustments:
none; age; age and education; fully adjusted. Afterwards, we tested for the
interaction using another strategy: the multivariate model included an additional
variable calculated by multiplying the two main exposure variables together
(continuous by continuous interaction).
Regarding sensitivity analysis, we excluded participants who experienced an outcome
within six months from recruitment to diminish the chances of reverse causality. We
did not carry out any sensitivity analysis on missing values because they were
minimal.
7.3 Results
We recorded 569 IHD events during the average 2.9 year follow-up (median= 3.0).
The overall incidence rate of hospitalisation for acute IHD event was 2.7 per 1,000
person years (95% confidence interval [CI]= 2.5-3.0).
Table 7.1 and 7.2 describe the sample according to categories of
helplessness/hopelessness (HH) and incidence of IHD events. HH, IMD, and IHD
appeared to be associated with each other, with higher-HH and lower-IMD women
having higher incidence of IHD, and lower-IMD women having higher level of HH. All
other variables were also associated with both HH and IHD, with the exception of
rheumatoid arthritis that was associated with HH only: women with high HH scores
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were typically older and less educated, had higher BMI, blood pressure, and blood
cholesterol, had higher prevalence of diabetes, rheumatoid arthritis, osteoarthritis,
and osteoporosis, were more likely to be smokers and to live in deprived areas, and
showed higher incidence of IHD events; similarly, women with higher incidence of
IHD events were typically older and less educated, had higher BMI, blood pressure,
and blood cholesterol, had higher prevalence of diabetes, osteoarthritis, and
osteoporosis, were more likely to be smokers and to live in deprived areas, and had
higher levels of hopelessness/helplessness (Table 7.1 and 7.2).
Table 7.1. Study 3 - Sample description by categories of hopelessness/helplessness index.
Variable at the beginning of the follow-up
HH Index at the beginning of the follow-up
P
Low (scores 2-4) Medium/High (scores 5-10)
(n =44,184) (n =36,013)
Age (mean years ± s.d.) 63.7 ±5.9 65.0 ±6.2 <0.001
BMI (mean kg/m2 ± s.d.) 26.1 ±4.4 26.3 ±4.5 <0.001
IMD Index (mean ± s.d.) 17.9 ±13.6 18.7 ±14.0 <0.001
IMD Index (geom. mean ± s.d.) 13.6 ±2.1 14.3 ±2.1 <0.001
IMD Index = 20 or more 32.3% n=14,267 34.6% n=12,450 <0.001
Level of Education*
<0.001
None 24.6% n=10,847 33.8% n=12,180
Basic 51.2% n=22,635 48.8% n=17,556
Higher 24.2% n=10,701 17.4% n=6,277
Current Smoker 42.9% n=18,959 45.2% n=16,271 <0.001
High Blood Pressure 27.6% n=12,195 30.9% n=11,128 <0.001
High Blood Cholesterol 19.5% n=8,625 23.1% n=8,301 <0.001
Diabetes 4.0% n=1,759 4.7% n=1,700 <0.001
Rheumatoid Arthritis 3.9% n=1,701 5.1% n=1,847 <0.001
Osteoarthritis 14.4% n=6,345 17.5% n=6,309 <0.001
Osteoporosis 5.9% n=2,585 7.0% n=2,514 <0.001
Incident IHD event during the follow-up 0.6% n=283 1.0% n=342 <0.001
P values were computed using univariate logistic regression. *The ordered categorical variable education was treated
as linear (P for trend). Basic level includes O-level, A-level, nursing, teaching, clerical or commercial qualification.
Higher level indicates university degree.
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Table 7.2. Study 3 - Sample description by incidence of IHD, with unadjusted hazard ratios, 95%
confidence intervals, and P values, from univariate Cox regression.
Variable at the beginning of the
follow-up
Incident IHD event within the follow-
up time
HR (95% CI) PYes No
(n =569) (n =79,628)
Age (mean years ± s.d.) 66.5 ±6.0 64.3 ±6.1 1.07 (1.06 1.08) <0.001
BMI (mean kg/m2) 27.1 ±4.8 26.2 ±4.5 1.04 (1.02 1.06) <0.001
IMD Index (mean ± s.d.) 20.9 ±14.7 18.3 ±13.8 1.01 (1.01 1.02) <0.001
IMD Index (geom. mean ± s.d.) 16.0 ±2.2 13.9 ±2.1 1.25 (1.12 1.39) <0.001
IMD Index = 20 or more 40.8% n=232 33.3% n=26,492 1.33 (1.12 1.57) 0.001
Level of Education*
0.78 (0.69 0.88) <0.001
None 35.9% n=204 28.7% n=22,837
Basic 48.9% n=278 50.1% n=39,910
Higher 15.2% n=86 21.2% n=16,881
Current Smoker 49.9% n=284 43.9% n=34,949 1.25 (1.06 1.47) 0.008
High Blood Pressure 45.2% n=257 29.0% n=23,068 2.05 (1.74 2.41) <0.001
High Blood Cholesterol 32.0% n=182 21.0% n=16,746 1.81 (1.52 2.16) <0.001
Diabetes 5.8% n=33 4.3% n=3,424 1.38 (0.97 1.97) 0.070
Rheumatoid Arthritis 4.9% n=28 4.4% n=3,520 1.09 (0.75 1.60) 0.650
Osteoarthritis 22.7% n=129 15.7% n=12,533 1.57 (1.29 1.91) <0.001
Osteoporosis 9.1% n=52 6.3% n=5,048 1.50 (1.13 2.00) 0.005
HH Index (mean ± s.d.) 5.0 ±1.7 4.7 ±1.7 1.11 (1.06 1.16) <0.001
Category of HH Index
1.33 (1.17 1.50) <0.001
Low (scores 2-4) 44.8% n=255 54.8% n=43,668
Medium (scores 5-7) 47.1% n=268 38.2% n=30,426
High (scores 8-10) 8.1% n=46 7.0% n=5,542
Ordered categorical variables such as education and HH were treated as linear (P for trend). *Basic level includes O-
level, A-level, nursing, teaching, clerical or commercial qualification. Higher level indicates university degree.
Table 7.3 shows the results for the multivariate analysis. After adjusting for age,
smoking, high blood pressure, osteoarthritis, osteoporosis, BMI, and high blood
cholesterol, HH was associated with greater incidence of IHD. For each one point
increase in HH score the incidence rate of IHD increased by seven percent on average
(HR =1.07, 95%CI =1.02-1.12, P =0.006). The other independent predictors of IHD
were older age (P <0.001), smoking (P =0.001), high blood pressure (P <0.001),
osteoarthritis (P =0.004), osteoporosis (P =0.042), BMI (P =0.006), and high blood
cholesterol (P =0.002).
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Table 7.3. Study 3 - Multivariate Cox regression model showing adjusted hazard ratios, 95%
confidence intervals, and P values for IHD event incidence.
Variable at the beginning of the follow-up Mutually-adjusted HR for
IHD event
(95%CI) P
HH Index (one point increase) 1.07 (1.02 1.12) 0.006
Age (one year increase) 1.05 (1.04 1.07) <0.001
Current smoker 1.32 (1.12 1.56) 0.001
High blood pressure 1.53 (1.28 1.84) <0.001
Osteoarthritis 1.34 (1.10 1.64) 0.004
Osteoporosis 1.35 (1.01 1.81) 0.042
BMI (unit increase) 1.03 (1.01 1.04) 0.006
High blood cholesterol 1.35 (1.12 1.63) 0.002
Table 7.4 show the results for the interaction analysis. For each level of adjustment
there was a trend such that the augmented incidence of IHD for people who
experienced HH were higher in people of low SES, medium in people of medium SES,
and lower in people of high SES (P values <0.03).
Table 7.4. Study 3 - Multivariate Cox regression model showing hazard ratios, 95% confidence
intervals, and P values for hopelessness/helplessness index towards IHD event incidence, stratified by
tertiles of socioeconomic status (IMD).
Stratum of
IMD
Effect of each one-point increase in HH on IHD event incidence rate, HR (95%CI)
Crude Adjusted for age Adjusted for age andeducation Multi-adjusted*
Least
deprived
1.05 (1.01 1.10) 1.02 (0.98 1.06) 1.02 (0.98 1.07) 1.02 (0.97 1.06)
Medium
tertile
1.08 (1.04 1.13) 1.05 (1.01 1.10) 1.05 (1.01 1.09) 1.04 (1.00 1.09)
Most
deprived 1.12 (1.07 1.16) 1.09 (1.05 1.13) 1.07 (1.03 1.12) 1.06 (1.02 1.10)
Likelihood
Ratio test
P value
0.015 0.027 0.021 0.018
*Adjusted for age, education, smoking, blood pressure, osteoarthritis, osteoporosis, BMI, and high blood cholesterol.
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Table 7.5 also shows results from the interaction analysis, but instead of presenting
the results for the association between HH and IHD in three separate groups of
women to highlight the difference between IMD categories, this time the analysis
was not stratified and included an extra covariate calculated as an interaction
parameter between HH and IMD. After having adjusted for demographic and clinical
variables, HH was associated with higher rates of incident IHD, such that people had
an average 11% increase in incidence rates per each point increase in HH score, when
they had no socio-economic deprivation (HR =1.11, 95%CI =1.01-1.23, P =0.033).
Socio-economic status was also associated with IHD, with an average 7% increase per
each decile increase in IMD, when people had no HH (HR =1.07, 95%CI =1.01-1.13, P
=0.023). When both risk factors deviated from their zero values, some extra
increased risk appeared, evaluated to be 2% per each combined unit increase (HR
=1.02, 95%CI =1.01-1.03, P =0.013), meaning that the effects of
hopelessness/helplessness and socio-economic deprivation are amplified by each
other. The other independent predictors of IHD remained significant; these were
older age (P<0.001), smoking (P <0.005), high blood pressure (P <0.001),
osteoarthritis (P =0.005), osteoporosis (P 0.043), BMI (P =0.014), and high blood
cholesterol (P =0.002).
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Table 7.5. Study 3 - Multivariate Cox regression model showing adjusted hazard ratios, 95%
confidence intervals, and P values for IHD event incidence.
Variable at the beginning of the follow-up Mutually-adjusted HR for
IHD event
(95%CI) P
HH Index (one point increase) 1.11 (1.01 1.23) 0.033
IMD Index (one decile increase) 1.07 (1.01 1.13) 0.023
Continuous interaction between IMD and HH 1.02 (1.01 1.03) 0.013
Age (one year increase) 1.06 (1.04 1.07) 0.000
Current Smoker 1.28 (1.08 1.51) 0.005
High Blood Pressure 1.53 (1.27 1.84) 0.000
Osteoarthritis 1.34 (1.09 1.64) 0.005
Osteoporosis 1.35 (1.01 1.81) 0.043
BMI (one unit increase) 1.02 (1.00 1.04) 0.014
High blood cholesterol 1.34 (1.11 1.62) 0.002
The interaction between HH and IMD was calculated manually.
The sensitivity analysis carried out by excluding participants who experienced the
outcome during the first six months of follow-up showed a pattern of results that
was similar to that found in the main analysis, with no differences in the key
interaction (Appendix 5).
7.4 Discussion
This study confirms our previous findings that stress-related psychological factors
and socio-economic status interact with each other for the pathogenesis of IHD. We
modified several important design features adopted in previous studies and
consistently found that people in lower-SES conditions are more vulnerable to the
detrimental effect of psychosocial adversities on IHD. The magnitude of the
synergistic effect found in this study is similar compared to that found in the other
study (Chapter 6). Comparing Table 6.8 with table 7.5, the HR for the interaction
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parameter was 1.03 for the previous study and 1.02 for this one, with confidence
intervals abundantly overlapping. Moreover, the sensitivity analysis carried out in the
previous study by restricting the analysis to female participants - rendering that study
more comparable to this one - gave very similar results (HR =1.01). Although these
hazard ratios appear to be very small and close to the null value of 1, their effect
should not be underestimated. This is a consequence of the fact that they result from
analyses performed on continuous interaction parameters, i.e. on scales that
measure each combined increase in the two exposure variables, and therefore a HR
of 1.01 for example reflects a one percent increase in the event rate for each one
unit increase in the parameter, and the parameter can range over several units.
It may be argued that the estimates from this study are overall smaller than the
estimates from the previous study (Chapter 6). For example, the HR for the mental
stress variable was 1.27 in the previous study (females only) and 1.11 in the present
study, and the HR for the SES variable was 1.21 whereas it is now 1.07. However it
has to be noted that the two measures were taken on different scales. In the
previous study mental stress and SES had three possible values, while in the present
study mental stress has eight possible values and SES has ten. It follows that a HRs for
one unit increase calculated on longer scales tend to be smaller than a HRs for one
unit increase calculated on smaller scales, and this accounts for the apparently
different results.
Our findings can have important implications for health policy makers, because they
can constitute the foundations for large scale programmes aiming at identifying
persons who are particularly vulnerable to psychosocial adversities. Such forms of
screening may have high cost-effectiveness in preventing cardiovascular disease.
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We may have had missing information for those events that were treated in private
hospitals or that were asymptomatic (e.g. silent AMIs in diabetes patients), or if
hospitals recorded their administrative records with some inaccuracies, as Herrett at
al. suggested.227 This may account for our findings if people with higher vulnerability
to mental stress tend to go to public rather the private hospitals, or tend to have
silent rather than manifest heart attacks, or if hospital records were more accurate
for people with higher susceptibility to mental stress. These instances would make
stress-vulnerable people more present in our dataset in an unnatural way, therefore
altering the results. This is very unlikely. Rather, if these missing values exist in our
dataset, they have probably occurred independently from the patterns of
interactions that we have focused on. As I have described in my second study, these
non-differential (non-informative) biases do not distort the results, but they actually
provide more robustness once the results are found to be statistically significant.
Our previous measurement of stress was based on the GHQ-12 which is not designed
to assess specific aspects of mental health such as anxiety and depression, which we
think are assessed by the hopelessness/helplessness score. The two scores gave
consistent results.
The IMD score is an area-based score and we had to assume that the amount of
deprivation recorded in each area was an accurate measurement of residents’
deprivation, while people living in an area might vary in their affluence and
socioeconomic status. The argument that was put forward in the discussion of
missing values is applicable for this potential limitation too: it is very unlikely that the
occurrence of inaccuracies in the SES measurements was dependent on individuals’
vulnerability to mental stress.
153
The adjustment for clinical covariates may have been inefficient because they were
self-reported in self-administered questionnaires. Nonetheless, those factors may be
on the causal pathway between IMD or HH and IHD and therefore adjusting for them
would obscure a real interaction. From this perspective, the more appropriate
analysis to consider would be the one adjusted for age and education.
There is much less literature on psychosocial factors and heart disease in women
than men, so the focus of the present study on women is particularly valuable. We
know that women are at lower risk of IHD then men and it is therefore plausible to
hypothesise that they may also have different patterns of SES-stress interaction.
However, our analyses found similar interaction patterns between the two genders.
Our study design did not allow for changes in HH over time, i.e. participants’
conditions were assessed only at baseline with no repeated measurements during
the follow-up. However, the average follow-up time was relatively short and this
diminished the occurrence of the changes, which, if ever happened, would have not
distorted the interaction analysis (non-differential misclassification).
The relatively short-term nature of the study has also other implications. We have
seen that atherosclerosis and IHD take several years to develop, and therefore it is
probable that the pathophysiological dynamics that lead to IHD had already initiated
before the study recruitment in most of the women who have then suffered a cardiac
event during our follow-up. Therefore it is likely that the phenomenon that we have
detected, i.e. the interaction between SES and mental stress, has a role in the trigging
of acute events as well as in the chronic production of a substratum for the events.
Rather than leading to slowly progressive atherosclerosis, triggers represent the final
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step in the pathophysiological process leading to cardiovascular outcomes among
susceptible individuals, such as those with vulnerable atherosclerotic plaque, chronic
atherosclerotic disease, disorders of the cardiac conduction system, and
microvascular disease. In the presence of a vulnerable atherosclerotic plaque,
chemical, physical, and psychological stressors may trigger transient vasoconstrictive
and prothrombotic effects that ultimately cause plaque disruption and thrombosis.
Even in the absence of an occlusive thrombus, triggers may lower the threshold for
cardiac electric instability and increase cardiac sympathetic activation via centrally
mediated release of catecholamines.239–241 From a public health perspective, it has
been argued that mental triggers have similar or even higher population attributable
fractions (PAF) for the incidence of heart attacks compared to respiratory infections,
physical exertion, alcohol abuse, pollution, sexual activity, and cocaine use.242
In conclusion, the hypothesis that low socio-economic status amplifies the harmful
effect of psychosocial adversities for the development of IHD is strongly supported by
the present findings.
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Chapter 8 – Final discussion
Summary of findings
I have shown that the interaction between socioeconomic status and mental stress is
associated with ischemic heart disease, in such a way that people in low
socioeconomic circumstances are more vulnerable to the negative effects of mental
stress. In other words, the harmful effect of mental stress for human cardiac health
appears to be modified by socioeconomic position and rendered more deleterious
for people from disadvantaged backgrounds. This is different to saying that
socioeconomic status is a mediator or a confounder between stress and ischemic
heart disease and that mental stress is a mediator or a confounder between
socioeconomic status and ischemic heart disease.
In addition, I found evidence of interaction between mental stress and
socioeconomic status even when the outcome was all-cause mortality. There are four
main possible explanations for this observation:
 Ischemic heart disease is the leading cause of death both in the UK and
worldwide. It is responsible for more than 73,000 deaths in the UK each year.
About 1 in 6 men and 1 in 10 women die from ischemic heart disease. In the
UK, there are an estimated 2.3 million people living with ischemic heart
disease and around 2 million people affected by angina (the most common
symptom of ischemic heart disease).243 Since my three studies were all based
on British samples, all-cause mortality may have been mainly driven by IHD
deaths.
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 Diseases such as cancer may share a common pathophysiology with
ischaemic heart disease. The extent to which psychosocial factors can
promote cancer incidence has been highly controversial. In contrast, there is
much stronger evidence supporting a role of psychosocial factors in cancer
progression and mortality.244 Converging evidence from clinical, animal, and
in vitro models supports the presence of both direct and indirect links
between psychosocial risk factors, related neuroendocrine hormones, and a
number of dynamic biological processes that promote cancer growth
modulate immunocompetence, or both. Stress-related factors have been
associated with impairment of the cellular immune response and
upregulation of pathways supporting inflammation, angiogenesis, invasion,
and metastases.244 Since cancer deaths will have been another major driver
for all-cause mortality in my sample, along with ischaemic heart disease,
common pathophysiological processes may explain the association.
 The combination of high mental stress and low socioeconomic status may
operate as a determinant of general susceptibility to chronic disease. Indeed,
the concept of general susceptibility to disease has developed as a unifying
explanation for the finding that a variety of health outcomes are associated
with certain social and cultural situations.245 Also, from a more clinical and
less sociological perspective, it has to be considered that the fight against
infectious disease advanced dramatically with the consolidation of the germ
theory in the 19th century. This focus on a predominant cause of infections
(i.e., microbial pathogens) ultimately led to medical and public health
advances (e.g., immunization, pasteurization, antibiotics). However, the
resulting declines in infections in the 20th century were matched by a rise in
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chronic, non-communicable diseases, for which there is no single underlying
etiology. The discovery of a form of low-grade systemic and chronic
inflammation (“metaflammation”), linked to inducers (broadly termed
“anthropogens”) associated with modern man-made environments and
lifestyles, suggests an underlying basis for chronic disease that could provide
a 21st-century equivalent of the germ theory.246 However, these postulates
have not yet been scientifically validated.
 Other mechanisms may have operated in determining all-cause mortality or
even in causing ischaemic heart disease incidence and mortality. For
example, a prospective cohort study on depressive disorder defined using
the GHQ-30, ischaemic heart disease, and stroke found evidence of a dose-
response effect of depressive symptoms on risk of ischaemic heart disease,
but not on stroke.247 This finding contrasts with the widely-accepted idea
that primarily somatic aspects of depression are linked with ischaemic heart
disease.248 The GHQ-30 was developed from the GHQ-60 and involved
removing most questions related to somatic symptoms. The study by
Brunner et al suggests it would be valuable to explore other processes in the
determination of cardiovascular disease. There are two very different types
of stroke - ischaemic and haemorrhagic - and this may partly explain the
study findings by Brunner et al. While ischaemic stroke may share a common
pathophysiology with ischaemic heart disease, haemorrhagic stroke may
have different determinants.
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Strengths and limitations
 Power. This dissertation is based on secondary analysis. I have not carried
out any sample size calculation before the design of any of the presented
studies because their data had already been collected before I became
involved in them. The original sample size calculation for none of the studies
was based on my original research hypothesis. Study one is probably
underpowered to address my research hypothesis; however, although the P
values for the statistical tests were non-significant, the results showed a
positive trend in the interaction, meaning that the lower the socioeconomic
status of the individuals, the higher the measure of effect (odds ratio) for the
association between mental stress and heart disease. Studies two and three
had sufficient power to test my research hypothesis as they have showed the
expected statistically significant trends.
 Information bias. Possible measurement errors in the key variables can
distort the results if they are differential (informative), i.e. if they happen to a
greater or lesser extent in certain categories of study participants. For
example, if people with high levels of mental stress who then develop heart
disease are wrongly diagnosed as not having the disease, the effect is
underestimated (lower relative risk than the true one); whereas if people
with low stress who then develop heart disease are wrongly diagnosed as not
having the disease, the effect is overestimated (higher relative risk than the
true one). Additionally, if people with high levels of stress who then do not
develop heart disease are wrongly diagnosed as having the disease, the
effect is overestimated, whereas if people with low levels of stress who then
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do not develop heart disease are wrongly diagnosed as having the disease,
the effect is underestimated. My results would be due to those kinds of
distortions if errors tending to overestimate the results happened more
often in low socio-economic status groups and/or if errors tending to
underestimate the results happened more often in high socio-economic
status groups. This is unlikely to have happened because the outcome
ascertainment for all studies was blind, i.e. the researchers or clinicians who
recorded the outcome did not know the levels of mental stress and the
socioeconomic position of the study participants. Instead, non-differential
(non-informative) measurement errors are those that happen randomly or
for reasons that are not linked with the research hypothesis. In this case they
do not distort the results, but they do create some “noise” in the data, i.e.
they decrease the power of the analysis and therefore they increase the P
values. As a consequence, when a P value is small and non-differential
information bias is present the results acquire more importance. As I have
explained in the chapters pertaining to each study, it is very likely that if
there were measurement errors in any of the presented studies they would
be of the non-differential type. I have measured the exposure variable only
at baseline for studies two and three, and therefore I could not account for
changes of those measures during the follow-up period, which would
introduce non-differential misclassification. However, my third study had a
relatively short follow-up time, and hence had a reduced probability of such
bias. Moreover my first study was cross-sectional and was carried out in
laboratory-based experimental conditions, and therefore the measurement
of the exposure variable was optimal in that case. The outcome variable and
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the effect modifier could also be affected by measurement error; however
the three studies had three different methods of ascertainment for both
measures, and the results were consistent between them.
 Selection bias and generalisability. Selection bias can distort the results in
two main ways: if potential participants with certain patterns of association
are more/less likely to be recruited and selected for a study, and if they are
more/less likely to drop out from the study once they are in. It is improbable
that these potential distortions account for my results because participants’
recruitment for all studies was blind towards my research hypothesis and
because it is very unlikely that people with higher vulnerability to mental
stress were more prone to be selected or less prone to drop out, rendering
them artificially more frequent in my datasets than they are in the general
population. Moreover the sample of my second study was representative of
the national population, thus rendering selection bias less likely and
increasing the generalisibility of my results.
 Heterogeneity of measures and settings. My research hypothesis was
confirmed in three separate studies that had different key features from
each other such as the study design, the index for mental stress, socio-
economic status, and heart disease used, the follow-up time resolution and
duration, the reference population, the calendar time (time of data
collection), and the severity of the events (fatal and non-fatal). Therefore my
research results appear to have considerable validity and generalisibility.
 Confounding. Confounding is a common issue in studies assessing the
association between two variables. The results can be confounded if a third
factor is associated with the exposure variable and is a risk factor for the
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outcome variable, therefore explaining the results by being the real
determinant of the outcome and disproving a causal relationship between
the exposure and the outcome. For example, chronic inflammation may
cause both heart disease and mental disease, thus explaining the association
between those two. Smoking is a risk factor for heart disease and can be
another confounder, if people who are more stressed tend to smoke more.
My analyses have been adjusted for several determinants of heart disease
such as the ones that I have mentioned, although for my third study the
covariates may have not been robust enough. Further confounding may have
come from unmeasured variables. For example, there could be genetic
polymorphisms that affect vulnerability to stress, and these polymorphisms
could be over-represented in the lower SES groups, thus explaining not only
the association between mental stress and heart disease but also the
interaction between mental stress and socio-economic status. Childhood
infections may also give a similar explanation, if some of them are able to
cause augmented vulnerability to mental stress (through immune function
dysregulation for example) and if they cluster in lower socioeconomic sectors
of the population.249
 Interaction. It is theoretically possible that a fourth variable can act as a
further effect modifier, resulting in a four-dimensional interaction. For
example, the augmented effect of mental stress for heart disease seen in
people from low socioeconomic backgrounds can be further increased if
these people are females, or older, or have some other characteristics. The
possibility of gender interaction has been evaluated by restricting one
analysis to female participants, and the results were consistent. We did not
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carry out any other four-dimension analysis because it has been shown that
post hoc subgroup analysis can lead to false positive results simply due to
chance, and therefore there has to be a strong biological plausibility, along
with an increased sample size, for these sub-analyses to be valid.
 Reverse causality. In studies for the association between two variables the
issue of reverse causality is never ruled out completely. Unless the exposure
variable is experimentally and randomly assigned (randomised controlled
trials), there is always a chance that variable A is the effect of variable B, and
not its cause. My three studies were all observational and therefore I cannot
rule out the problem of reverse causality. It is possible that people at early
stages of heart disease felt more stressed, as a consequence of metabolic
unbalances due to coronary disease for example. Reverse causality is a major
limitation of my research and it may also explain the interaction effect that I
have found. In study one for example people with subclinical or initial
ischaemic heart disease could have had alterations in their cortisol reactivity,
and people in higher socioeconomic conditions may have engaged less in the
performance of the stress tasks. In study two and three, people at initial
stages of ischaemic heart disease, or people with conditions that are
prodromes of ischaemic heart disease, may have had higher chances of
answering questions related to anxiety or depression positively, and, most
importantly, people from different socioeconomic sectors may have
answered the subjective measurements (questionnaires) with differential
accuracy. To tackle this issue, in my two cohort studies I carried out
sensitivity analyses by excluding study participants who developed the
outcome soon after their recruitment, and who might have been thought to
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be already affected by subclinical heart disease. In study two I excluded the
51/1,007 (5.1%) participants who experienced the outcome within one year
from recruitment. In study three I excluded the 65/569 (11.4%) participants
who experienced the outcome within six months from recruitment. The
results from these sensitivity analyses were similar to those from the main
analyses. Also, by checking the proportional hazards - as explained in the
Methods section of the two studies (p.122-123, 144) - we observed that
there was no evidence of changes in the incidence rates during the follow-up
times. If the samples included considerable numbers of people who were
already affected by heart disease at the beginning, the incidence rates would
have appeared higher in the first period of time, then lower, and then higher
again, whereas the rates appeared always stable in time.
 Types of outcome. For this dissertation I have used three different CVD
outcomes. For study 1 I have used HS-CTnT measured in a laboratory-based
experimental setting, for study 2 I have measured mortality for IHD using
death records from the Office for National Statistics, and for study 3 I have
measured hospitalisation rates for IHD using Hospital Episode Statistics
records. The results from those different sources of outcome data were
consistent and this gives my findings particular value. While for studies 2 and
3 the outcome variable was a binary variable measuring the incidence of a
real event, study 1 had a continuous outcome variable that is routinely used
to mark cardiac damage in the context of emergency diagnosis of AMI. The
finding of troponin abnormalities is the condition sine qua non for a
conclusive diagnosis of AMI: an AMI is confirmed if an elevation or a decline
in troponin concentration above the 99th percentile upper reference limit is
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detected in the peripheral blood plasma of an individual, and if at least one
of the following conditions is also present: symptoms of ischaemia;
electrocardiographic abnormalities; imaging evidence of new loss of viable
myocardium or new regional wall motion abnormality; identification of an
intracoronary thrombus by angiography or autopsy.250 However causes of
troponin elevation not related to AMI have become common findings with
the advent of high-sensitivity assays, not only in patients with chest pain but
also in people with no symptoms. People who do strenuous physical exercise
such as a marathon for example can have troponin elevations. All the
conditions leading to troponin release in the absence of AMI are largely
unknown, and wrong diagnosis (false positive) may occur if one of such
conditions couples with another spurious condition (e.g. physical exercise +
chest pain due to heartburn).22 Although experimental data strongly suggest
that troponin leaks out of the cell only after membrane disruption following
myocardial cell death,251 the detection of brief rise and subsequent fall of
troponin concentration during marathon running252 and rise after inducible
myocardial ischaemia253 has cast some doubts on the hypothesis that
troponin is released only upon irreversible damage. Although the hypothesis
that there may be a leakage of troponin through myocyte membranes
without necrosis is not implausible, there is no scientific evidence supporting
this theory yet and troponin abnormalities have to be considered as a sign of
cardiac damage.254 Moreover, in healthy people not fulfilling any diagnostic
criterion for AMI, greater HS-CTnT is associated with a greater incidence of
structural and functional heart disease, cardiovascular mortality, and all-
cause mortality.176,177 Therefore, although the outcome for study 1 does not
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mark an incident event, it is a prodrome of IHD that is relevant to my
research hypothesis and hence the findings from study 1 support the findings
from the other studies.
Comparison with other studies
Other studies have had a similar research hypothesis to mine. Out of the eleven
observational studies found through my literature review, five found an interaction
and confirm our results, four found no interaction, one study on a male population
found a negative interaction, with high-SES participants being more vulnerable to
stress, and one study found positive interaction in men and negative in women. In
the following paragraphs I will go through the papers that do not confirm my results
and will evaluate the differences to my studies.
Kuper and Marmot (2003) found no interaction between job strain and employment
grade on around 10,000 participants from the Whitehall II study.155 Their result may
be due to the fact that their study was underpowered to detect an interaction, since
some of my results showed borderline significance (P around 0.05) in spite of having
more than six times (for study two) and more than eight times (for study three) the
sample size of Kuper&Marmot’s study.
Janszky et al. (2010) had a sample size that was comparable to mine (about 50,000
men).157 However, they measured mental stress (adolescent depression or anxiety)
and SES (self-reported occupation of the head of the household during participants’
childhood) only at baseline for a follow-up of 37 years of duration on average. Those
measures may have been less relevant than more contemporary measures of SES,
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introducing information bias and therefore a decrease in power. Moreover, the
authors do not report the results from any statistical test for interaction.
Toivanen (2011) had a smaller sample size (about 2,600 persons),159 as well as
possible information bias leading to further power reduction, since they have
considered self-reported health as an outcome. Although self-reported health is a
validated end-point in epidemiological studies, its measurement has less precision
and accuracy than hard clinical outcomes such as acute myocardial infarction or
other IHD events.
Tsutsumi et al. (2011) found a positive interaction in men (the lower the SES, the
higher the vulnerability) and a negative in women (the lower the SES, the lower the
vulnerability).160 This study had also a relatively small sample size (about 6,400
people) and the authors did not carry out any formal test for interaction; their
conclusions are drawn solely from observing stratified results. A further limitation
may have arisen from the choice of the variables and from the adjustments. The
authors considered occupational stress as the exposure variable and occupational
class as the effect modifier, and their analysis was adjusted for level of education. All
these three variables may be correlated with each other (e.g. education is also an
index of SES as occupational class is), hence introducing potential bias and
overadjustment.
A negative interaction was found in men by Suadicani et al. in 2011.161 Their sample
size was relatively small (about 4,900) and the follow-up was long (about 30 years),
thus introducing information bias and power reduction. Moreover their exposure
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variable (perceived psychological work pressure) was measured using a non-
validated questionnaire.
Mittag et al. (2012) had an adequate sample size (about 64,000).162 The main
limitation of this study is that it was cross-sectional, and the exposure variable, the
effect modifier, and the outcome were self-reported using non-validated
questionnaires (e.g. the existence of IHD was assumed if any of these items were
answered positively: “has a doctor ever told you that you had angina pectoris or
coronary artery disease? Has a doctor ever told you that you had a myocardial
infarction or heart attack?”).
Therefore my research has several advantages over the previous studies. For studies
two and three my sample size was considerably larger than most of the previous
research in this specific research area. Study two was representative of the English
national population and is therefore stronger than the previous literature in terms of
generalizability. In all my studies, all three main variables were uncorrelated with
each other, to the contrary of most previous studies that had a focus on job stress.
Studies two and three had different follow-up times; a short follow-up time has the
disadvantage of being more prone to reverse causality, whereas a long follow-up
time has the disadvantage of being more prone to information bias (change in the
exposure variable), so by having a study with a long follow-up time and a study with a
short follow-up time my results acquire more validity. The quality of the
measurements in my studies is considerably higher than most of the studies that
attempted to address my research hypothesis.
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This dissertation advances the scientific knowledge not only in the area of
psychosocial research, but also in the study of the association between
socioeconomic status and health, and has helped to establish a link between the two
areas. We have seen how mental stress may influence human health though chronic
inflammation and neuroendocrine-immune interactions; but also socioeconomic
status is traditionally seen as a major determinant of health and well-being, and
psychoneuroimmunological processes may contribute to the links between
socioeconomic status and health outcomes. There is extensive population evidence
that socioeconomic status is inversely associated with chronic inflammation indexed
by markers such as C-reactive protein, interleukin-6, and fibrinogen. Both childhood
and adult socioeconomic status contribute to this pattern. Evidence for
socioeconomic status differences in acquired immunity is more sparse, but it also
implicates lower SES in the dysregulation of immune responses. However, while
there is an inverse correlation between SES and seropositivity for common infections
acquired early in the life course that may in turn contribute to low-grade
inflammation in adult life, there is limited experimental data from humans showing
that lower SES is associated with heightened inflammation following acute stress. It
has been argued that SES differences in immunity and inflammation are also
mediated in part by variations in health-related behaviours such as smoking and
energy balance, and by direct stress-related processes, and that longitudinal research
linking SES, psychosocial adversity, immune function, is needed.255 Therefore my
research covers an area of investigation that has been previously indicated as
important and substantially unexplored, and creates important connections between
areas of knowledge.
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Possible explanation of the findings: putting results in context.
Health disparities associated with SES are in part due to differences in the
distribution of basic resources such as health care, nutrition, and sanitary
environments.152 This focus may be particularly relevant to explaining poor health in
groups characterised by poverty, but the effect of SES on health is not only at the
poverty line. Rather, health discrepancies have a monotonic relationship with SES, so
that even relatively affluent groups exhibit worse health than their higher SES
counterparts. Thus, numerous interconnected factors appear to contribute to SES
disparities in health and we have seen how one prominent explanation is that
cognitive and emotional factors and disorders play a role in understanding how low
SES results in augmented risk of morbidity and mortality. But although SES is
consistently related to cognitive and emotional symptoms, which predict worse
health outcomes, these three components cannot be considered to be on a
unidimensional causal cascade to determine a mechanism of mediation. Rather, we
speculate that low levels of tangible, interpersonal, and intrapersonal resources, i.e.
a deficient reserve capacity associated with low SES, may exacerbate the effect of
SES-associated stress on negative emotions and attitudes, recognising that low SES
can both deplete resources and impede the development and restoration of the
resource bank.152 There is indeed evidence that SES is associated with low reserve
capacity. For example, individuals with low SES have access to fewer financial and
material goods, which might otherwise offset tangible stressors such as job loss,
illness, or disability.256 Low-SES environments also contain deficient community
resources, such as safe neighbourhoods, parks, transportation, and child care.257–259 If
present, these resources might reduce chronic or daily stress. SES is also associated
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with diverse aspects of social functioning, including contact with others, network
size, reciprocity in relationships, satisfaction with support, the tendency to seek
social support, work support, and generalized support perceptions. 260–272
Furthermore, neighbourhood as well as individual SES appears to influence social
experiences.273,274 Social stressors typical of low-SES environments (e.g., crowding,
violence, high crime rates) may interfere with the development of supportive
contacts by discouraging interpersonal trust265,275,276 In addition, individuals with low
SES may be vulnerable to factors that could degrade social support and increase
social stress, such as marital instability,277 domestic violence,278–281 substance
abuse,282 and single parenting.283 Furthermore, the association between low
educational attainment and cognitive decline linked to aging is not simply due to the
fact that less educated people have lower mental abilities throughout their lives but
that education encourages the development of a set of reserves that allows more
efficient processing or develops compensatory processes to protect against age-
related decrements in functioning.284,285
My results are therefore consistent with the reserve capacity model proposed by
Matthews and Gallo, which I have detailed in Chapter 1.7. The theory that they have
described from a sociological and a psychological perspective seems to have
implications in the real world and impact on robust clinical outcomes such as heart
disease measured using an epidemiological approach. That model focuses on
interpersonal and intrapersonal resources as modifiers of the effect of environmental
demands and stresses on emotional and physiological responses. Low-SES individuals
may maintain a smaller bank of resources to deal with stressful events when
compared to their higher-SES counterparts.
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The complex pathophysiology of heart disease and the dynamics through which
mental health affects cardiovascular health cannot explain my findings alone. This is
sustained by several arguments: (a) in my first study I have adjusted for coronary
calcification and for factors that link mental stress with heart disease (cytokines,
inflammatory factors, etc.) but the interaction trend remained; (b) in study two, I
carried out an analysis on all-cause mortality along with IHD-mortality (thus including
diseases with different pathophysiology compared to heart disease), and the
interaction was similarly present; (3) in my third study, I adjusted for inflammatory
conditions that are linked with both mental stress and heart disease (osteoarthritis,
osteoporosis) and the interaction remained evident. Although I could not directly
measure the reserve capacities of my study participants, i.e. their interpersonal and
intrapersonal resources, the reserve capacity model is the most plausible explanation
for my study findings, but needs fuller investigation, also in connection with the
clinical determinants of heart disease. Other researchers have in fact tested the
reserve capacity model, with mixed results. For example in a study on socioeconomic
status, cognitive-emotional factors, and health status following myocardial infarction,
partial support for the reserve capacity model emerged: for physical health status,
results supported direct rather than indirect effects of socioeconomic status.286
However, that study had limited sample size (about 2,000) and the data were
analysed using mediation models rather than interaction tests.
A challenge of any model of SES and mental stress is to consider the potential for
bidirectional relationships: emotions and cognitions can influence the availability of
resources, which can alter interpretations of stressful circumstances; there can be a
connection from health outcomes, or intermediate paths, back to emotions and
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cognitions; health endpoints such as IHD can affect the intermediate psychosocial
factors included in the model, as well as socioeconomic standing.287 However, IHD
and premature mortality represent distal health outcomes that typically occur late in
the natural history of disease, well after the usual establishment of socioeconomic
position.
Another potential limitation of the reserve capacity model is the fact that the
supposed interaction operates for all forms of psychosocial adversity in an unspecific
way. On page 77 I showed a diagram for the reserve capacity model (Figure 1.8). In
that representation of the dynamics linking socioeconomic status, psychological
conditions, and physical health, the reserve capacity interferes (line D) in the
association between objective experiences and perceived emotions (line B). In
people with abundant resources, the actual harms are more efficiently buffered and
therefore they raise less negative emotions. However the reserve capacity model
does not disentangle the different types of stimuli and responses. As I have described
in the Introduction of this thesis (p.68), some of the affective and behavioural
conditions that are linked with ischaemic heart disease appear to be different or
sometimes opposite from each other. Anxiety and depression are an example of that.
Anxiety is an unpleasant state that is often accompanied by nervous behaviour and a
feeling of worry that usually lead to overreaction to normal situations (high arousal),
whereas depression is a persistent sadness or low mood with associated loss of
interest in activities and often failure to react to situations (low arousal). In spite of
those differences, both conditions are positively associated with higher chances of
IHD. It has been argued that affective dispositions can overlap and that a general
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disposition toward negative affectivity may be more important for disease risk than
any specific negative affect.107
The reserve capacity model is therefore compatible with the concept of general
disposition toward negative affectivity. My results also support this idea, since I have
tested different exposure variables and got similar results for all of them: cortisol
response to stress (Study one) can be seen as an index of anxious temperament
because it marks physical overreaction to mild stressors; GHQ-12 (Study two),
contains items of both anxiety and depression (see Appendix two for the list of
items); the hopelessness/helplessness index (Study three) includes two items linked
to depression only. The measure in study 3 may be considered as a subtype of the
mental stress measured in study 2 and it may therefore be possible that the results
from study 2 are driven by the same items of study 3. However the effect estimates
from the two studies were similar and this goes against that hypothesis. If the
relevant items were those related to depression only, I would have found higher
estimates in study 3 compared to study 2 because these latter estimates would have
been diluted but the additional presence of less relevant items; if, conversely, the
items related to anxiety were the more relevant I would have found higher estimates
in study 2; if anxiety and depression interacted with each other I would have found
higher estimates in study 2. So the most likely explanation of my results is that
general disposition toward negative affectivity may be more important for disease
risk than any specific negative affect.107 However, my analyses had just enough
power to detect the interaction between mental stress and SES and it therefore likely
that the power to make these finer comparisons between the different dimensions of
mental stress is not enough in my samples and that the similarity in the estimates
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found between studies 2 and 3 may be a chance finding. Moreover, it would have
been interesting to conduct separate analyses for the different items in the GHQ-12
score (anxiety items versus depression items) and compare their results with each
other and with the other studies. Unfortunately we did not have access to the scores
of each individual item.
Cortisol reactivity has been studied in conjunction with very different outcomes, for
example tobacco and alcohol dependence,288–290 exercise addiction,291 depression,292
bulimia,293 and motivation.294 Although it is difficult to see the commonality among
some of these apparently diverse outcomes, it has recently been argued that they all
are different manifestations of the same underlying central corollary of a deficient
peripheral stress response and that all these outcomes, to different degrees, reflect
motivational dysregulation, that is, a dysfunction of the neural systems that support
motivated behavior.294 The results from those studies are apparently opposite from
mine: they imply that low or blunted cardiovascular and/or cortisol reactions to
acute psychological stress are associated with higher occurrence of those conditions.
However, from the perspective of the allostasis theory those results are compatible
with mine. The notion of allostasis has drawn attention to the complex system of
neuroendocrine responses to environmental challenges that is characteristic of living
organisms. It has been conceptualised as the process through which organisms
actively adjust to both predictable and unpredictable external events through the
anabolism and catabolism of mediators, i.e. the way in which they maintain stability
through change.295 From this perspective, serious pathophysiology may occur when
chronic overload resulting from sustained stress stimulates prolonged allostatic
actions that in the long term lose their effectiveness and ability to respond.296 The
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allostatic model suggests that sustained load is characterised by changes in the
morphology of responses that are manifest in chronically-heightened basal levels,
inadequate biological responses (blunted stress reactivity), and impaired post-stress
recovery.297 Study one was carried out on healthy older individuals who have perhaps
not yet encountered prolonged allostatic actions that decreased their reactivity,
whereas the studies that found blunted responses in at-risk people were carried out
on samples drawn from the general population (including diseased people) or
deliberately on people with manifest diseases.
Future work
Mental stress is becoming increasingly recognised as a risk factor and trigger for
heart disease and some experts in the field have argued that the effect that mental
stress has on the likelihood of developing heart disease may have a similar
magnitude compared to that of more conventional risk factors such as high blood
cholesterol and high blood pressure.54,55,167 However, unlike for these other risk
factors, guidelines for screening strategies or preventive cures for mental stress have
never been developed, in spite of this risk factor being very frequent in the general
population and therefore having a large impact on public health. In contemporary
western life-style conditions, mental stress is difficult to avoid or attenuate, unlike
other risk factors for heart disease such as high blood cholesterol, diabetes, etc. for
which effective treatments are available. Risk assessment coupled with tailored
protective intervention is therefore a possible preventive strategy for those
numerous heart attacks and strokes triggered by mental stress and, as a
consequence, mass screening for vulnerability to mental stress would be extremely
beneficial, may have considerable public health effects, and save many lives.
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I have demonstrated that the effect that mental stress exerts on heart disease is not
the same for everybody, and in some individuals it is greatly amplified. In particular I
found that low-income individuals are much more vulnerable to mental stress. While,
for example, the average effect of mental stress for heart disease is mild in the
general population, the estimates diverge after stratification by socioeconomic
status, and I found the effect to be almost null in high-income sectors and strong in
low-income.228,298 It would be valuable to study these interactions more deeply, as
well as other possible interactions, because these results still do not justify the
implementation of targeted interventions. This is due to two reasons: (a) the target
population (low-income sectors) would still be too wide and too difficult to define for
public health interventions; (b) the relative incidence rates are still too small and the
NNT (number needed to treat) to obtain public health benefits would consequently
be too large, and therefore screening would not be cost-effective.
It would be desirable to further restrict the target population to very vulnerable
individuals (higher effects) by answering questions such as: what socioeconomic
aspects are more relevant? What types of mental stress are more deleterious? Are
there any environmental, clinical, or genetic factors that predispose these negative
effects or are independent effect modifiers? Therefore an important long-term
research aim is to identify the demographic, clinical, environmental, and genetic
variables that increase susceptibility to mental stress and may serve to identify
people who are particularly vulnerable to stressful events, so that mass screening
programs and consequent tailored interventions would become feasible, effective,
and cost-effective.
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It is plausible that the resources that modify the effect of mental stress develop
during one’s childhood or may even be genetically determined. Therefore the ideal
resolution to address these issues would be the development of a new birth cohort.
A birth cohort would also have the additional advantage that it would be possible to
assess outcomes other than heart disease, or outcomes that are precursor of heart
disease such as health behaviour or immune dysregulation for example, thus
explaining these interactions not only for the sake of public health policies but also in
terms of basic research in human pathophysiology. However the research that I have
outlined in this thesis does not identify new potential effect modifiers or outcomes or
precursors of outcomes and it would be appropriate to explore other existing
datasets before new cohorts are developed. The results from my present work and
from these eventual new studies may then serve as pilot studies for the development
of a birth cohort to test these specific issues. For these other analyses, one possibility
would be to extract data from UK-Biobank, MINAP, and possibly other databases,
and analyse them prospectively (cohort studies). This means that those databases
would constitute the baseline of cohorts, and incident outcomes would be recorded
during a follow-up time using records from the Hospital Episode Statistics and the
Office for National Statistics, as I have done for the present thesis.
The UK-Biobank questionnaire can be categorised into the following broad topic
areas of interest: sociodemographics and occupation; lifestyle exposures (including
smoking, alcohol, physical activity and diet); early life exposures; psychological state;
cognitive function; family history of illness; and medical history and general health.
Therefore UK-Biobank routinely measure variables related to psychological and
cognitive state. With respect to psychological state, the approach in the UK-Biobank
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questionnaire has been to assess psychological traits and moods based on
standardized questionnaires, and to record serious life events and medical
presentations for psychological symptoms.299
MINAP (Myocardial Ischaemia National Audit Project) is a national clinical audit of
the management of heart attack. It supplies participating hospitals with a record of
their management and compares this with nationally and internationally agreed
standards. MINAP provides comparative data to help clinicians and managers to
monitor and improve the quality and outcomes of their local services. Although the
main focus of my proposed research is on healthy people for the primary prevention
of cardiovascular acute events due to mental stress and not on patients, it is
biologically plausible that patients’ recovery from those events, their prognosis, and
their reoccurrence rates also depend on mental stress and on its interactions with
other clinical, environmental, and genetic factors. MINAP has a dedicated section for
heart conditions that do not require coronary intervention such as the increasingly
recognised syndrome of Takotsubo cardiomyopathy.300 This condition, presenting as
a heart attack – often following an extremely stressful event – appears not to be
related to coronary artery occlusion at all. Rather the heart damage, from which a full
recovery is possible, is driven by the effects of naturally occurring though excessive
catecholamine (e.g. adrenaline) stimulation due to mental stress.189,301 MINAP now
provides additional detailed information about such cases300 and therefore MINAP
will be an excellent source of data for a new research project.
179
Conclusion
In this thesis I have shown the potential importance of the interaction between SES
and stress for understanding human disease and cardiovascular disease in particular.
The epidemiological approach to investigating these issues has proven to be valid
compared to other approaches such as clinical and animal research, especially with
regards to statistical power in the ascertainment of hard endpoints. I hope that this
research programme will stimulate new work focused on understanding the
processes better at a mechanistic level, on devising instruments that will identify
vulnerable individuals with greater precision, and on developing interventions aimed
at reducing these negative influences on health and survival.
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Appendix 1 - Sensitivity analyses for Study 1.
This appendix presents the results from sensitivity analyses carried out for Study 1.
The multiple logistic regression models for the association between salivary cortisol
response to standard laboratory mental stress tasks and plasma detectable high-
sensitivity cardiac troponin T were conducted using different settings. For each table,
the changed setting is underlined.
Multiple logistic regression models for the association between salivary cortisol
response to standard laboratory mental stress tasks (continuous exposure variable
calculated as the difference between post-tasks and pre-task values) and plasma
detectable high-sensitivity cardiac troponin T (binary outcome).
Model for detectable HS-cTnT (outcome) OR for cortisol response(exposure) P (95% CI)
Crude association 1.10 0.004 (1.03 1.17)
Adjusted* 3.68 0.001 (1.75 7.76)
*Adjusted for baseline salivary cortisol (pre-task), time of the session (am or pm), age, gender, smoking, systolic
blood pressure, total cholesterol/HDL ratio, and glycated haemoglobin, CRP, IL-6 and coronary calcification score,
treated as a binary variable with cut-off at 0. This level of adjustment is parallel to Model 6a in Table 5.3
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Multiple logistic regression models for the association between salivary cortisol
response to standard laboratory mental stress tasks (continuous exposure variable
calculated as the ratio between post-tasks and pre-task values) and plasma
detectable high-sensitivity cardiac troponin T (binary outcome).
Model for detectable HS-cTnT (outcome)
OR for cortisol response
(exposure) P (95% CI)
Crude association 1.38 0.005 (1.10 1.73)
Adjusted* 1.13 0.024 (1.03 1.23)
*Adjusted for baseline salivary cortisol (pre-task), time of the session (am or pm), age, gender, smoking, systolic
blood pressure, total cholesterol/HDL ratio, and glycated haemoglobin, CRP, IL-6 and coronary calcification score,
treated as a binary variable with cut-off at 0. This level of adjustment is parallel to Model 6a in Table 5.3
Multiple logistic regression models for the association between salivary cortisol
response to standard laboratory mental stress tasks (binary exposure) and plasma
detectable high-sensitivity cardiac troponin T (binary outcome).
Model for detectable HS-cTnT (outcome) OR for cortisol response(exposure) P (95% CI)
Adjusted* 1.13 0.024 (1.03 1.23)
*Adjusted for baseline salivary cortisol (pre-task), time of the session (am or pm), age, gender, smoking, systolic
blood pressure, total cholesterol/HDL ratio, and glycated haemoglobin, CRP, IL-6, coronary calcification score treated
as a binary variable with cut-off at 0, physical activity, BMI, diastolic blood pressure, triglycerides, LDL, and alcohol
consumption.
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Multiple logistic regression models for the association between salivary cortisol
response to standard laboratory mental stress tasks (binary exposure) and plasma
detectable high-sensitivity cardiac troponin T (binary outcome), restricted to male
participants.
Model for detectable HS-cTnT (outcome) OR for cortisol response(exposure) P (95% CI)
Crude association 1.15 0.008 (1.12 8.75)
Adjusted* 1.98 0.007 (1.24 9.00)
*Adjusted for baseline salivary cortisol (pre-task), time of the session (am or pm), age, gender, smoking, systolic
blood pressure, total cholesterol/HDL ratio, and glycated haemoglobin, CRP, IL-6 and coronary calcification score,
treated as a binary variable with cut-off at 0. This level of adjustment is parallel to Model 6a in Table 5.3
Multiple logistic regression models for the association between salivary cortisol
response to standard laboratory mental stress tasks (binary exposure) and plasma
detectable high-sensitivity cardiac troponin T (binary outcome), restricted to female
participants.
Model for detectable HS-cTnT (outcome) OR for cortisol response(exposure) P (95% CI)
Crude association 3.56 <0.001 (1.96 9.62)
Adjusted* 5.80 0.001 (2.14 21.70)
*Adjusted for baseline salivary cortisol (pre-task), time of the session (am or pm), age, gender, smoking, systolic
blood pressure, total cholesterol/HDL ratio, and glycated haemoglobin, CRP, IL-6 and coronary calcification score,
treated as a binary variable with cut-off at 0. This level of adjustment is parallel to Model 6a in Table 5.3
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Appendix 2 - The 12-item General Health Questionnaire.
Twelve-item General Health Questionnaire
We want to know how your health has been in general over the last few weeks.
Please read the questions below and each of the four possible answers.
Circle the response that best applies to you.
Thank you for answering all the questions.
Have you recently:
1 - been able to concentrate on whatyou’re doing?
Better than
usual
Same as
usual
Less than
usual
Much less
than usual
2 - lost much sleep over worry? Not at all No morethan usual
Rather more
than usual
Much more
than usual
3 - felt that you are playing a useful partin things?
More so than
usual
Same as
usual
Less so than
usual
Much less
than usual
4 -
felt capable of making decisions about
things?
More so than
usual
Same as
usual
Less so than
usual
Much less
than usual
5 - felt constantly under strain? Not at all No morethan usual
Rather more
than usual
Much more
than usual
6 - felt you couldn’t overcome your
difficulties?
Not at all No more
than usual
Rather more
than usual
Much more
than usual
7 - been able to enjoy your normal day today activities?
More so than
usual
Same as
usual
Less so than
usual
Much less
than usual
8 - been able to face up to your
problems?
More so than
usual
Same as
usual
Less so than
usual
Much less
than usual
9 - been feeling unhappy or depressed? Not at all No morethan usual
Rather more
than usual
Much more
than usual
10 - been losing confidence in yourself? Not at all No morethan usual
Rather more
than usual
Much more
than usual
11 -
been thinking of yourself as a
worthless person? Not at all
No more
than usual
Rather more
than usual
Much more
than usual
12 - been feeling reasonably happy, allthings considered?
More so than
usual
Same as
usual
Less so than
usual
Much less
than usual
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Appendix 3 - Sensitivity analyses for Study 2.
This appendix presents the results from sensitivity analyses carried out for Study 2.
They are multiple Cox regression models for the association of mental stress (GHQ-
12), socioeconomic status (profession), and an interaction parameter with either IHD
mortality or all-cause mortality.
Modified Table 6.7 (two more covariates were included). Multivariate Cox regression model
showing hazard ratios, 95% confidence intervals, and P values for all-cause mortality.
Factor at the beginning of the follow-up
Mutually-adjusted all-cause mortality
HR (95%CI) P
Unit increase in GHQ-12 (3 categories) 1.28 (1.12 1.47) <0.001
Unit increase in SES going from high to low (3 categories) 1.20 (1.07 1.34) 0.001
Interaction SESxGHQ-12 (3x3) 1.07 (1.01 1.11) 0.047
Gender male 1.58 (1.47 1.70) <0.001
One-year increase in age 1.11 (1.10 1.11) <0.001
Current smoking 1.43 (1.32 1.54) <0.001
BMI <18.5 versus BMI 18.5-29.9 2.61 (2.08 3.27) <0.001
BMI 30+ versus BMI 18.5-29.9 1.00 (0.92 1.09) 0.963
Diabetes 1.48 (1.28 1.71) <0.001
Physical activity 0.94 (0.92 0.96) <0.001
Hypertension 1.15 (1.06 1.24) <0.001
The interaction between SES and GHQ-12 was calculated manually.
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Modified Table 6.8 (two more covariates were included). Multivariate Cox regression model
showing hazard ratios, 95% confidence intervals, and P values for IHD mortality.
Factor at the beginning of the follow-up
Mutually-adjusted IHD mortality
HR (95%CI) P
Unit increase in GHQ-12 (3 categories) 1.19 (1.02 1.89) 0.039
Unit increase in SES going from high to low (3 categories) 1.21 (1.05 2.15) 0.024
Interaction SESxGHQ-12 (3x3) 1.05 (1.00 1.14) 0.052
Gender male 2.36 (1.91 2.93) <0.001
One-year increase in age 1.11 (1.10 1.12) <0.001
Current smoking 1.29 (1.04 1.60) 0.023
Unit increase in BMI 1.03 (1.00 1.05) 0.021
Diabetes 2.69 (1.95 3.73) <0.001
Physical activity 0.93 (0.87 0.99) 0.020
Hypertension 1.12 (0.90 1.39) 0.325
The interaction between SES and GHQ-12 was calculated manually.
Modified Table 6.7 (the analysis was restricted to females). Multivariate Cox regression
model showing hazard ratios, 95% confidence intervals, and P values for all-cause mortality.
Factor at the beginning of the follow-up
Mutually-adjusted all-cause mortality
HR (95%CI) P
Unit increase in GHQ-12 (3 categories) 1.23 (1.06 1.43) 0.005
Unit increase in SES going from high to low (3 categories) 1.19 (1.06 1.34) 0.003
Interaction SESxGHQ-12 (3x3) 1.02 (1.00 1.04) 0.049
One-year increase in age 1.11 (1.11 1.12) <0.001
Current smoking 1.50 (1.40 1.61) <0.001
BMI <18.5 versus BMI 18.5-29.9 2.63 (2.19 3.17) <0.001
BMI 30+ versus BMI 18.5-29.9 0.99 (0.91 1.07) 0.763
Diabetes 1.75 (1.51 2.05) <0.001
The interaction between SES and GHQ-12 was calculated manually.
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Modified Table 6.8 (the analysis was restricted to females). Multivariate Cox regression
model showing hazard ratios, 95% confidence intervals, and P values for IHD mortality.
Factor at the beginning of the follow-up
Mutually-adjusted IHD mortality
HR 95%CI P
Unit increase in GHQ-12 (3 categories) 1.27 (1.20 1.35) 0.031
Unit increase in SES going from high to low (3 categories) 1.21 (1.15 1.30) 0.030
Interaction SESxGHQ-12 (3x3) 1.01 (0.99 1.03) 0.077
One-year increase in age 1.13 (1.12 1.14) 0.000
Current smoking 1.58 (1.27 1.97) 0.000
Unit increase in BMI 1.01 (0.99 1.03) 0.428
Diabetes 3.82 (2.70 5.40) 0.000
The interaction between SES and GHQ-12 was calculated manually.
Modified Table 6.7 (the analysis was restricted to males). Multivariate Cox regression model
showing hazard ratios, 95% confidence intervals, and P values for all-cause mortality.
Factor at the beginning of the follow-up
Mutually-adjusted all-cause mortality
HR (95%CI) P
Unit increase in GHQ-12 (3 categories) 1.35 (1.18 1.54) <0.001
Unit increase in SES going from high to low (3 categories) 1.28 (1.15 1.43) <0.001
Interaction SESxGHQ-12 (3x3) 1.03 (1.01 1.05) 0.038
One-year increase in age 1.11 (1.11 1.11) <0.001
Current smoking 1.49 (1.37 1.62) <0.001
BMI <18.5 versus BMI 18.5-29.9 2.66 (1.95 3.62) <0.001
BMI 30+ versus BMI 18.5-29.9 1.08 (0.99 1.17) 0.090
Diabetes 1.47 (1.29 1.67) <0.001
The interaction between SES and GHQ-12 was calculated manually.
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Modified Table 6.8 (the analysis was restricted to males). Multivariate Cox regression model
showing hazard ratios, 95% confidence intervals, and P values for IHD mortality.
Factor at the beginning of the follow-up
Mutually-adjusted IHD mortality
HR 95%CI P
Unit increase in GHQ-12 (3 categories) 1.10 (1.05 1.15) 0.006
Unit increase in SES going from high to low (3 categories) 1.07 (1.02 1.14) 0.006
Interaction SESxGHQ-12 (3x3) 1.08 (1.02 1.14) 0.037
One-year increase in age 1.11 (1.10 1.12) 0.000
Current smoking 1.48 (1.19 1.84) 0.000
Unit increase in BMI 1.04 (1.02 1.06) 0.000
Diabetes 1.92 (1.41 2.62) 0.000
The interaction between SES and GHQ-12 was calculated manually.
Modified Table 6.7 (the analysis was restricted to the participants who have not experience
the outcome within one year from recruitment). Multivariate Cox regression model
showing hazard ratios, 95% confidence intervals, and P values for all-cause mortality.
Factor at the beginning of the follow-up
Mutually-adjusted all-cause mortality
HR (95%CI) P
Unit increase in GHQ-12 (3 categories) 1.28 (1.16 1.42) <0.001
Unit increase in SES going from high to low (3 categories) 1.26 (1.16 1.36) <0.001
Interaction SESxGHQ-12 (3x3) 1.04 (1.02 1.06) 0.010
Gender male 1.50 (1.42 1.58) <0.001
One-year increase in age 1.11 (1.11 1.11) <0.001
Current smoking 1.47 (1.39 1.55) <0.001
BMI <18.5 versus BMI 18.5-29.9 2.52 (2.12 2.98) <0.001
BMI 30+ versus BMI 18.5-29.9 1.05 (0.98 1.11) 0.151
Diabetes 1.60 (1.44 1.77) <0.001
The interaction between SES and GHQ-12 was calculated manually.
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Modified Table 6.8 (the analysis was restricted to the participants who have not experience
the outcome within one year from recruitment). Multivariate Cox regression model
showing hazard ratios, 95% confidence intervals, and P values for IHD mortality.
Factor at the beginning of the follow-up
Mutually-adjusted IHD mortality
HR 95%CI P
Unit increase in GHQ-12 (3 categories) 1.22 (1.12 1.32) 0.017
Unit increase in SES going from high to low (3 categories) 1.17 (1.08 1.13) 0.016
Interaction SESxGHQ-12 (3x3) 1.02 (1.00 1.04) 0.048
Gender male 2.13 (1.83 2.48) <0.001
One-year increase in age 1.12 (1.11 1.12) <0.001
Current smoking 1.50 (1.28 1.75) <0.001
Unit increase in BMI 1.03 (1.01 1.05) <0.001
Diabetes 2.52 (1.99 3.19) <0.001
The interaction between SES and GHQ-12 was calculated manually.
Modified Table 6.7 (the analysis was rerun after recoding GHQ-12 missing value to valid
values scoring 4). Multivariate Cox regression model showing hazard ratios, 95% confidence
intervals, and P values for all-cause mortality.
Factor at the beginning of the follow-up
Mutually-adjusted all-cause mortality
HR (95%CI) P
Unit increase in GHQ-12 (3 categories) 1.39 (1.27 1.51) <0.001
Unit increase in SES going from high to low (3 categories) 1.20 (1.15 1.25) <0.001
Interaction SESxGHQ-12 (3x3) 1.07 (1.02 1.11) 0.019
Gender male 1.46 (1.39 1.53) <0.001
One-year increase in age 1.12 (1.12 1.12) <0.001
Current smoking 1.41 (1.34 1.48) <0.001
BMI <18.5 versus BMI 18.5-29.9 2.38 (2.03 2.79) <0.001
BMI 30+ versus BMI 18.5-29.9 1.09 (1.03 1.16) 0.006
Diabetes 1.65 (1.51 1.80) <0.001
The interaction between SES and GHQ-12 was calculated manually.
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Modified Table 6.8 (the analysis was rerun after recoding GHQ-12 missing value to valid
values scoring 4). Multivariate Cox regression model showing hazard ratios, 95% confidence
intervals, and P values for IHD mortality.
Factor at the beginning of the follow-up
Mutually-adjusted IHD mortality
HR 95%CI P
Unit increase in GHQ-12 (3 categories) 1.19 (1.16 1.30) <0.001
Unit increase in SES going from high to low (3 categories) 1.16 (1.14 1.18) <0.001
Interaction SESxGHQ-12 (3x3) 1.04 (1.02 1.06) 0.034
Gender male 2.13 (1.84 2.47) <0.001
One-year increase in age 1.10 (1.09 1.11) <0.001
Current smoking 1.50 (1.28 1.75) <0.001
Unit increase in BMI 1.03 (1.02 1.05) 0.003
Diabetes 2.53 (2.01 3.18) <0.001
The interaction between SES and GHQ-12 was calculated manually.
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Appendix 4 - Example of Nelson-Aalen plot
This figure shows an example of a Nelson-Aalen plot, created to give a visual
impression of the proportionality of a hazard function during the follow-up time, i.e.
to see if the effect of a variable on an outcome is stable throughout the follow-up
time. A bias is introduced if the effect of a risk factor on an outcome changes after a
certain time. In this example, mental stress (GHQ-12) is the risk factor and all-cause
mortality is the outcome. The X-axis shows the follow-up time in years and the Y-axis
the cumulative hazard on a logarithmic scale. The cumulative hazard ratio is
represented by the distance between the two lines. The dotted line (high mental
stress) is always above (higher hazard) than the solid line (low mental stress), and the
two lines run roughly in parallel, thus the proportionality assumption is satisfied.
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Appendix 5 - Sensitivity analysis for Study 3.
This appendix presents the results from a sensitivity analysis carried out for Study 3.
The multivariate Cox regression model for the association between
hopelessness/helplessness index (used as a marker of mental stress), the index of
multiple deprivation (used as a marker of socioeconomic status), and a multiplication
of those two factors (interaction) for the determination of hospitalisation for acute
ischemic heart disease event was restricted to participants who experienced the
outcome at least after six month from recruitment.
Modified Table 7.5 (the analysis was restricted to participants who experienced the
outcome at least after six months from recruitment). Multivariate Cox regression model
showing adjusted hazard ratios, 95% confidence intervals, and P values for IHD event
incidence.
Variable at the beginning of the follow-up Mutually-adjustedHR for IHD event 95%CI P
HH Index (one point increase) 1.12 (1.01 1.24) 0.030
IMD Index (one decile increase) 1.07 (1.01 1.14) 0.029
Continuous interaction between IMD and HH 1.03 (1.01 1.04) 0.039
Age (one year increase) 1.05 (1.04 1.07) <0.001
Current Smoker 1.28 (1.07 1.53) 0.007
High Blood Pressure 1.45 (1.19 1.76) <0.001
Osteoarthritis 1.39 (1.13 1.72) 0.002
Osteoporosis 1.36 (1.00 1.85) 0.052
BMI (one unit increase) 1.03 (1.01 1.05) 0.002
High blood cholesterol 1.31 (1.07 1.61) 0.009
The interaction between HH and IMD was calculated manually.
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Appendix 6 – Study 3 - Histogram of the
Hopelessness/Helplessness Index.
Histogram of the Hopelessness/Helplessness Index for 80,197 participants drawn
from the United Kingdom Collaborative Trial of Ovarian Cancer Screening
(UKCTOCS) study, recruited from July 2005 to December 2012.
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